ACL 

  1. Gueneuc A, Bertin GI, Deloron P. Usefulness of a biomarker to identify placental dysfunction in the context of malaria. Malaria J, 2017, 16:11.
  2. Develoux M, Hennequin C, Le Loup G, Paris L, Magne D, Belkadi G, Pialoux G. Imported filariasis in Europe: A series of 31 cases from Metropolitan France. Eur J Intern Med, 2017, 37:e37-e39.
  3. d’Almeida TC, Sadissou I, Milet J, Cottrell G, Mondière A, Avokpaho E, Gineau L, Sabbagh A, Massougbodji A, Moutairou K, Donadi EA, Favier B, Carosella E, Moreau P, Rouas-Freiss N, Courtin D, Garcia A. Soluble human leukocyte antigen -G during pregnancy and infancy in Benin: Mother/child resemblance and association with the risk of malaria infection and low birth weight. PLoS One, 2017, 12:e0171117.
  4. Duval R, Duplais C. Fluorescent natural products as probes and tracers in biology. Nat Prod Rep, 2017, 34:161-93.
  5. Argy N, Bertin GI, Milet J, Hubert V, Clain J, Cojean S, Houzé P, Tuikue-Ndam N, Kendjo E, Deloron P, Houzé S and the FNRCM study group. Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum Erythrocyte Membrane Protein 1 in severe french imported malaria. Clin Microbiol Infect, 2017, 23:e1-211.e4.
  6. Lennartz F, Adams Y, Bengtsson A, Olsen RW, Turner L, Ndam NT, Ecklu-Mensah G, Moussiliou A, Ofori MF, Gamain B, Lusingu JP, Petersen JE, Wang CW, Nunes-Silva S, Jespersen JS, Lau CK, Theander TG, Lavstsen T, Hviid L, Higgins MK, Jensen AT. Structure-guided identification of a family of dual receptor-binding PfEMP1 that is associated with cerebral malaria. Cell Host Microbe, 2017, 21:403-14.
  7. Houzé S. [Rapid diagnostic test for malaria]. Bull Soc Pathol Exot, 2017, 110:49-54.
  8. Kurz X, Bauchau V, Mahy P, Glismann S, van der Aa LM, Simondon F; ADVANCE consortium. The ADVANCE Code of Conduct for collaborative vaccine studies. Vaccine. 2017, 35:1844-55.
  9. Barbosa AN, Boyer L, Chippaux JP, Medolago NB, Caramori CA, Paixão AG, Poli JP, Mendes MB, Dos Santos LD, Ferreira RS Jr, Barraviera B. A clinical trial protocol to treat massive Africanized honeybee (Apis mellifera) attack with a new apilic antivenom. J Venom Anim Toxins Incl Trop Dis, 2017, 23:14.
  10. Tuikue Ndam N, Basco LK, Foumane Ngane V, Ayouba H, Ngolle EM, Deloron P, Peeters M, Tahar R. Reemergence of chloroquine sensitive pfcrt K76 Plasmodium falciparum genotype in Southern East Cameroon. Malaria J, 2017, 16:130.
  11. Argy N, Kendjo E, Auge-Courtoi C, Cojean S, Clain J, Houzé P, Thellier M, Hubert V, Deloron P, Houzé S and the CNRP study group. Influence of host factors and parasite biomass on the severity of imported Plasmodium falciparum PLoS One, 2017, 12:e0175328.
  12. Aurégan C, Argy N, Hubert V, Aprahamian A, Clain J, Cheron G. [Acquisition of atovaquone-proguanil resistance in imported falciparum malaria in a young child]. Presse Med, 2017, 46:344-6.
  13. Tétard M, Milet J, Dechavanne S, Fievet N, Dorin-Semblat D, Elion J, Fairhurst R, Deloron P, Tuikue-Ndam N, Gamain B. Heterozygous HbC and not HbS is associated with higher newborn birthweight among women with pregnancy-associated malaria. Sci Rep, 2017, 7:1414.
  14. Dambrun M, Dechavanne C, Emmanuel A, Aussenac F, Leduc M, Giangrande C, Vinh J, Dugoujon JM, Lefranc MP, Guillonneau F, Migot-Nabias F. Human immunoglobulin heavy gamma chain polymorphisms: molecular confirmation of proteomic assessment. Mol Cell Proteomics, 2017, 16:824-39.
  15. Patin E, Lopez M, Grollemund R, Verdu P, Harmant C, Quach H, Laval G, Perry GH, Barreiro LB, Froment A, Heyer E, Massougbodji A, Fortes-Lima C, Migot-Nabias F, Bellis G, Dugoujon JM, Pereira JB, Fernandes V, Pereira L, Van der Veen L, Mouguiama-Daouda P, Bustamante CD, Hombert JM, Quintana-Murci L.   Dispersals and genetic adaptation of Bantu-speaking populations in Africa and North America. Science, 2017, 356:543-6.
  16. Derrough T, Olsson K, Gianfredi V, Simondon V, Hejbel H, Danielsson N, Pastore-Celentano L. Survey on the EU Member States’ experiences with Immunisation Information Systems. Euro Surveill, 2017, 22:17.
  17. Day KP, Artzy-Randrup Y, Tiedje KE, Rougeron V, Chen D, Rask TS, Rorick MM, Migot-Nabias F, Deloron P, Luty AJF, Pascual M. Evidence of strain structure in Plasmodium falciparum var gene repertoires in children from Gabon, West Africa. Proc Natl Acad Sci USA, 2017, 114:E4103-11.
  18. Gbedande K, Fievet N, Viwami F, Ezinmegnon S, Issifou S, Chippaux JP, Dossou Y, Moutairou K, Massougbodji A, Tuikue Ndam N, de Jongh W, Soegaard M, Salanti A, Nielsen MA, Esen M, Mordmuller B, Deloron P, Luty AJF. Clinical development of a VAR2CSA-based placental malaria vaccine PamVac: quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae. Vaccine, 2017, sous presse.
  19. Tuikue Ndam N, Moussiliou A, Lavstsen T, Kamaliddin C, Jensen ATR, Mama A, Wang CW, Jespersen JS, Viwami F, Alao JM, Gamain B, Theander TG, Deloron P. Parasites causing cerebral falciparum malaria bind multiple endothelial receptors and express EPCR and ICAM1-binding PfEMP1. J Infect Dis, 2017, sous presse.

ACL

  1. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E. Serological diagnosis of Toxoplasma gondii infection: recommendations from the French National Reference Center for Toxoplasmosis. Diagn Microbiol Infect Dis, 2016, 84:22-33.
  2. Lin Ouédraogo A, Gonçalves BP, Gnémé A, Wenger EA, Guelbeogo MW, Ouédraogo A, Gerardin J, Bever CA, Lyons H, Pitroipa X, Verhave JP, Eckhoff PA, Drakeley C, Sauerwein R, Luty AJ, Kouyaté B, Bousema T. Dynamics of the human infectious reservoir for malaria determined by mosquito feeding assays and ultra-sensitive malaria diagnosis in Burkina Faso. J Infect Dis, 2016, 213:90-9.
  3. Dominiak-Felden G, Gobbo C, Simondon F. Evaluating the early benefit of quadrivalent HPV vaccine on genital warts in Belgium. A cohort study. PLoS One, 2016, 11:e0148665.
  4. Marcelon L, Verstraeten T, Dominiak-Felden G, Simondon F. Quantitative benefit-risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in males. Expert Rev Vaccines, 2016, 15:139-48.
  5. Lecarpentier E, Bhatt M, Bertin GI, Deloison B, Salomon LJ, Lai Kuen R, Deloron P, Fournier T, Barakat A, Tsatsaris V. Computational fluid dynamic simulations of maternal circulation: wall shear stress in the human placenta and its biological implications. PLoS One, 2016, 11:e0147262.
  6. Moya-Alvarez V, Mireku MO, Ayotte P, Cot M, Bodeau-Livinec F. Elevated blood lead levels are associated with reduced risk of malaria in beninese infants. PLoS One, 2016, 11:e0149049.
  7. Luty AJ, Elliott AM. Tackling neglect: treating schistosomiasis in pregnancy. Lancet Infect Dis, 2016, 16:137-9.
  8. d’Almeida T, Sadissou I, Cottrell G, Tahar R, Moreau P, Favier B, Moutairou K, Donadi EA, Massougbodji A, Rouas-Freiss N, Courtin D, Garcia A. Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis. Malaria J, 2016, 15:78.
  9. Souza JP, Betran AP, Dumont A, de Mucio B, Gibbs Pickens CM, Deneux-Tharaux C, Ortiz-Panozo E, Sullivan E, Ota E, Togoobaatar G, Carroli G, Knight H, Zhang J, Cecatti JG, Vogel JP, Jayaratne K, Leal MC, Gissler M, Morisaki N, Lack N, Oladapo OT, Tunçalp Ö, Lumbiganon P, Mori R, Quintana S, Costa Passos AD, Marcolin AC, Zongo A, Blondel B, Hernández B, Hogue CJ, Prunet C, Landman C, Ochir C, Cuesta C, Pileggi-Castro C, Walker D, Alves D, Abalos E, Moises E, Vieira EM, Duarte G, Perdona G, Gurol-Urganci I, Takahiko K, Moscovici L, Campodonico L, Oliveira-Ciabati L, Laopaiboon M, Danansuriya M, Nakamura-Pereira M, Costa ML, Torloni MR, Kramer MR, Borges P, Olkhanud PB, Pérez-Cuevas R, Agampodi SB, Mittal S, Serruya S, Bataglia V, Li Z, Temmerman M, Gülmezoglu AM. A global reference for caesarean section rates (C-Model): a multicountry cross-sectional study. BJOG, 2016, 123:427-36.
  10. Laude A, Valot S, Desoubeaux G, Argy N, Nourrisson C, Pomares C, Machouart M, Le Govic Y, Dalle F, Botterel F, Bourgeois N, Cateau E, Leterrier M, Le Pape P, Morio F. Is real-time PCR-based diagnosis similar in performance to routine parasitological examination for the identification of Giardia intestinalis, Cryptosporidium parvum/Cryptosporidium hominis and Entamoeba histolytica from stool samples? Evaluation of a new commercial multiplex PCR assay and literature review. Clin Microbiol Infect, 2016, 22:e1-8.
  11. Milet J, Sabbagh A, Migot-Nabias F, Luty AJ, Gaye O, Garcia A, Courtin D. Genome-wide association study of antibody responses to Plasmodium falciparum candidate vaccine antigens. Genes Immun, 2016, 17:110-7.
  12. Rupérez M, González R, Mombo-Ngoma G, Kabanywanyi AM, Sevene E, Ouédraogo S, Kakolwa MA, Vala A, Accrombessi M, Briand V, Aponte JJ, Manego Zoleko R, Adegnika AA, Cot M, Kremsner PG, Massougbodji A, Abdulla S, Ramharter M, Macete E, Menéndez C. Mortality, morbidity, and developmental outcomes in infants born to women who received either mefloquine or sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy: a cohort study. PLoS Med, 2016, 13:e1001964.
  13. Bureau-Point E, 2016, Anthropologie du médicament au Sud. La pharmaceuticalisation à ses marges, L’Homme, n° 218.
  14. Bodeau-Livinec F, Glorennec P, Cot M, Dumas P, Durand S, Massougbodji A, Ayotte P, Le Bot B. Elevated blood lead levels in infants and mothers in Benin and potential sources of exposure. Int J Environ Res Public Health, 2016, 13:316.
  15. Chafiq F, El Hattimy F, Rhalem N, Chippaux JP, Soulaymani A, Mokhtari A, Soulaymani-Bencheikh R. Snakebites notified to the poison control center of Morocco between 2009 and 2013 J Venom Anim Toxins Incl Trop Dis, 2016, 22:190.e1-8.
  16. Lam A, Camara B, Kane O, Diouf A, Chippaux JP. Epidemiology of snakebites in Kédougou region (eastern Senegal): comparison of various methods for assessment of incidence and mortality. J Venom Anim Toxins Incl Trop Dis, 2016, 22:8.
  17. Gampini S, Nassouri S, Chippaux JP, Semde R. Retrospective study on the incidence of envenomation and accessibility to antivenom in Burkina Faso. J Venom Anim Toxins Incl Trop Dis, 2016, 22:9.
  18. Chippaux JP, Akaffou MH, Allali BK, Dosso M, Massougbodji A, Barraviera B. The 6th international conference on envenomation by Snakebites and Scorpion Stings in Africa: a crucial step for the management of envenomation. J Venom Anim Toxins Incl Trop Dis, 2016, 22:10.
  19. Brembilla A, Mauny F, Garcia A, Koura GK, Deloron P, Faucher JF. Antibiotics usage in infants during the first 18 months of life in Benin: a population-based cohort study. Eur J Clin Microbiol Infect Dis, 2016, 35:681-9.
  20. Tchaou BA, Savi de Tové KM, Sissinto-Savi de Tové Y, Djomga AT, Aguemon AR, Massougbodji A, Chippaux JP. Contribution of ultrasonography to the diagnosis of internal bleeding in snakebite envenomation. J Venom Anim Toxins Incl Trop Dis, 2016, 22:13.
  21. Andriantsoanirina V, Fang F, Ariey F, Izri A, Foulet F, Botterel F, Bernigaud C, Chosidow O, Huang W, Guillot J, Durand R. Are humans the initial source of canine mange? Parasit Vectors, 2016, 9:177.
  22. Hamza M, Idris MA, Maiyaki MB, Lamorde M, Chippaux JP, Warrell DA, Kuznik A, Habib AG. Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa. PLoS Negl Trop Dis, 2016, 10:e0004568.
  23. Torrado-Carvajal A, Herraiz JL, Alcain E, Montemayor AS, Garcia-Cañamaque L, Hernandez-Tamames JA, Rozenholc Y, Malpica N. Fast patch-based pseudo-CT synthesis from T1-weighted MR images for PET/MR attenuation correction in brain studies. J Nucl Med, 2016, 57:136-43.
  24. Adamou R, Chénou F, Sadissou I, Sonon P, Dechavanne C, Djilali-Saïah A, Cottrell G, Port AL, Massougbodji A, Remarque EJ, Luty AJ, Sanni A, Garcia A, Migot-Nabias F, Milet J, Courtin D. Plasmodium falciparum infection and age influence parasite growth inhibition mediated by IgG in Beninese infants. Acta Trop, 2016, 159:111-9.
  25. Chippaux JP, Akaffou M, Allali B, Dosso M, Massougbodji A.   The 6th International Conference on snakebites and scorpion stings envenoming in Africa: a crucial step for the management of envenoming. Med Sante Trop, 2016, 26:8-9.
  26. Bandje K, Naissant B, Bigey P, Lohezic M, Vayssières M, Blaud N, Kermasson L, Lopez-Rubio JJ, Langsley G, Lavazec C, Deloron P, Merckx A. Characterization of an A-kinase anchoring protein-like suggests an alternative way of PKA anchoring in Plasmodium falciparum. Malaria J, 2016, 15:248.
  27. Ilboudo H, Jamonneau V, Koffi M, Kaboré J, Amoussa R, Holzmuller P, Garcia A, Bucheton B, Courtin D. Trypanosome-induced Interferon-γ production in whole blood stimulation assays is associated with latent Trypanosoma brucei gambiense Microbes Infect, 2016, 18:436-40.
  28. WWARN Gametocyte Study Group (dont Cot M, Deloron P et Faucher JF). Gametocyte carriage in uncomplicated Plasmodium falciparum malaria following treatment with artemisinin combination therapy: a systematic review and meta-analysis of individual patient data. BMC Med, 2016, 14:79.
  29. Bertin GI, Sabbagh A, Argy N, Salnot V, Ezimegnon S, Agbota G, Ladipo Y, Alao JM, Sagbo G, Guillonneau F, Deloron P. Proteomic analysis of Plasmodium falciparum parasites from patients with cerebral and uncomplicated malaria. Sci Rep, 2016, 6:26773.
  30. Boels D, Le Roux G, De Haro L, Sapori JM, Quistinic P, Chippaux JP, Harry P. The French snake antivenom bank. Clin Toxicol, 2016, 54:511.
  31. Casalino E, Etienne A, Mentré F, Houzé S; Imported Malaria Hospitalization Study Group. Hospitalization and ambulatory care in imported-malaria: evaluation of trends and impact on mortality. A prospective multicentric 14-year observational study. Malar J, 2016, 15:312.
  32. Naissant B, Dupuy F, Duffier Y, Lorthiois A, Duez J, Scholz J, Buffet P, Merckx A, Bachmann A, Lavazec C. Plasmodium falciparum STEVOR phosphorylation regulates host erythrocyte deformability enabling malaria parasite transmission. Blood, 2016, 127:e42-53.
  33. Ménard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, Rahim-Awab G, Barnadas C, Berry A, Boum Y, Bustos MD, Cao J, Chen JH, Collet L, Cui L, Thakur GD, Dieye A, Djallé D, Dorkenoo MA, Eboumbou-Moukoko CE, Espino FE, Fandeur T, Ferreira-da-Cruz MF, Fola AA, Fuehrer HP, Hassan AM, Herrera S, Hongvanthong B, Houzé S, Ibrahim ML, Jahirul-Karim M, Jiang L, Kano S, Ali-Khan W, Khanthavong M, Kremsner PG, Lacerda M, Leang R, Leelawong M, Li M, Lin K, Mazarati JB, Ménard S, Morlais I, Muhindo-Mavoko H, Musset L, Na-Bangchang K, Nambozi M, Niaré K, Noedl H, Ouédraogo JB, Pillai DR, Pradines B, Quang-Phuc B, Ramharter M, Randrianarivelojosia M, Sattabongkot J, Sheikh-Omar A, Silué KD, Sirima SB, Sutherland C, Syafruddin D, Tahar R, Tang LH, Touré OA, Tshibangu-wa-Tshibangu P, Vigan-Womas I, Warsame M, Wini L, Zakeri S, Kim S, Eam R, Berne L, Khean C, Chy S, Ken M, Loch K, Canier L, Duru V, Legrand E, Barale JC, Stokes B, Straimer J, Witkowski B, Fidock DA, Rogier C, Ringwald P, Ariey F, Mercereau-Puijalon O; KARMA Consortium (dont Deloron P). A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. New England J Med, 2016, 374:2453-64.
  34. Barata L, Houzé P, Boutbibe K, Zanghi G, Franetich JF, Mazier D, Clain J. In vitro analysis of the interaction between atovaquone and proguanil against malaria liver stage. Antimicrob Agents Chemother, 2016, 60:4333-5.
  35. Greenberg M, Simondon F, Saadatian-Elahi M. Perspectives on benefit-risk decision-making in vaccinology: conference report. Hum Vaccin Immunother, 2016, 12:176-81.
  36. Tahar R, Albergaria C, Zeghidour N, Ngane VF, Basco LK, Roussilhon C. Plasma levels of eight different mediators and their potential as biomarkers of various clinical malaria conditions in African children. Malar J, 2016, 15:337.
  37. Mombo-Ngoma G, Mackanga JR, González R, Ouedraogo S, Kakolwa MA, Manego RZ, Basra A, Rupérez M, Cot M, Kabanywany AM, Matsiegui PB, Agnandji ST, Vala A, Massougbodji A, Abdulla S, Adegnika AA, Sevene E, Macete E, Yazdanbakhsh M, Kremsner PG, Aponte JJ, Menéndez C, Ramharter M. Young adolescent girls are at high risk for adverse pregnancy outcomes in sub-Saharan Africa: an observational multicountry study. BMJ Open, 2016, 6:
  38. Faucher JF, Morquin D, Reynes J, Chirouze C, Hoen B, Le Moing V. Serial use of pentamidine and miltefosine for treating Leishmania infantum-HIV coinfection. Parasitol Int, 2016, 65:444-6.
  39. Briand V, Saal J, Ghafari C, Huynh BT, Fievet N, Schmiegelow C, Massougbodji A, Deloron P, Zeitlin J, Cot M. Fetal growth restriction is associated with malaria in pregnancy: a prospective longitudinal study in Benin. J Infect Dis, 2016, 214:417-25.
  40. Chaumeau V, Andolina C, Fustec B, Tuikue Ndam N, Brengues C, Herder S, Cerqueira D, Chareonviriyaphap T, Nosten F, Corbel V. Comparison of the performances of five primer sets for the detection and quantification of Plasmodium in Anopheline vectors by real-time PCR. PLoS One, 2016, 11:e0159160.
  41. Ogouyèmi-Hounto A, Damien G, Deme AB, Ndam NT, Assohou C, Tchonlin D, Mama A, Hounkpe VO, Moutouama JD, Remoué F, Ndiaye D, Gazard DK. Lack of artemisinin resistance in Plasmodium falciparum in northwest Benin after 10 years of use of artemisinin-based combination therapy. Parasite, 2016, 23:28.
  42. Chippaux JP. Management of scorpion stings in Africa and the Mediterranean region. Med Sante Trop, 2016, 26:130-3.
  43. Houzé S, Hubert V, Argy N, Joste V, Thellier M, du CNR du Paludisme. TROP-09 – Comparaison des accès à Plasmodium ovale curtisi et à Plasmodium ovale wallikeri dans le paludisme d’importation en France métropolitaine. Med Mal Infect, 2016, 46(S1):106.
  44. Calvete JJ, Arias AS, Rodríguez Y, Quesada-Bernat S, Sánchez LV, Chippaux JP, Pla D, Gutiérrez JM. Preclinical evaluation of three polyspecific antivenoms against the venom of Echis ocellatus: Neutralization of toxic activities and antivenomics. Toxicon, 2016, 119:280-8.
  45. Chesnais CB, Sabbagh A, Pion SD, Missamou F, Garcia A, Boussinesq M. Familial aggregation and heritability of Wuchereria bancrofti J Infect Dis, 2016, 214:587-94.
  46. Briand V, Le Hesran JY, Mayxay M, Newton PN, Bertin G, Houzé S, Keomany S, Inthavong Y, Vannavong N, Chindavongsa K, Hongvanthong B, Fievet N. Prevalence of malaria in pregnancy in southern Laos: a cross-sectional survey. Malar J, 2016, 15:436.
  47. Otienoburu SD, Maïga-Ascofaré O, Schramm B, Jullien V, Jones JJ, Zolia YM, Houzé P, Ashley EA, Kiechel JR, Guérin PJ, Le Bras J, Houzé S. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Malar J, 2016, 15:452.
  48. Chêne A, Houard S, Nielsen M, Hundt S, D’Alessio F, Sirima SB, Luty AJF, Theander T, Duffy P, Leroy O, Gamain B, Viebig NK. Clinical development of placental malaria vaccines and immunoassays harmonisation: a workshop report. Malaria J, 2016, 15:476.
  49. Gbedande K, Cottrell G, Vianou B, Ibitokou S, Fernando A, Troye-Blomberg M, Theander T, Salanti A, Moutaïrou K, Massougbodji A, Tuikue Ndam N, Salanti A, Deloron P, Luty AJF, Fievet N. Infections with Plasmodium falciparum during pregnancy affect VAR2CSA DBL-5 domain-specific T cell cytokine responses. Malaria J, 2016, 15:485.
  50. Moya-Alvarez V, Bodeau-Livinec F, Cot M. Iron and malaria: a dangerous liaison? Nutr Rev, 2016, 74:612-23.
  51. Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M; PALUREA Study Group. Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study. Intensive Care Med, 2016, 42:1588-96.
  52. Dechavanne C, Sadissou I, Bouraïma A, Ahouangninou C, Amoussa R, Milet J, Moutairou K, Massougbodji A, Theisen M, Remarque EJ, Courtin D, Nuel G, Migot-Nabias F, Garcia A. Acquisition of natural humoral immunity to falciparum in early life in Benin: the key impact of clinical, environmental and host factors. Sci Rep, 2016, 6:33961.
  53. Belaid L, Dumont A, Chaillet N, Zertal A, De Brouwere V, Hounton S, Ridde V. Effectiveness of demand generation interventions on use of modern contraceptives in low- and middle-income countries. Trop Med Int Health, 2016, 21:1240-54.
  54. Gineau L, Courtin D, Camara M, Ilboudo H, Jamonneau V, Dias FC, Tokplonou L, Milet J, Mendonça PB, Castelli EC, Camara O, Camara M, Favier B, Rouas-Freiss N, Moreau P, Donadi EA, Bucheton B, Sabbagh A, Garcia A. Human leukocyte antigen-G: a promising prognostic marker of disease progression to improve the control of human African trypanosomiasis. Clin Infect Dis, 2016, 63:1189-97.
  55. Pécuchet N, Rozenholc Y, Zonta E, Pietraz D, Didelot A, Combe P, Gibault L, Bachet JB, Taly V, Fabre E, Blons H, Laurent-Puig P. Analysis of base-position error rate of next-generation sequencing to detect tumor mutations in circulating DNA. Clin Chem, 2016, 62:1492-1503.
  56. Wammes LJ, Hamid F, Wiria AE, May L, Kaisar MM, Prasetyani-Gieseler MA, Djuardi Y, Wibowo H, Kruize YCM, Verweij JJ, de Jong SE, Tsonaka R, Houwing-Duistermaat JJ, Sartono E, Luty AJ, Supali T, Yazdanbakhsh M. Community deworming alleviates geohelminth-induced immune hyporesponsiveness. Proc Natl Acad Sci USA, 2016, 113:12526-31.
  57. Kaboré C, Ridde V, Kouanda S, Agier I, Queuille L, Dumont A. Determinants of non-medically indicated cesarean deliveries in Burkina Faso. Int J Gynaecol Obstet, 2016, 135 Suppl 1:S58-S63.
  58. Kaboré C, Chaillet N, Kouanda S, Bujold E, Traoré M, Dumont A. Maternal and perinatal outcomes associated with a trial of labour after previous caesarean section in sub-Saharan countries. BJOG, 2016, 123:2147-55.
  59. Kaboré C, Ridde V, Kouanda S, Queuille L, Somé PA, Agier I, Dumont A. DECIDE: a cluster randomized controlled trial to reduce non-medically indicated caesareans in Burkina Faso. BMC Pregnancy Childbirth, 2016, 16:322.
  60. Villard O, Cimon B, L’Ollivier C, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E; Network of the French National Reference Center for Toxoplasmosis. Help in the choice of automated or semi-automated immunoassays for the serological diagnosis of toxoplasmosis: Evaluation of nine immunoassays by the French National reference center for toxoplasmosis. J Clin Microbiol, 2016, 54:3034-42.
  61. Kouanda S, Kabra R, Dumont A. Maternal and neonatal health in Africa at MDG end: Availability of and access to maternal health services, and outcomes of intervention strategies. Int J Gynaecol Obstet, 2016, 135 Suppl 1:S84-S88.
  62. Tort J, Traoré M, Hounkpatin B, Bodin C, Rozenberg P, Dumont A. Initial management of postpartum hemorrhage: A cohort study in Benin and Mali. Int J Gynaecol Obstet, 2016, 135 Suppl 1:S84-S88.
  63. Mireku MO, Davidson LL, Boivin MJ, Zoumenou R, Massougbodji A, Cot M, Bodeau-Livinec F. Prenatal iron deficiency, neonatal ferritin, and infant cognitive function. Pediatrics, 2016, 138:6.
  64. Unger HW, Cates JE, Gutman J, Briand V, Fievet N, Valea I, Tinto H, d’Alessandro U, Landis SH, Adu-Afarwuah S, Dewey KG, Ter Kuile F, Dellicour S, Ouma P, Slutsker L, Terlouw DJ, Kariuki S, Ayisi J, Nahlen B, Desai M, Madanitsa M, Kalilani-Phiri L, Ashorn P, Maleta K, Mueller I, Stanisic D, Schmiegelow C, Lusingu J, Westreich D, van Eijk AM, Meshnick S, Rogerson S. Maternal Malaria and Malnutrition (M3) initiative, a pooled birth cohort of 13 pregnancy studies in Africa and the Western Pacific. BMJ Open, 2016, 6:e012697.
  65. Pécuchet N, Zonta E, Didelot A, Combe P, Thibault C, Gibault L, Lours C, Rozenholc Y, Taly V, Laurent-Puig P, Blons H, Fabre E. Base-position error rate analysis of next-generation sequencing applied to circulating tumor dna in non-small cell lung cancer: a prospective study. PLoS Med, 2016, 13:e1002199.
  66. Ya-Umphan P, Cerqueira D, Parker DM, Cottrell G, Poinsignon A, Remoue F, Brengues C, Chareonviriyaphap T, Nosten F, Corbel V. Anopheles salivary biomarker to assess malaria transmission risk along the Thailand-Myanmar border. J Infect Dis, 2016, 215:396-404.
  67. Hemming-Harlo M, Vesikari T, Uhari M, Renko M, Salminen M, Torcel-Pagnon L, Hartwig S, Simondon F, Bricout H. Sustained high effectiveness of RotaTeq on hospitalizations due to rotavirus gastroenteritis during 4 years in Finland. J Ped Infect Dis Soc, 2016, sous presse.
  68. Boko I, Baxerres C, Ouattara F, Guillaume A. Interroger au Bénin les usages populaires d’un médicament abortif, le misoprostol. Rev Méd Périnat, 2016, sous presse.

OS UMR216 

  1. Bureau-Point E. Les patients experts dans la lutte contre le sida au Cambodge, Anthropologie d’une norme globalisée, Presses Universitaires de Provence, 2016, p. 250 p.
  2. Sabbagh A, Darlu P, Vangenot C, Poloni ES. Arylamine N-acetyltransferases in anthropology. In: “Arylamine N-Acetyltransferases in Health and Disease”, Chapter 1.7, 2016, edited by E Sim and N Laurieri, World Scientific Publishing Group.
  3. Boukouvala S, Sabbagh A, Fakis G. The genomics and evolution of arylamine N-acetyltransferases in animals. In: “Arylamine N-Acetyltransferases in Health and Disease”, Chapter 2.1, 2016, edited by E Sim and N Laurieri, World Scientific Publishing Group.

ACL 

  1. Huynh BT, Cottrell G, Cot M, Briand V. Burden of malaria in early pregnancy: a neglected problem? Clin Infect Dis, 2015, 60:598-604.
  2. Gineau L, Luisi P, Castelli EC, Milet J, Courtin D, Cagnin N, Patillon B, Laayouni H, Moreau P, Donadi EA, Garcia A, Sabbagh A. Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G. Genes Immun, 2015, 16:57-70.
  3. Faucher JF, Chirouze C, Hoen B, Leroy J, Hustache-Mathieu L, Estavoyer JM. Short-course treatment with ceftriaxone for leptospirosis: A retrospective study in a single center in Eastern France. J Infect Chemother, 2015, 21:227-8.
  4. Mireku MO, Boivin MJ, Davidson LL, Ouédraogo S, Koura GK, Alao MJ, Massougbodji A, Cot M, Bodeau-Livinec F. Impact of helminth infection during pregnancy on cognitive and motor functions of one-year-old children. PLoS Negl Trop Dis, 2015, 9:e0003463.
  5. Lysaniuk B, Ladsous R, Tabeaud M, Cottrell G, Pennetier C, Garcia A. Types of homes and ways of life: a territorial analysis of the environmental determinants that factor into the proliferation of malaria vectors in the rural region of Allada in Benin. Rural Remote Health, 2015, 15:2696.
  6. Chippaux JP, Boyer LV, Alagón A. Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategy. J Venom Anim Toxins Incl Trop Dis, 2015, 21:3.
  7. The WorldWide Antimalarial Resistance Network (WWARN) ASAQ Study (dont Cot M, Deloron P, Faucher JF). The effect of dosing strategies on the therapeutic efficacy of artesunate amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. BMC Med, 2015, 13:66.
  8. Moussiliou A, Alao MJ, Denoeud-Ndam L, Tahar R, Ezimegnon S, Sagbo G, Amoussou A, Luty AJ, Deloron P, Ndam NT. High plasma sEPCR levels are associated with increased mortality in children with cerebral malaria in Benin. J Infect Dis, 2015, 211:1484-8.
  9. Tamou Sambo B, Hodonou A, Youssouf M, Fatigba H, Allode A, Mensah É, Chippaux JP. Perineoscrotal gangrene after a snake bite: a case report. Med Sante Trop, 2015, 25:107-9.
  10. Chippaux JP, Baldé MC, Sessinou É, Yéro Boiro M, Massougbodji A. Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp® Panafricain) in two different epidemiological settings: Northern Benin and Maritime Guinea. Med Sante Trop, 2015, 25:56-64.
  11. Zongo A, Dumont A, Fournier P, Traore M, Kouanda S, Sondo B. Effect of maternal death reviews and training on maternal mortality among cesarean delivery: post-hoc analysis of a cluster-randomized controlled trial. Eur J Obstet Gynecol Reprod Biol, 2015, 185:174-80.
  12. Alam N, Hajizadeh M, Dumont A, Fournier P. Inequalities in maternal health care utilization in sub-saharan african countries: a multiyear and multi-country analysis. PLoS One, 2015, 10:e0120922.
  13. Tuikue Ndam N, Denoeud-Ndam L, Doritchamou J, Viwani F, Salanti A, Nielsen MA, Fievet N, Massougbodji A, Luty AJF, Deloron P. Protective antibodies against placental malaria and poor outcomes during pregnancy, Benin. Emerg Infec Dis, 2015, 21:813-23.
  14. Cottrell G, Moussiliou A, Luty AJF, Cot M, Massougbodji A, Deloron P, Tuikue Ndam N. Submicroscopic malaria infections in pregnant women have serious impact on anemia, prematurity and low birth weight of the offspring: a longitudinal study in Benin. Clin Infec Dis, 2015, 60:1481-8.
  15. Imbard A, Pasmant E, Sabbagh A, Luscan A, Soares M, Goussard P, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanne-Chantelot C, Vidaud D, Wolkenstein P; the members of the NF France Network, Parfait B. NF1 single and multi-exons copy number variations in neurofibromatosis type 1. J Hum Genet, 2015, 60:221-4.
  16. Sicuri E, Fernandes S, Macete E, González R, Mombo-Ngoma G, Massougbodgi A, Abdulla S, Kuwawenaruwa A, Katana A, Desai M, Cot M, Ramharter M, Kremsner P, Slustker L, Aponte J, Hanson K, Menéndez C. Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy. PLoS One, 2015, 10:e0125072.
  17. Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E; French Artesunate Working Group. Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013. Emerg Infect Dis, 2015, 21:804-12.
  18. Foumane Ngane V, Allico Djaman J, Culeux C, Piette N, Carnevale P, Besnard P, Fortes F, Basco LK, Tahar R. Molecular epidemiology of drug-resistant Plasmodium falciparum in Benguela province, Angola. Malar J, 2015, 14:113.
  19. Pull L, Touafek F, Paris L, Le Loup G, Brutus L, Siriez JY. Negativation of Trypanosoma cruzi PCR within six months after treatment of a child with nifurtimox. PLoS Negl Trop Dis, 2015, 9:e0003667.
  20. Chaillet N, Dumont A, Abrahamowicz M, Pasquier JC, Audibert F, Monnier P, Abenhaim HA, Dubé E, Dugas M, Burne R, Fraser WD, QUARISMA Trial Research Group. A cluster-randomized trial to reduce cesarean delivery rates in Quebec. N Engl J Med, 2015, 372:1710-21.
  21. Moya-Alvarez V, Cottrell G, Ouedraogo S, Accrombessi M, Massougbodji A, Cot M. Does iron increase the risk of malaria in pregnancy? Open Forum Infect Dis, 2015, 2:10.
  22. Cura CI, Duffy T, Lucero RH, Bisio M, Péneau J, Jimenez-Coello M, Calabuig E, Gimenez MJ, Valencia Ayala E, Kjos SA, Santalla J, Mahaney SM, Cayo NM, Nagel C, Barcán L, Málaga Machaca ES, Acosta Viana KY, Brutus L, Ocampo SB, Aznar C, Cuba Cuba CA, Gürtler RE, Ramsey JM, Ribeiro I, VandeBerg JL, Yadon ZE, Osuna A, Schijman AG. Multiplex real-time PCR assay using taqman probes for the identification of Trypanosoma cruzi DTUs in biological and clinical samples. PLoS Negl Trop Dis, 2015, 9:e0003765.
  23. Dechavanne S, Srivastava A, Gangnard S, Nunes-Silva S, Dechavanne C, Fievet N, Deloron P, Chêne A, Gamain B. The parity-dependent recognition of the DBL1X-3X suggests an important role of the VAR2CSA high affinity CSA-binding region in the development of the humoral response against placental malaria. Infec Immun, 2015, 83:2466-74.
  24. Andriantsoanirina V, Ariey F, Izri A, Bernigaud C, Fang F, Guillot J, Chosidow O, Durand R. Wombats acquired scabies from humans and/or dogs from outside Australia. Parasitol Res, 2015, 114:2079-83.
  25. The Worldwide Antimalarial Resistance Network (WWARN) AL dose impact study group (dont Cot M, Deloron P, Faucher JF). The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and poooled analysis of individual patient data. Lancet Inf Dis, 2015, 15:692-702.
  26. Chippaux JP. Epidemiology of envenomations by terrestrial venomous animals in Brazil based on case reporting: from obvious facts to contingencies. J Venom Anim Toxins Incl Trop Dis, 2015, 21:13.
  27. Délicat-Loembet L, Rougeron V, Ollomo B, Arnathau C, Roche B, Elguero E, Moukodoum ND, Okougha AP, Mve Ondo B, Boundenga L, Houzé S, Galan M, Nkoghé D, Leroy EM, Durand P, Paupy C, Renaud F, Prugnolle F. No evidence for ape Plasmodium infections in humans in Gabon. PLoS One, 2015, 10:e0126933.
  28. Bacci A, Marchi S, Fievet N, Massougbodji A, Perrin RX, Chippaux JP, Sambri V, Landini MP, Varani S, Rossini G. High seroprevalence of Chikungunya virus antibodies among pregnant women living in an urban area in Benin, West Africa. Am J Trop Med Hyg, 2015, 92:1133-6.
  29. Accrombessi M, Ouédraogo S, Agbota GC, Gonzalez R, Massougbodji A, Menéndez C, Cot M. Malaria in pregnancy is a predictor of infant haemoglobin concentrations during the first year of life in Benin, West Africa. PLoS One, 2015, 10:e0129510.
  30. Tuikue-Ndam N, Deloron P. Developing vaccines to prevent malaria in pregnant women. Expert Opin Biol Ther, 2015, 15:1173-82.
  31. Le Loup G. [Highly transmissible diseases]. Rev Prat, 2015, 65:529-30.
  32. Song Z, Clain J, Iorga BI, Yi Z, Fisher N, Meunier B. Yeast-based mutational analysis of the bc1 complex Qo site residue 279 to study the trade-off between atovaquone resistance and function. Antimicrob Agents Chemother, 2015, 59:4053-8.
  33. Badaut C, Guyonnet L, Milet J, Renard E, Durand R, Viwami F, Sagbo G, Lalya F, Deloron P, Bonnefoy S, Migot-Nabias F. Immunoglobulin response to Plasmodium falciparum RESA proteins in uncomplicated and severe malaria. Malaria J, 2015, 14:278.
  34. Mireku MO, Davidson LL, Koura GK, Ouédraogo S, Boivin MJ, Xiong X, Accrombessi MM, Massougbodji A, Cot M, Bodeau-Livinec F. Prenatal hemoglobin levels and early cognitive and motor functions of one-year-old children. Pediatrics, 2015, 136:e76-83.
  35. Ibitokou SA, Denoeud-Ndam L, Ezinmegnon S, Ladékpo R, Zannou DM, Massougbodji A, Girard PM, Cot M, Luty AJF, Tuikue Ndam N. Insights into circulating cytokine dynamics during pregnancy in HIV-infected Beninese exposed to Plasmodium falciparum Am J Trop Med Hyg, 2015, 93:287-292.
  36. Drame PM, Poinsignon A, Dechavanne C, Cottrell G, Farce M, Ladekpo R, Massougbodji A, Cornélie S, Courtin D, Migot-Nabias F, Garcia A, Remoué F. Specific antibodies to Anopheles gSG6-P1 salivary peptide to assess early childhood exposure to malaria vector bites. Malar J, 2015, 14:285.
  37. Madamet M, Gaillard T, Velut G, Ficko C, Houzé P, Bylicki C, Mérat S, Houzé S, Taudon N, Michel R, Pasquier P, Rapp C, Pradines B. Malaria prophylaxis failure with doxycycline, Central African Republic, 2014. Emerg Infect Dis, 2015, 21:1485-6.
  38. Fang F, Bernigaud C, Candy K, Melloul E, Izri A, Durand R, Botterel F, Chosidow O, Huang W, Guillot J. Efficacy assessment of biocides or repellents for the control of Sarcoptes scabiei in the environment. Parasit Vectors, 2015, 8:416.
  39. Fortes-Lima C, Brucato N, Croze M, Bellis G, Schiavinato S, Massougbodji A, Migot-Nabias F, Dugoujon JM. Genetic population study of Y-chromosome markers in Benin and Ivory Coast ethnic groups. Forensic Sci Int Genet, 2015, 19:232-7.
  40. Briand V, Escolano S, Journot V, Massougbodji A, Cot M, Tubert-Bitter P. Mefloquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment in pregnancy: a joint analysis on efficacy and tolerability. Am J Trop Med Hyg. 2015, 93:300-4.
  41. Zappella N, Desmard M, Chochillon C, Ribeiro-Parenti L, Houze S, Marmuse JP, Montravers P. Positive peritoneal fluid fungal cultures in postoperative peritonitis after bariatric surgery. Clin Microbiol Infect, 2015, 21:853.
  42. Izri A, Andriantsoanirina V, Chosidow O, Durand R. Dermatosis caused by blood-sucking Corythucha ciliata. JAMA Dermatol, 2015, 151:909-10.
  43. Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S. High rate of acquisition but short duration of carriage of multidrug-resistant Enterobacteriaceae after travel to the tropics. Clin Infect Dis, 2015, 61:593-600.
  44. Ravit M, Philibert A, Tourigny C, Traore M, Coulibaly A, Dumont A, Fournier P. The hidden costs of a free caesarean section policy in West Africa (Kayes region, Mali). Matern Child Health J, 2015, 19:1734-43.
  45. Nielsen MA, Resende M, de Jongh WA, Ditlev SB, Mordmüller B, Houard S, Ndam NT, Agerbæk MØ, Hamborg M, Massougbodji A, Issifou S, Strøbæk A, Poulsen l, Leroy O, Kremsner PG, Chippaux JP, Luty AJ, Deloron P, Theander TG, Dyring C, Salanti A. The influence of sub-unit composition and expression system on the functional antibody response in the development of a VAR2CSA based Plasmodium falciparum placental malaria vaccine. PLoS One, 2015, 10:e0135406.
  46. WWARN Artemisinin based Combination Therapy (ACT) Africa Baseline Study Group (dont Faucher JF). Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data. BMC Med, 2015, 13:212.
  47. Doritchamou J, Sabbagh A, Jespersen JS, Renard E, Salanti A, Nielsen MA, Deloron P, Tuikue Ndam NG. Identification of a major dimorphic region in the functionally critical N-terminal ID1 domain of VAR2CSA.  PLos One, 2015, 10:e0135406.
  48. Gaillard T, Wurtz N, Houzé S, Sriprawat K, Wangsing C, Hubert V, Lebras J, Nosten F, Briolant S, Pradines B; French National Reference Centre for Imported Malaria Study Group. Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline. Malar J, 2015, 14:348.
  49. WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group (dont Deloron P, Faucher JF). Artemether-lumefantrine treatment of uncomplicated falciparum malaria: a meta-analysis of day-7 lumefantrine concentrations and therapeutic response. BMC Med, 2015, 13:227.
  50. Aubouy A, Olagnier D, Bertin G, Ezinmegnon S, Majorel C, Mimar S, Massougbodji A, Deloron P, Pipy B, Coste A. Nrf2-driven CD36 and HO-1 gene expression in circulating monocytes correlates with favourable clinical outcome in pregnancy-associated malaria. Malaria J, 2015, 14:358.
  51. Habib AG, Kuznik A, Hamza M, Abdullahi MI, Chedi BA, Chippaux JP, Warrell DA. Snakebite is under appreciated: appraisal of burden from West Africa. PLoS Negl Trop Dis, 2015, 9:e0004088.
  52. Song Z, Clain J, Iorga BI, Vallières C, Lalève A, Fisher N, Meunier B. Interplay between the hinge region of iron sulphur protein and the Qo site in the bc1 complex – Analysis of Plasmodium-like mutations in the yeast enzyme. Biochim Biophys Acta, 2015, 1847:1487-1494.
  53. Sánchez LV, Pla D, Herrera M, Chippaux JP, Calvete JJ, Gutiérrez JM. Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria. Toxicon, 2015, 106:97-107
  54. Tort J, Rozenberg P, Traore M, Fournier P, Dumont A. Factors associated with postpartum hemorrhage maternal death in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey. BMC Pregnancy Childbirth, 2015, 15:235.
  55. Belaid L, Dumont A, Chaillet N, De Brouwere V, Zertal A, Hounton S, Ridde V. Protocol for a systematic review on the effect of demand generation interventions on uptake and use of modern contraceptives in LMIC. Syst Rev, 2015, 4:124.
  56. Chippaux JP. Management of snakebites in Sub-Saharan Africa. Med Sante Trop, 2015, 25:245-8.
  57. Kone GK, Lalou R, Audibert M, Lafarge H, Dos Santos S, Ndonky A, Le Hesran JY. Use of health care among febrile children from urban poor households in Senegal: does the neighbourhood have an impact? Health Policy Plan, 2015, 30:1307-19.
  58. Viebig NK, D’Alessio F, Draper SJ, Sim BK, Mordmüller B, Bowyer PW, Luty AJ, Jungbluth S, Chitnis CE, Hill AV, Kremsner P, Craig AG, Kocken CH, Leroy O. Workshop report: Malaria vaccine development in Europe-preparing for the future. Vaccine, 2015, 33:137-44.
  59. Nouatin O, Gbédandé K, Ibitokou S, Vianou B, Houngbegnon P, Ezinmegnon S, Borgella S, Akplogan C, Cottrell G, Varani S, Massougbodji A, Moutairou K, Troye-Blomberg M, Deloron P, Luty AJF, Fievet N. Infants’ peripheral blood lymphocyte composition reflects both maternal and post-natal infection with Plasmodium falciparum. PLos One, 2015, 10:e0139606.
  60. Andriantsoanirina V, Ariey F, Izri A, Bernigaud C, Fang F, Charrel R, Foulet F, Botterel F, Guillot J, Chosidow O, Durand R. Sarcoptes scabiei mites in humans are distributed into three genetically distinct clades. Clin Microbiol Infect, 2015, 21:1107-14.
  61. Sanchez LV, Pla D, Herrera M, Chippaux JP, Calvete JJ, Gutierrez JM. Evaluation of the preclinical efficacy of four antivenoms, distributed in sub-Saharan Africa, to neutralize the venom of the carpet viper, Echis ocellatus, from Mali, Cameroon, and Nigeria. Toxicon, 2015, 106:97-107.
  62. Bonnal C, Leleu C, Brugière O, Chochillon C, Porcher R, Boelle PY, Menotti J, Houze S, Lucet JC, Derouin F. Relationship between fungal colonisation of the respiratory tract in lung transplant recipients and fungal contamination of the hospital environment. PLoS One, 2015, 10:e0144044.
  63. Lalève A, Vallières C, Golinelli-Cohen MP, Bouton C, Song Z, Pawlik G, Tindall SM, Avery SV, Clain J, Meunier B. The antimalarial drug primaquine targets Fe-S cluster proteins and yeast respiratory growth. Redox Biol, 2015, 7:21-29.
  64. Chippaux JP, Habib AG. Antivenom shortage is not circumstantial but structural. Trans R Soc Trop Med Hyg, 2015, 109:747-8.
  65. Podgorna E, Diallo I, Vangenot C, Sanchez-Mazas A, Sabbagh A, Cerny V, Poloni ES. Variation in NAT2 acetylation phenotypes is associated with differences in food-producing subsistence modes and ecoregions in Africa. BMC Evol Biol, 2015, 15:263.
  66. Castelli EC, Sabbagh A, Mendes-Junior CT, Porto IOP, Garcia A, Ramalho J, Lima THA, Massaro JD, Dias FC, Collares CVA, Jamonneau V, Bucheton B, Camara M, Donadi EA. HLA-E coding and 3′ untranslated region variability determined by next-generation sequencing in two West-African population samples. Hum Immunol, 2015, 76:945-53.
  67. Nunes-Silva S, Dechavanne S, Moussiliou A, Pstrąg N, Semblat JP, Gangnard S, Tuikue-Ndam N, Deloron P, Chêne A, Gamain B. Beninese children with cerebral malaria do not develop humoral immunity against the IT4-VAR19-DC8 PfEMP1 variant linked to EPCR and brain endothelial binding. Malaria J, 2015, 14:493.
  68. Dechavanne C, Cottrell G, Garcia A, Migot-Nabias F. Placental malaria: decreased transfer of maternal antibodies directed to Plasmodium falciparum and impact on the incidence of febrile infections in infants. PLoS One, 2015, 10:e0145464.
  69. Chippaux JP, Massougbodji A, Diouf A, Baldé CM, Boyer LV. Snake bites and antivenom shortage in Africa. Lancet, 2015, 386:2252-3.

C-COM

  1. Tahar R, Almelli T, Debue C, Foumane Ngane V, Djaman Allico J, Whegang Youdom S, Basco LK. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children. Centre de Lutte Intégré contre le Paludisme CLIP du 12-14 mars 2015 Cotonou, Bénin.

DO

  1. Baxerres C. Les médicaments du marché informel sont des faux médicaments ! In : Ridde V., Ouattara F. (eds). Des idées reçues en santé mondiale, Montréal, 2015, Presses Universitaires de Montréal, p. 39-42.
  2. Baxerres C, Egrot M, Houngnihin R, Le Hesran JY. Dualité de l’accès au médicament en Afrique de l’Ouest : Les CTA entre large distribution et consommation sous surveillance. In: Desclaux A, Badji M (eds). Nouveaux enjeux éthiques autour du médicament en Afrique. Analyses en anthropologie, droit et santé publique, Dakar, 2015, L’Harmattan Sénégal, p. 141-158.

OS UMR216 

  1. Secor WE, Le Bras J, Clain J. Mechanisms of resistance to antiparasitic agents. In Manual of clinical microbiology, 11th edition (2015), ASM Press, Washington, DC. Vol. 2: 2550-62.
  2. Le Bras JClain J, Secor WE.  Susceptibility test methods: parasites. In Manual of clinical microbiology, 11th edition (2015), ASM Press, Washington, DC. Vol. 2: 2563-71.
  3. Mayor A, Ibitokou Akanni S, Deloron P. Physiopathology of malaria during pregnancy: Pregnancy-specific malaria immune responses. Encyclopedy of Malaria, Hommel M and Kremsner P ed., SpringerReference.com, http://link.springer.com/referenceworkentry/10.1007/978-1-4614-8757-9_64-1.
  4. Maranhão Costa FT, Albrecht L, Tuikue Ndam N. Physiopathology of malaria during pregnancy: adhesion and sequestration phenotypes of malaria infection. Encyclopedy of Malaria, Hommel M and Kremsner P ed., SpringerReference.com, http://link.springer.com/referenceworkentry/10.1007/978-1-4614-8757-9_66-1
  5. Baxerres C., Les « faux médicaments » : Analyse d’une notion ambigüe à partir d’une étude anthropologique au Bénin. In: Desclaux A, Badji M (eds). Nouveaux enjeux éthiques autour du médicament en Afrique. Analyses en anthropologie, droit et santé publique, Dakar, 2015, L’Harmattan Sénégal, p. 169-78.
  6. Baxerres C. Contrefaçon pharmaceutique : la construction sociale d’un problème de santé publique. In: Egrot M, Desclaux A (eds). Anthropologie du médicament au Sud. La pharmaceuticalisation à ses marges, Paris, 2015, L’Harmattan – Editions de l’IRD, Collections Anthropologies et Médecines, p. 129-46.
  7. Desai M, Cot M. Epidemiology of malaria during pregnancy: Burden and impact of Plasmodium falciparum malaria on maternal and infant health. Encyclopedy of Malaria 2015, Aug:1-13, Hommel M and Kremsner P eds.

PV 

  1. Le Loup G. [Highly transmissible diseases]. Rev Prat, 2015, 65:529-30.

ACL

  1. Dahlström S, Aubouy A, Maïga-Ascofaré O, Faucher JF, Wakpo A, Ezinmègnon S, Massougbodji A, Houzé P, Kendjo E, Deloron P, Le Bras J, Houzé S. Plasmodium falciparum polymorphisms associated with ex vivo drug susceptibility and clinical effectiveness of artemisinin-based combination therapies in Benin. Antimicrob Agents Chemother, 2014, 58:1-10.
  2. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D. A molecular marker of artemisinin-resistant Plasmodium falciparum Nature, 2014, 505:50-5.
  3. Hardwick RJ, Ménard A, Sironi M, Milet J, Garcia A, Sese C, Yang F, Fu B, Courtin D, Hollox EJ. Haptoglobin (HP) and Haptoglobin-related protein (HPR) copy number variation, natural selection, and trypanosomiasis. Hum Genet, 2014, 133:69-83.
  4. Denoeud-Ndam L, Zannou DM, Fourcade C, Taron-Brocard C, Porcher R, Atadokpede F, Komongui DG, Dossou-Gbete L, Afangnihoun A, Ndam NT, Girard PM, Cot M. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials. J Acquir Immune Defic Syndr, 2014, 65:198-206.
  5. Andriantsoanirina V, Izri A, Botterel F, Foulet F, Chosidow O, Durand R. Molecular survey of knockdown resistance to pyrethroids in human scabies mites. Clin Microbiol Infect, 2014, 20:139-41.
  6. Felício LP, Porto IO, Mendes-Junior CT, Veiga-Castelli LC, Santos KE, Vianello-Brondani RP, Sabbagh A, Moreau P, Donadi EA, Castelli EC. Worldwide HLA-E nucleotide and haplotype variability reveals a conserved gene for coding and 3′ untranslated regions. Tissue Antigens, 2014, 83:82-93.
  7. Padonou G, Le Port A, Cottrell G, Guerra J, Choudat I, Rachas A, Bouscaillou J, Massougbodji A, Garcia A, Martin-Prevel Y. Prematurity, intra-uterine growth retardation, low birth weight: risk factors in a malaria endemic area in southern Benin. T Roy Soc Trop Med H, 2014, 108:77-83.
  8. Lemaître M, Watier L, Briand V, Garcia A, Le Hesran JY, Cot M. Coinfection with Plasmodium falciparum and Schistosoma haematobium: additional evidence of the protective effect of schistosomiasis on malaria in Senegalese children. Am J Trop Med Hyg, 2014, 90:329-34.
  9. Chaillet N, Dumont A, Bujold E, Pasquier JC, Audibert F, Dube E, Dugas M, Burne R. Abrahamowicz M, Fraser W. Quality of care, obstetrics risk management and mode of delivery in Quebec (QUARISMA): a cluster-randomized trial. Am J Obstetrics and Gynecology, 2014, 210:S2-S2.
  10. Izri A, Bendjaballah A, Andriantsoanirina V, Durand R. Cutaneous Leishmaniasis Caused by Leishmania killicki, Algeria. Emerg Infect Dis, 2014, 20:502-4.
  11. Sabbagh A, Luisi P, Castelli EC, Gineau L, Courtin D, Milet J, Massaro JD, Laayouni H, Moreau P, Donadi EA, Garcia A. Worldwide genetic variation at the 3′ untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes Immun, 2014, 15:95-106.
  12. Boussari O, Subtil F, Moiroux N, Djenontin A, Iwaz J, Corbel V, Fonton N, Garcia A, Etard JF, Ecochard R. Modeling the seasonality of Anopheles gambiae s.s. biting rates in a South Benin sanitary zone. T Roy Soc Trop Med H, 2014, 108:237-43.
  13. Zeeman AM, van Amsterdam SM, McNamara C, Voorberg-van der Wel A, Klooster EJ, van den Berg A, Remarque EJ, Plouffe D, van Gemert GJ, Luty AJF, Sauerwein R, Gagaring K, Borboa R, Chen Z, Kuhen K, Glynne R, Chatterjee A, Nagle A, Roland J, Winzeler E, Leroy D, Campo B, Diagana TT, Yeung BK, Thomas AW, Kocken CHM. KAI407, a potent non 8-amino-quinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro. Antimicrob Ag Chemother, 2014, 58:1586-95.
  14. Chippaux JP. About snake bites in children at the Fez University Hospital (Morocco). Med Sante Trop, 2014, 24:
  15. Chippaux JP, Postigo JR. Appraisal of snakebite incidence and mortality in Bolivia. Toxicon, 2014, 84:28-35.
  16. Padonou G, Le Port A, Cottrell G, Guerra J, Choudat I, Rachas A, Bouscaillou J, Massougbodji A, Garcia A, Martin-Prevel Y. Factors associated with growth patterns from birth to 18 months in a Beninese cohort of children. Acta Trop, 2014, 135:1-9.
  17. Bordbar B, Tuikue Ndam N, Renard E, Ghemouri S, Gnidehou S, Tahar R, Menard D, Gamboa D, Bendezu J, Tavul L, Siba PM, Jennison C, Barry AE, Deloron P, Sabbagh A. Genetic diversity of VAR2CSA ID1-DBL2Xb in worldwide Plasmodium falciparum populations: impact on vaccine design for pregnancy-associated malaria. Infect Genet Evol, 2014, 25:81-92.
  18. Baxerres C. Faux médicaments, de quoi parle-t-on ? Contrefaçons, marché informel, qualité des médicaments… Réflexions à partir d’une étude anthropologique conduite au Bénin. Bull Soc Pathol Exot, 2014, 107:121-6.
  19. Dolab JA, de Roodt AR, de Titto EH, García SI, Funes R, Salomón OD, Chippaux JP. Epidemiology of snakebite and use of antivenom in Argentina. Trans R Soc Trop Med Hyg, 2014, 108:269-76.
  20. Gnidehou S, Doritchamou J, Arango EM, Cabrera A, Arroyo MI, Kain KC, Ndam NT, Maestre A, Yanow SK. Functional antibodies against VAR2CSA in non-pregnant populations from Colombia exposed to Plasmodium falciparum and Plasmodium vivax. Infect Immun, 2014, 82:2565-73.
  21. Faye A, Dumont A, Ndiaye P. Fournier P. Development of an instrument to evaluate intrapartum care quality in Senegal: evaluation quality care. Int J Qual Health Care, 2014, 26:184-9.
  22. Pirkle CM, Dumont A, Traore M, Zunzunegui MV. Training and nutritional components of PMTCT programmes associated with improved intrapartum quality of care in Mali and Senegal. Int J Qual Health Care, 2014, 26:174-83.
  23. Zongo A, Kouanda S, Fournier P, Traoré M, Sondo B, Dumont A. Effet du Programme GESTA International sur la pratique de la césarienne au Sénégal et au Mali. Rev Epidémiol Santé Publique, 2014, Suppl 3, 62:S89
  24. Ibitokou SA, Boström S, Brutus L, Tuikue Ndam N, Vianou B, Agbowaï C, Amadoudji Zin M, Huynh BT, Massougbodji A, Deloron P, Troye-Blomberg M, Fievet N, Luty AJF. Sub-microscopic infections with Plasmodium falciparum during pregnancy and their association with circulating cytokine, chemokine and cellular profiles. Clin Vaccine Immun, 2014, 21:859-66. Erratum in: 21:1468.
  25. Kouanda S, Coulibaly A, Ouedraogo A, Millogo T, Meda BI, Dumont A. Audit of cesarean delivery in Burkina Faso. Int J Gynaecol Obstet, 2014, 125:214-8.
  26. Doritchamou J, Sossou-Tchatcha S, Cottrel G, Moussiliou A, Hounton Houngbeme C, Massougbodji A, Deloron P, Tuikue Ndam N. Dynamics in the cytoadherence phenotypes of Plasmodium falciparum infected erythrocytes isolated during pregnancy. PLoS One, 2014, 9:e98577.
  27. Taylor S, Mayor A, Mombo-Ngoma G, Kenguele HM, Ouédraogo S, Tuikue Ndam N, Mkali H, Mwangoka G, Valecha N, Singh JP, Clark MA, Verweij JJ, Adegnika AA, Severini C, Menegon M, Macete E, Menendez C, Cisteró P, Njie F, Affara M, Otieno K, Kariuki S, ter Kuile FO, Meshnick SR. A quality control program within a clinical trial consortium for PCR protocols to detect Plasmodium J Clin Microbiol, 2014, 52:2144-9.
  28. Traoré M, Arsenault C, Schoemaker-Marcotte C, Coulibaly A, Huchon H, Dumont A, Fournier P. Obstetric competence among primary healthcare workers in Mali. Int J Gynaecol Obstet, 2014, 126:50-5.
  29. Huchon C, Tourigny C, Coulibaly A, Traore M, Dumont A, Fournier P. Obstetric competence among referral healthcare providers in Mali. Int J Gynaecol Obstet, 2014, 126:56-9.
  30. Moya-Alvarez V, Abellana R, Cot M. Pregnancy-associated malaria and malaria in infants: an old problem with present consequences. Malar J, 2014, 13:271.
  31. Duvignaud A, Denoeud-Ndam L, Akakpo J, Agossou KV, Afangnihoun A, Komongui DG, Atadokpédé F, Dossou-Gbété L, Girard PM, Zannou DM, Cot M. Incidence of malaria-related fever and morbidity due to Plasmodium falciparum among HIV1-infected pregnant women: a prospective cohort study in South Benin. Malar J, 2014, 13:255.
  32. Chêne A, Briand V, Ibitokou S, Dechavanne S, Massougbodji A, Deloron P, Luty AJ, Gamain B, Fievet N. Placental cytokine and chemokine profiles reflect pregnancy outcomes in women exposed to Plasmodium falciparum Infect Immun, 2014, 82:3783-9.
  33. Cottrell G, Musset L, Hubert V, Le Bras J, Clain J. Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports. Antimicrob Agents Chemother, 2014, 58:4504-14.
  34. Almelli T, Tuikue Ndam N, Ezimegnon S, Alao MJ, Ahouansou C, Sagbo G, Amoussou A, Deloron P, Tahar R. Cytoadherence phenotype of Plasmodium falciparum-infected erythrocytes is associated with specific Pfemp-1 expression in parasites from children with cerebral malaria. Malaria J, 2014, 13:331.
  35. Denoeud-Ndam L, Briand V, Zannou DM, Girard PM, Cot M. Is cotrimoxazole prophylaxis effective to prevent malaria in HIV-infected pregnant women? Clin Infect Dis, 2014, 59:603-4.
  36. Sadissou I, d’Almeida T, Cottrell G, Luty A, Krawice-Radanne I, Massougbodji A, Moreau P, Moutairou K, Garcia A, Favier B, Rouas-Freiss N, Courtin D. High plasma levels of HLA-G are associated with low birth weight and with an increased risk of malaria in infancy. Malar J, 2014, 13:312.
  37. Conort O, Siguret V, Bourdon O, Nazaraly S, Brignone M, Pons-Kerjean N, Houze S, Laribe Cage S, Berthet F, Golmard JL, Brion F, Tilleul P. Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course]. Ann Pharm Fr, 2014, 72:287-95.
  38. Egrot M, Houngnihin R, Baxerres C, Damien G, Djènontin A, Chandre F, Pennetier C, Corbel V, Remoué F. Reports of long-lasting insecticidal bed nets catching on fire: a threat to bed net users and to successful malaria control? Malar J, 2014, 13:247.
  39. Huchon C, Dumont A, Chantry A, Falissard B, Fauconnier A. Triage using a self-assessment questionnaire to detect potentially life-threatening emergencies in gynecology. World J Emerg Surg, 2014, 9:46.
  40. Ibikounlé M, Ogouyèmi-Hounto A, Sissinto Savi de Tové Y, Dansou A, Courtin D, Kindé-Gazard D, Mouahid G, Moné H, Massougbodji A. [Epidemiology of urinary schistosomiasis among school children in Péhunco area, Northern Benin. Malacological survey.] Bull Soc Pathol Exot, 2014, 107:177-84.
  41. Ramanah R, Dumont A, Schepens F, Traore M, Gaye A, Schaal JP, Riethmuller D, Rude N. [Satisfaction with obstetrical care: Development and validation of a scale on quality of care. Gynecol Obstet Fertil, 2014,42:477-82.
  42. Faucher JF, Bellanger AP, Shaniya N, Hustache-Mathieu L, Hoen B, Chirouze C. Compliance to recommendations for the management of curative treatment of Plasmodium vivax/ovale infections. Med Mal Infect, 2014, 44:387-9.
  43. González R, Mombo-Ngoma G, Ouédraogo S, Kakolwa MA, Abdulla S, Accrombessi M, Aponte JJ, Akerey-Diop D, Basra A, Briand V, Capan M, Cot M, Kabanywanyi AM, Kleine C, Kremsner P, Macete E, Mackanga JR, Massougbodgi A, Mayor A, Nhacolo A, Pahlavan G, Ramharter M, Rupérez M, Sevene E, Vala A, Zoleko-Manego R, Menéndez C. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial. PLoS Med, 2014, 11:e1001733.
  44. Houzé S, Hoang NT, Lozach O, Bras JL, Meijer L, Galons H, Demange L. Several human cyclin-dependent kinase inhibitors, structurally related to roscovitine, are new anti-malarial agents. Molecules, 2014, 19:15237-57.
  45. Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, Mårtensson A, Rosenthal PJ, Dorsey G, Sutherland CJ, Guérin P, Davis TM, Ménard D, Adam I, Ademowo G, Arze C, Baliraine FN, Berens-Riha N, Björkman A, Borrmann S, Checchi F, Dhorda MD, Djimdé AA, El-Sayed BB, Eshetu T, Eyase F, Falade C, Faucher JF, Fröberg G, Grivoyannis A, Hamour S, Houzé S, Johnson J, Kamugisha E, Kariuki S, Kiechel JR, Kironde F, Kofoed PE, Le Bras J, Malmberg M, Mwai L, Ngasala B, Nosten F, Nsobya SL, Nzila A, Oguike AN, Dahlström Otienoburu S, Ogutu B, Ouédraogo JB, Piola P, Rombo L, Schramm B, Somé AF, Thwing J, Ursing J, Wong RP, Zeynudin A, Zongo I, Plowe CV, Sibley CH, and ASAQ Molecular Marker Study Group. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. Am J Trop Med Hyg, 2014, 91:833-43.
  46. Khim N, Andrianaranjaka V, Popovici J, Kim S, Ratsimbasoa A, Benedet C, Barnadas C, Durand R, Thellier M, Legrand E, Musset L, Menegon M, Severini C, Nour BY, Tichit M, Bouchier C, Mercereau-Puijalon O, Ménard D. Effects of mefloquine use on Plasmodium vivax multidrug resistance. Emerg Infect Dis, 2014, 20:1629-36.
  47. Fournier P, Dumont A, Tourigny C, Philibert A, Coulibaly A, Traore M. The free caesareans policy in low-income settings: an interrupted time series analysis in Mali (2003-2012). Plos One, 2014, 9: e105130.
  48. Castelli EC, Ramalho J, Porto IO, Lima TH, Felício LP, Sabbagh A, Donadi EA, Mendes-Junior CT. Insights into HLA-G Genetics Provided by Worldwide Haplotype Diversity. Front Immunol, 2014, 5:476.
  49. Chippaux JP. Outbreaks of Ebola virus disease in Africa: the beginnings of a tragic saga. J Venom Anim Toxins Incl Trop Dis, 2014, 20:44.
  50. Almelli T, Nuel G, Bischoff E, Aubouy A, Elati M, Wang CW, Dillies MA, Copée JY, Nko Ayissi G, Basco LK, Rogier C, Tuikue Ndam N, Deloron P, Tahar R. Differences in gene transcriptomic pattern of Plasmodium falciparum in children with cerebral malaria and asymptomatic carriers. PLoS One, 2014, 9:e114401.
  51. Tahar R, Almelli T, Debue C, Ngane VF, Allico JD, Youdom SW, Basco LK. Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children. J Infect Dis, 2014, 210:1962-71.
  52. Bauer R, Mentré F, Kaddouri H, Le Bras J, Le Nagard H. Benefits of a new Metropolis-Hasting based algorithm, in non-linear regression for estimation of ex vivo antimalarial sensitivity in patients infected with two strains. Comput Biol Med, 2014, 55:16-25.
  53. Patillon B, Luisi P, Poloni ES, Boukouvala S, Darlu P, Genin E, Sabbagh A. A homogenizing process of selection has maintained an ‘ultra-slow’ acetylation NAT2 variant in humans. Hum Biol, 2014, 86:185-214.

C-INV 

  1. Dumont A. Modalités des revues de morbi-mortalité (RMM) en Obstétrique. Conférence Franco-Vietnamienne de Gynécologie et d’Obstétrique, 2014, Hanoi, Vietnam.
  2. Dumont A. Modalités des revues de morbi-mortalité (RMM) en Obstétrique. 14ème conférence Vietnam–France–Asie Pacifique de Gynécologie et Obstétrique, 2014, Ho Chi Minh Ville, Vietnam.
  3. Dumont A. Prise en charge de la pré-éclamspie dans les pays en voie de développement. Séminaire sur la pré-éclamspie organisé par la Fondation PREMUP (Fondation de coopération scientifique sur la grossesse et la prématurité), 2014, Paris.

OS UMR216 

  1. Baxerres C. Du médicament informel au médicament libéralisé : une anthropologie du médicament pharmaceutique au Bénin. Paris, 2014, Les Éditions des Archives Contemporaines.
  2. Baxerres C, Egrot M, Houngnihin R, Le Hesran J-Y. Dualité de l’accès au médicament en Afrique de l’Ouest : Les CTA entre large distribution et consommation sous surveillance. In: Desclaux A, Badji M (eds). Nouveaux enjeux éthiques autour du médicament en Afrique. Eclairages juridiques, anthropologiques et de santé publique, Dakar, 2014, L’Harmattan Sénégal, sous presse.

ACL

  1. Tahar R, Sayang C, Foumane Ngane V, Soula G, Moyou-Somo R, Delmont J, Basco LK. Field evaluation of rapid diagnostic tests for malaria in Yaounde, Cameroon. Acta Trop, 2013, 125:214-9.
  2. Chippaux JP, Salas-Clavijo AN, Postigo JR, Schneider D, Santalla JA, Brutus L. Evaluation of compliance to congenital Chagas disease treatment: results of a randomised trial in Bolivia. Trans R Soc Trop Med Hyg, 2013, 107:1-7.
  3. Andriantsoanirina V, Khim N, Ratsimbasoa A, Witkowski B, Benedet C, Canier L, Bouchier C, Tichit M, Durand R, Ménard D. Plasmodium falciparum Na+/H+ Exchanger (Pfnhe-1) genetic polymorphism in Indian Ocean malaria-endemic areas. Am J Trop Med Hyg, 2013, 88:37-42.
  4. Teirlinck AC, Roestenberg M, van de Vegte-Bolmer M, Scholzen A, Heinrichs MJL, Siebelink-Stoter R, Graumans W, van Gemert GJ, Teelen K, Vos M, NganouMakamdop K, Borrmann S, Rozier YPA, Erkens MAA, Luty AJF, Hermsen CC, Sim BKL, van Lieshout L, Hoffman SL, Visser LG, Sauerwein RW. C10: a new Plasmodium falciparum clone for controlled human malaria infections. J Infect Dis, 2013, 207:656-60.
  5. Deloron P, Milet J, Badaut C. Plasmodium falciparum variability and immune evasion proceed from antigenicity of consensus sequences from DBL6e; generalization to all DBL from VAR2CSA. PLoS One, 2013, 8:e54882.
  6. Ouedraogo S, Koura GK, Bodeau-Livinec F, Accrombessi MKM, Massougbodji A, Cot M. Maternal anemia in pregnancy: assessing the effect of routine preventive measures in a malaria-endemic area. Am J Trop Med Hyg, 2013, 88:292-300.
  7. Villard O, Breit L, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houze S, Paris L, Pelloux H, Villena I, Candolfi E; the French National Reference Center for Toxoplasmosis Network. Comparison of four commercially available avidity tests for Toxoplasma gondii-specific IgG antibodies. Clin Vaccine Immunol, 2013, 20:197-204.
  8. Gharbi M, Flegg J, Hubert V, Kendjo E, Metcalf J, Guerin Pj, Le Bras J, CNR Study Group. Longitudinal study assessing the return of chloroquine susceptibility of Plasmodiumn falciparum isolates from travellers returning from West Africa, 2000-2011. Malaria J, 2013, 12:35.
  9. de Roodt AR, de Titto E, Dolab JA, Chippaux JP. Envenoming by coral snakes (Micrurus) in Argentina, during the period between 1979-2003. Rev Inst Med Trop Sao Paulo, 2013, 55:13-8.
  10. Chippaux JP, Diouf A, Lam-Faye A, Stock RP, Massougbodji A. Creation of the african society of toxinology. Bull Soc Pathol Exot, 2013, 106:81-82.
  11. Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D; S 130 APOLLO Trial Study Group (dont Faucher JF). Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial. J Antimicrob Chemother, 2013, 68:690-6.
  12. Descamps D, S 130 APOLLO Trial Study Group (dont Faucher JF). Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial. J Antimicrob Chemother, 2013, 68:690-6.
  13. Pirkle C, Dumont A, Traoré M, Zunzunegui MV. Effect of a facility-based multifaceted intervention on the quality of obstetrical care: A cluster randomized controlled trial in Mali and Senegal. BMC Medicine, 2013, 13:24.
  14. Arsenault C, Fournier P, Philibert A, Sissoko K, Coulibaly A, Tourigny C, Traoré M, Dumont A. Emergency obstetric care in Mali: catastrophic spending and its impoverishing effects on households. Bull World Health Organ, 2013, 91:207-16.
  15. Faucher JF, Bellanger AP, Chirouze C, Hustache-Mathieu L, Genton S, Hoen B. Primaquine for radical cure of Plasmodium vivax and Plasmodium ovale malaria: an observational survey (2008-2010). J Travel Med, 2013, 20:134-6.
  16. Sabbagh A, Marin J, Veyssière C, Lecompte E, Boukouvala S, Poloni ES, Darlu P, Crouau-roy B. Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection. BMC Evol Biol, 2013, 13:62.
  17. Patillon B, Génin E, Sabbagh A. La variabilité de réponse aux anticoagulants oraux, une conséquence de la sélection naturelle. Médecine Sciences, 2013, 29:157-64.
  18. Wiria AE, Hamid F, Wammes LJ, Kaisar MM, May L, Prasetyani MA, Wahyuni S, Djuardi Y, Ariawan I, Wibowo H, Lell B, Sauerwein R, Brice GT, Sutanto I, van Lieshout L, de Craen AJ, van Ree R, Verweij JJ, Tsonaka R, Houwing-Duistermaat JJ, Luty AJ, Sartono E, Supali T, Yazdanbakhsh M. The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial. PLoS One, 2013, 8:e57899.
  19. Lokossou AG, Dechavanne C, Bouraïma A, Courtin D, Le Port A, Ladekpo R, Noukpo J, Bonou D, Ahouangninou C, Sabbagh A, Fayomi B, Massougbodji A, Garcia A, Migot-Nabias F. Association of IL-4 and IL-10 maternal haplotypes with immune responses to falciparum in mothers and newborns. BMC Infectious Diseases, 2013, 13:215.
  20. Denoeud-Ndam L, Fourcade C, Ogouyemi-Hounto A, Azon-Kouanou A, d’Almeida M, Azondékon A, Alao MJ, Dossou-Gbété V, Afangnihoun A, Girard PM, Cot M, Zannou DM. Predictive factors of plasma HIV suppression during pregnancy: a prospective cohort study in Benin. PLoS One, 2013;8:e59446.
  21. Wammes LJ, Wiria AE, Toenhake C, Hamid F, Liu KY, Suryani H, Kaisar MM, Verweij JJ, Sartono E, Supali T, Smits HH, Luty AJ, Yazdanbakhsh M. Asymptomatic plasmodial infection is associated with increased TNFRII-expressing Tregs and suppressed type 2 immune responses. J Infect Dis, 2013, 207:1590-9.
  22. Gangnard S, Badaut C, Rambourina S, Baron B, Ramdani T, Gamain B, Deloron P, Lewit-Bentley A, Bentley GA. Structural and immunological correlations between the variable blocks of the DBL6e-VAR2CSA domain from two Plasmodium falciparum parasite lines. J Mol Biol, 2013, 425:1697-1711.
  23. Courtin D, Milet J, Sabbagh A, Massaro J.D, Castelli E.C, Jamonneau B, Bucheton B, Sese C, Favier B, Rouas-Freiss N, Moreau P, Donadi EA, Garcia A. HLA-G 3′ UTR-2 haplotype is associated with human african trypanosomiasis susceptibility. Infect Genet Evol, 2013, 17C:1-7.
  24. Garcia A, Milet J, Courtin D, Sabbagh A, Massaro JD, Castelli EC, Migot-Nabias F, Favier B, Rouas-Freiss N, Donadi EA, Moreau P. Association of HLA-G 3’UTR polymorphisms with response to malaria infection: a first insight. Infect Genet Evol, 2013, 16C:263-9.
  25. Ibitokou S, Brutus L, Vianou B, Oesterholt M, Massougbodji A, Deloron P, Troye-Blomberg M, Fievet N, Luty AJF. Gestational age-related changes in the peripheral blood cell composition of sub-Saharan African women. J Reprod Immunol, 2013, 98:21-28.
  26. Koura GK, Garcia A, Todoégnon B, Deloron P, Cot M, Faucher JF. Prevalence and risk factors of antibiotics usage in Southern Benin: a school-based study. Acta Trop, 2013, 127:87-90.
  27. Ogouyèmi-Hounto A, Ndam NT, Kinde Gazard D, D’Almeida S, Koussihoude L, Ollo E, Azagnandji C, Bello M, Chippaux JP, Massougbodji A. Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy. Malar J, 2013, 12:147.
  28. Hammami I, Nuel G, Garcia A. Statistical properties of parasite density estimators in malaria. PLoS One, 2013, 8:e51987.
  29. Alout H, Tuikue Ndam N, Sandeu M, Djégbe I, Chandre F, Dabiré R, Djogbénou L, Corbel V, Cohuet A. Insecticide resistance alleles affect vector competence of Anopheles gambiae s.s. for Plasmodium falciparum field isolates. Plos One, 2013, 8:e63849.
  30. Kaisar MM, Supali T, Wiria AE, Hamid F, Wammes LJ, Sartono E, Luty AJ, Brienen EA, Yazdanbakhsh M, Lieshout LV, Verweij JJ.Epidemiology of Plasmodium infections in Flores Island, Indonesia using real-time PCR. Malar J, 2013, 12:169.
  31. Ndour C, Dossou Gbété S, Bru N, Abrahamowicz M, Fauconnier A, Traoré M, Diop A, Fournier P, Dumont A. Predicting in-hospital maternal mortality in Senegal and Mali. PLoS One, 2013, 8:e64157.
  32. Sabbagh A, Courtin D, Milet J, Massaro JD, Castelli EC, Migot-Nabias F, Favier B, Rouas-Freiss N, Moreau P, Garcia A, Donadi EA Association of HLA-G 3’UTR polymorphisms with antibody response against P. falciparum antigens. Tissue Antigens, 2013, 82:53-8.
  33. Moussiliou A, Sissinto-Savi De Tove Y, Doritchamou J, Luty AJF, Massougbodji A, Alifrangis M, Deloron P, Tuikue Ndam N. High rates of recrudescence following intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Benin. Malaria J, 2013, 12:195.
  34. Le Port A, Cottrell G, Chandre F, Cot M, Massougbodji A, Garcia A. Importance of adequate spatiotemporal transmission measures in malaria cohort studies: application to the relation between placental malaria and first malaria infections in infants. Am J Epidemiol, 2013, 178:136-43.
  35. Woodrow CJ, Dahlström S, Cooksey R, Flegg J, Le Nagard H, Mentré F, Murillo C, Ménard D, Nosten F, Sriprawat K, Musset L, Quashie N, Lim P, Fairhurst R, Nsobya S, Sinou V, Noedl H, Pradines B, Johnson J, Guerin PJ, Sibley CH, Le Bras J. High throughput analysis of in vitro antimalarial susceptibility data by the WWARN In Vitro Analysis and Reporting Tool (IVART). Antimicrob Agents Chemother, 2013, 57:3121-30.
  36. Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L’ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H; the network from the French National Reference Center for Toxoplasmosis. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicentre retrospective study. J Clin Microbiol, 2013, 51:2103-11.
  37. Faye A, Fournier P, Diop I, Philibert A, Morestin F, Dumont A. Developing a tool to measure satisfaction among health professionals in sub-Saharan Africa. Hum Resour Health, 2013, 11:30.
  38. Gbédandé K, Varani S, Ibitokou S, Houngbegnon P, Borgella S, Nouatin O, Ezinmegnon S, Adeothy A, Cottrell G, Massougbodji A, Moutairou K, Troye-Blomberg M, Deloron P, Fievet N, Luty A. Malaria modifies neonatal and early-life Toll-like receptor cytokine responses. Inf Immun, 2013, 81:2686-96.
  39. Baldé MC, Chippaux JP, Boiro MY, Stock RP, Massougbodji A. Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa. J Venom Anim Toxins Incl Trop Dis, 2013, 19:6.
  40. Dumont A, Fournier P, Abrahamowicz M, Traoré M, Haddad S, Fraser WD; for the QUARITE research group. Quality of care, risk management, and technology in obstetrics to reduce hospital-based maternal mortality in Senegal and Mali (QUARITE): a cluster-randomised trial. The Lancet, 2013, 382:146-157.
  41. Dramé P, Diallo A, Poinsignon A, Boussari O, Dos Santos S, Machault V, Lalou R, Cornelie S, Le Hesran JY, Remoué F. Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific Anopheles salivary biomarker. Plos One, 2013, 8:e66354.
  42. Bertin GI, Lavstsen T, Guillonneau F, Doritchamou J, Wang CW, Jespersen JS, Ezimegnon S, Fievet N, Alao J, Lalya F, Massougbodji A, Tuikue Ndam N, Theander TG, Deloron P. Expression of the domain cassette 8 and 13 Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is associated with severe malaria in Benin. PLoS One, 2013, 8:e68368.
  43. Brutus L, Santalla J, Schneider D, Avila JC, Deloron P. Consequences of Plasmodium vivax malaria in pregnancy in Bolivia, (South America). Emerg Infect Dis, 2013, 19:1605-11.
  44. Dechavanne C, Pierrat C, Renard E, Costes B, Martin N, Ladekpo R, Ahouangninou C, Moya Alvarez M, Huynh BT, Garcia A, Migot-Nabias F. Genetic characterization of Plasmodium falciparum allelic variants infecting mothers at delivery and their children during their first plasmodial infections. Infect Genet Evol, 2013, 20:16-25.
  45. Minja DT, Schmiegelow C, Mmbando B, Boström S, Oesterholt M, Magistrado P, Pehrson C, John D, Salanti A, Luty AJ, Lemnge M, Theander T, Lusingu J, Alifrangis M. Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg Infect Dis, 2013, 19:1446-54.
  46. Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bourée P, Caumes E, Matheron S, Bouchaud O; ALA Study Group. Imported amoebic liver abscess in France. PLoS Negl Trop Dis, 2013, 7:e2333.
  47. Doritchamou J, Bigey P, Nielsen M, Gnidehou S, Ezinmegnon S, Burgain A, Massougbodji A, Deloron P, Salanti A, Tuikue Ndam N. Differential adhesion-inhibitory pattern of antibodies raised against two ‘serotypes’ of the NTS-DBL2X region of VAR2CSA. Vaccine, 2013, 31:4516-22.
  48. Rougeron V, Woods CM1, Tiedje KE, Bodeau-Livinec F, Migot-Nabias F, Deloron P, Luty AJ, Fowkes FJI, Day KP. Epistatic interactions between apolipoprotein e and hemoglobin S genes in regulation of malaria parasitemia. PLos One, 2013, 8:e76924.
  49. Sabbagh A, Pasmant E, Imbard A, Luscan A, Soares M, Blanché H, Laurendeau I, Ferkal S, Vidaud M, Pinson S, Bellanné-Chantelot C, Vidaud D, the members of the NF France Network, Parfait B and Wolkenstein P. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience. Human Mutation, 2013, 34:1510-8.
  50. Bodeau-Livinec F, Zeitlin J, Blondel B, Arnaud C, Fresson J, Burguet A, Subtil D, Marret S, Rozé JC, Marchand-Martin L, Ancel PY, Kaminski M, on behalf of the EPIPAGE group. Do very preterm twins and singletons differ in their neurodevelopment at 5 years of age? Arch Dis Child Fetal Neonatal Ed., 2013, 98:F480-7.
  51. Dumont A. Bouvier-Colle MH. Care assessment’s difficult relation with maternal mortality. Lancet, 2013; 381:1695-6.
  52. Huchon C, Dumont A, Traoré M, Abrahamowicz M, Fraser W, Fournier P. A maternal mortality score for patients delivering to referral hospitals in Senegal and Mali. Obstet Gynecol, 2013, 121:1049-56.
  53. Toret-Labeeuw F, Huchon C, Popowski T, Chantry A, Dumont A, Fauconnier A. Routine ultrasound examination by ob/gyn residents increase the accuracy of diagnosis for emergency surgery in gynecology. World J Emerg Surg, 2013, 8:16.
  54. Tort J, Hounkpatin B, Popowski T, Traoré M, Bodin C, Perrin R, Rozenberg P, Dumont A. A Randomized controlled trial to test the effectiveness of intrautetine balloon tamponade with condom catheter in severe postpartum hemorrhage management: a feasibility study in Benin. J Women’s Health Care, 2013, 2:135.
  55. Koura GK, Boivin MJ, Davidson LL, Ouedraogo S, Zoumenou R, Alao MJ, Garcia A, Massougbodji A, Cot M, Bodeau-Livinec F. Usefulness of child development assessments for low-resource settings in francophone Africa. J Dev Behav Pediatr, 2013, 34:486-93.
  56. Houzé S, Boutron I, Marmorat A, Dalichampt M, Choquet C, Poilane I, Godineau N, Le Guern AS, Thellier M, Broutier H, Fenneteau O, Millet P, Dulucq S, Hubert V, Houzé P, Tubach F, Le Bras J, Matheron S. Performance of Rapid Diagnostic Tests for imported malaria in clinical practice: results of a national multicenter study. PLoS One, 2013, 8:e75486.
  57. Baxerres C, Simon E. Regards croisés sur l’augmentation et la diversification de l’offre médicamenteuse dans les Suds, Autrepart, 2013, 63:3-29.
  58. Baxerres C. L’introduction différenciée des génériques entre pays francophones et anglophones d’Afrique de l’Ouest : une illustration de la globalisation du médicament à partir du cas du Bénin, Autrepart, 2013, 63:51-68.
  59. Santos KE, Lima TH, Felício LP, Massaro JD, Palomino GM, Silva AC, Oliveira SF, Sabbagh A, Garcia A, Moreau P, Donadi EA, Mendes-Junior CT, Castelli EC. Insights on the HLA-G evolutionary history provided by a nearby Alu insertion. Mol Biol Evol, 2013, 30:2423-34.
  60. Chippaux JP, Saz-Parkinson Z, Amate Blanco JM. Epidemiology of snakebite in Europe: Comparison of data from the literature and case reporting. Toxicon. 2013, 76:206-13.
  61. Ogouyèmi-Hounto A, Gazard DK, Ndam NT, Topanou E, Garba O, Elegbe P, Hountohotegbe T, Massougbodji A. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from children in South of Benin. Parasite, 2013; 20:413.
  62. Ogouyèmi-Hounto A, Ndam NT, Fadégnon G, Azagnandji C, Bello M, Moussiliou A, Chippaux JP, Kinde Gazard D, Massougbodji A. Low prevalence of the molecular markers of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in asymptomatic children in northern Benin. Malaria J, 2013, 12:413.
  63. Mimoun C, Fritel X, Fauconnier A, Deffieux X, Dumont A, Huchon C. Epidemiologie des kystes de l’ovaire supposés bénins. J Gynecol Obst Bio R, 2013, 42:722-9.
  64. Borgella S, Fievet N, Huynh BT, Ibitokou S, Hounguevou G, Affedjou J, Sagbo JC, Houngbegnon P, Guezo-Mévo B, Massougbodji A, Luty AJ, Cot M, Deloron P. Impact of pregnancy-associated malaria on infant malaria infection in southern Benin. PLoS One, 2013, 8:e80624.
  65. Bertin GI, Sabbagh A, Guillonneau F, Jafari-Guemouri S, Ezimegnon S, Federici C, Hounkpatin B, Fievet N, Theander TG, Deloron P. Differential protein expression profiles between Plasmodium falciparum parasites isolated from subjects presenting with pregnancy-associated malaria and uncomplicated malaria in Benin. J Infect Dis, 2013, 208:1987-97.
  66. Menard D, Chan ER, Benedet C, Ratsimbasoa A, Kim S, Chim P, Do C, Witkowski B, Durand R, Thellier M, Severini C, Legrand E, Musset L, Nour BY, Mercereau-Puijalon O, Serre D, Zimmerman PA. Whole genome sequencing of field isolates reveals a common duplication of the duffy binding protein gene in malagasy Plasmodium vivax PLoS Negl Trop Dis, 2013, 7:e2489.
  67. Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, Lavina M, Pascual A, Travaillé C, Le Bras J, Pradines B. PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum Malar J, 2013, 12:414.
  68. Guillaud Bataille M, Rhayem Y, Sousa SB, Libé R, Dambrun M, Chevalier C, Nigou M, Auzan C, Marie-Odile N, Sa J, Gomes L, Salpea P, Horvath A, Stratakis CA, Hamzaoui N, Bertherat J, Clauser E. Systematic screening for PRKAR1A gene rearrangement in Carney complex: identification and functional characterization of a new in-frame deletion. Eur J Endocrinol, 2013, 170:151-60.
  69. Abrahamowicz M, Beauchamp ME, Fournier P, Dumont A. Evidence of subgroup-specific treatment effect in the absence of an overall effect: is there really a contradiction? Pharmacoepidemiol Drug Saf, 2013, 22:1178-88.
  70. Yaba W, Msellati P, Chippaux JP. [Sexual behaviour and condom use by people living with HIV/AIDS in Gabon]. Santé Publique, 2013, 25:839-47.
  71. Yaba W, Chippaux JP, Obiang-Ndong GP, Msellati P. Alternative medicine, beliefs, and management of people with HIV in Gabon. Med Sante Trop, 2013, 23:403-11.
  72. Chippaux JP. Place de l’immunothérapie dans le traitement actuel des envenimations ophidiennes. Bull Acad Nat Méd, 2013, 197:993-1008.

C-INV

  1. Cot M. Prévention du paludisme de la femme enceinte. 18ème colloque sur le contrôle épidémiologique des maladies infectieuses (CEMI 18) : Prévention des infections transmises de la mère à l’enfant, 2013, Paris.
  2. Garcia A. Sensibilité génétique de l’homme au paludisme. Séminaire de Recherche sur le Paludisme, 2013, Saint Quentin en Yvelines.
  3. Deloron P. La quête du vaccin : la dernière croisade contre le paludisme ? Séminaire de Recherche sur le Paludisme, 2013, Saint Quentin en Yvelines.

C-AFF

  1. Ogouyemi Hounto A, Tuikue Ndam N, Kinde Gazard D, D’almeida S, Koussihouede L, Ollo E, Azangnandji C, Bello M, Chippaux JP, Massougbodji A. Prévalence des marqueurs moléculaires de résistance du Plasmodium falciparum à la chloroquine et à la sulfadoxine pyriméthamine sept ans après le changement de politique de traitement du paludisme au Bénin. Congrès conjoint Sociétés Française & Espagnole de Parasitologie, 2013, Dijon.
  2. Gineau L, Luisi P, Castelli E, Courtin D, Milet J, Moreau P, Donadi E, Garcia A, Sabbagh A. Tolerance versus immunity: evidence of balancing selection at the HLA-G promoter region. European Human Genetics Conference, 2013, Paris.

OS UMR216 : 

  1. Koura G, Bodeau-Livinec F, Cot M. Assessing the effects of maternal anemia on child development in Benin. In: Neuropsychology of children in Africa. Perspectives on risk and resilience, MJ Boivin and B Giordani Ed., Springer, New York 2013, 347 p.
  2. Baxerres C, Simon E (eds). Les médicaments dans les Suds, Autrepart, 2013, éditions des presses de Sciences Po, 192 p.

PV

  1. Chippaux JP. Les envenimations ophidiennes dans les départements de Martinique et Guyane : problèmes spécifiques liés aux conditions environnementales et logistiques. Mondes et Cultures, 2013, 72:sous presse.

 

 

ACL

  1. Faucher JF, Socolovschi C, Aubry C, Chirouze C, Hustache-Mathieu L, Raoult D, Hoen B. Brill-Zinsser disease in Moroccan man, France, 2011. Emerg Infect Dis, 2012, 18:171-2.
  2. Cottrell G, Kouwaye B, Pierrat C, Le Port A, Bouraïma A, Fonton N, Hounkonnou MN, Massougbodji A, Corbel V, Garcia A. Modeling the influence of local environmental factors on malaria transmission in Benin and its implications for cohort study. PLoS One, 2012, 7:e28812.
  3. Le Port A, Cottrell G, Martin-Prevel Y, Migot-Nabias F, Cot M, Garcia A. First malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results. BMJ Open, 2012, 2:e000342
  4. Moiroux N, Boussari O, Djènontin A, Damien G, Cottrell G, Henry MC, Guis H, Corbel V. Dry season determinants of malaria disease and net use in Benin, West Africa. PLoS One, 2012, 7:
  5. Slim R, Coullin P, Diatta AL, Chebaro W, Courtin D, Abdelhak S, Garcia A. NLRP7 and the genetics of postmolar choriocarcinomas in Senegal. Mol Hum Reprod, 2012, 18:52-6.
  6. Koura GK, Ouedraogo S, Le Port A, Watier L, Cottrell G, Guerra J, Choudat I, Rachas A, Bouscaillou J, Massougbodji A, Garcia A. Anaemia during pregnancy: impact on birth outcome and infant haemoglobin level during the first 18 months of life. Trop Med Int Health, 2012, 17:283-291.
  7. Rachas A, Le Port A, Cottrell G, Guerra J, Choudat I, Bouscaillou J, Massougbodji A, Garcia A. Placental malaria is associated with increased risk of non-malaria infection during the first 18 months of life in a Beninese population. Clin Infect Dis, 2012, 55:672-8.
  8. Jamonneau V, Ilboudo H, Kabore J, Kaba D, Koffi M, Solano P, Garcia A, Courtin D, Laveissiere C, Lingue K, Buscher P, Bucheton B. Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis, 2012, 6:113
  9. Chippaux JP. African Society of Toxinology: a new opportunity for integrating the control of envenomations in Africa. J Venom Anim Toxins incl Trop Dis, 2012, 18: 357-360.
  10. Chippaux JP. Epidemiological investigation on envenomation: from theory to practice. J Venom Anim Toxins incl Trop Dis, 2012, 18: 446-450.
  11. Drame PM, Machault V, Diallo A, Cornelie S, Poinsignon A, Lalou R, Sembene M, Dos Santos S, Rogier C, Pages F, Le Hesran JY, Remoue IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Senegal. Malar J, 2012, 11:72.
  12. Rouleau D, Fournier P, Philibert A, Mbengue B, Dumont A. Exploring the effects of midwives’ job satisfaction on burnout, intention to quit and turnover: a longitudinal study in Senegal. Hum Resour Health, 2012, 10:9.
  13. Zongo A, Dumont A. Effet de l’organisation des services de gynéco-obstétrique sur la mortalité maternelle hospitalière au Mali. Rev Epidémiol Santé Publique, 2012, 60:265-74.
  14. Develoux M, Le Loup G, Dautheville S, Belkadi G, Magne D, Lassel L, Bonnard P, Pialoux G. [Malaria among immigrants, experience of a Parisian hospital (2006-2010)]. Bull Soc Pathol Exot, 2012, 105:95-102.
  15. Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O, French Mycosis Study Group (dont Houzé S). Diagnosis, management and outcome of Candida Clin Microbiol Infect, 2012, 18:E99-E109.
  16. Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C, ANRS COPANA Cohort Study Group (dont Houzé S et JF Faucher). Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort. Antivir Ther, 2012, 17:91-100.
  17. Dray-Spira R, Legeai C, Le Den M, Boué F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L, ANRS-COPANA Cohort Study Group (dont Houzé S). Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use. AIDS, 2012, 26:207-15.
  18. Villard O, Cimon B, Franck J, Fricker-Hidalgo H, Godineau N, Houzé S, Paris L, Pelloux H, Villena I, Candolfi E, The network from the French National Reference Center for Toxoplasmosis. Evaluation of the usefulness of six commercial agglutination assays for serologic diagnosis of toxoplasmosis. Diagn Microbiol Infect Dis, 2012, 73:231-5.
  19. Baldé MC, Chippaux JP, Boiro MY, Stock R, Massougbodji A. [Clinical study of tolerance and effectiveness of a F(ab’)(2) polyvalent antienom for African snake bites in Kindia, Guinea.] Bull Soc Pathol Exot 2012, 105:157-61.
  20. Chippaux JP. Epidemiology of snakebites in Europe: a systematic review of the literature. Toxicon, 2012, 59:86-99.
  21. Piquet A, Toudonou C, Konetché L, Sinsin B, Chippaux JP. [Preliminary study of snake fauna in the Lama forest, South Benin.]. Bull Soc Pathol Exot, 2012, 105:166-70.
  22. Chippaux JP, Diouf A, Massougbodji A, Stock RP, Kane O, Dièye AM, Lam FA, Mbaye SM, Parra HJ. [The 4th International Conference on envenomation by snakebites and scorpion stings in Africa. Dakar 25-29 April 2011]. Bull Soc Pathol Exot, 2012, 105:194-188.
  23. Salas Clavijo NA, Postigo JR, Schneider D, Santalla JA, Brutus L, Chippaux JP. Prevalence of Chagas disease in pregnant women and incidence of congenital transmission in Santa Cruz de la Sierra, Bolivia. Acta Trop, 2012, 124:87-91.
  24. Denoeud-Ndam L, Clement MC, Briand V, Akakpo J, Agossou K, Atadokpede F, Dossou-Gbete L, Komongui D, Afangnihoun A, Girard PM, Zannou DM, Cot M. Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin. J Acquir Immune Defic Syndr, 2012, 61:64-72.
  25. Ouedraogo S, Koura GK, Accrombessi MMK, Bodeau-Livinec F, Massougbodji A, Cot M. Maternal anemia at first antenatal visit: prevalence and risk factors in a malaria-endemic area in Benin. Am J Trop Med Hyg, 2012, 87:418-24.
  26. Gharbi M, Pillai DR, Lau R, Hubert V, Khairnar K, Existe A, Kendjo E, Dahlström S, Guerin PJ, Le Bras J. Chloroquine-resistant Plasmodium falciparum malaria in travellers from Haiti after the 2010 earthquake. Emerg Infect Dis, 2012, 18:1346-9.
  27. Bordbar B, Tuikue Ndam N, Doritchamou J, Moussiliou A, Quiviger M, Scherman D, Bigey P, Deloron P. Identification of Id1-DBL2X of VAR2CSA as a key domain inducing highly inhibitory and cross-reactive antibodies. Vaccine, 2012, 30:1343-8.
  28. Carlier Y, Truyens C, Deloron P, Peyron F. Congenital parasitic infections: A review. Acta Trop, 2011, 2012, 121:55-70.
  29. Lino Cardenas CL, Devos A, Toure A, Cardenas Garcia J, Kenani A, Migot-Nabias F, Broly F, Chevalier D. Arachidonic acid ω-hydroxylase CYP4A11: inter-ethnic variations in the 8590T>C loss-of-function variant. Mol Biol Rep, 2012, 39:1503-8.
  30. Menard S, Morlais I, Tahar R, Sayang C, Issamou Mayengue P, Iriart X, Benoit-Vical F, Lemen B, Magnaval JF, Awono-Ambene P, Basco LK, Berry A. Molecular monitoring of Plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaounde, Cameroon: Implications for the future. Malar J, 2012, 11:113.
  31. Durand R, Migot-Nabias F, Andriantsoanirina V, Seringe E, Viwami F, Sagbo J, Lalya F, Deloron P, Mercereau-Puijalon O, Bonnefoy S. Possible association of the Plasmodium falciparum T1526C resa2 gene mutation with severe malaria. Malar J, 2012, 11:128.
  32. Seydel L, Petelski A, van Dam G, van der Kleij D, Kruize-Hoeksma Y, Luty AJF, Yazdanbakhsh M, Kremsner P. In utero sensitization to Schistosoma haematobium is associated with enhanced cord blood IgE and frequencies of CD5- B-cells are increased in African newborns. Am J Trop Med Hyg, 2012, 86:613-619.
  33. Minja D, Schmiegelow C, Oesterholt M, Magistrado P, Boström S, John D, Pearhson AC, Andersen D, Deloron P, Salanti A, Lemnge M, Luty AJF, Alifrangis M, Theander T, Lusingu J. Reliability of rapid diagnostic tests in diagnosing pregnancy associated malaria in northeastern Tanzania. Malaria J, 2012, 11:211.
  34. Haste NM, Talabani H, Doo A, Merckx A, Langsley G, Taylor SS. Exploring the Plasmodium falciparum cyclic-adenosine monophosphate (cAMP)-dependent protein kinase (PfPKA) as a therapeutic target. Microbes Infect, 2012, 14:838-50.
  35. Bordbar B, Gnidehou S, Tuikue Ndam N, Doritchamou J, Moussiliou A, Quiviger M, Deloron P, Scherman D, Bigey P. Electroporation-mediated genetic vaccination for antigen mapping: application to Plasmodium falciparum VAR2CSA protein. Bioelectrochemistry, 2012, 87:132-7.
  36. Diallo A, Ndam NT, Moussiliou A, Dos Santos S, Ndonky A, Borderon M, Oliveau S, Lalou R, Le Hesran JY. Asymptomatic carriage of Plasmodium in urban Dakar: the risk of malaria should not be underestimated. Plos One, 2012, 7:e31100.
  37. Huynh BT, Fievet N, Briand V, Borgella S, Massougbodji A, Deloron P, Cot M. Consequences of gestational malaria on birth weight: finding the best timeframe for intermittent preventive treatment administration. PLoS One, 2012, 7:
  38. Cojean S, Houzé S, Haouchine D, Huteau F, Lariven S, Hubert V, Michard F, Bories C, Pratlong F, Le Bras J, Loiseau PM, Matheron S. Leishmania resistance to miltefosine associated with genetic marker. Emerg Infect Dis, 2012, 18:704-6.
  39. Chippaux JP. Emerging options for the management of scorpion stings. Drug Des Devel Ther, 2012, 6:165-73.
  40. Diallo A, Dos Santos S, Lalou R, Le Hesran JY. Perceived malaria in the population of an urban setting: a skipped reality in Dakar, Senegal. Malaria J, 2012, 11:340.
  41. Dechavanne C, Guillonneau F, Chiappetta G, Sago L, Lévy P, Salnot V, Guitard E, Ehrenmann F, Broussard C, Chafey P, Le Port A, Vinh J, Mayeux P, Dugoujon JM, Lefranc MP, Migot-Nabias F. Mass spectrometry detection of G3m and IGHG3 alleles and follow-up of differential mother and neonate IgG3. PLoS One, 2012, 7:e46097.
  42. Briand V, Dumont A, Abrahamowicz M, Sow A, Traore M, Rozemberg PWatier L, Fournier P. Maternal and perinatal outcomes by mode of delivery in Senegal and Mali: a cross-sectional epidemiological survey. PLoS One, 2012, 7:e47352.
  43. Abdou A, Tligui M, Le Loup G, Raynal G. [A western cohort of urinary schistosomiasis]. Prog Urol, 2012, 22:598-601.
  44. Ouedraogo S, Bodeau-Livinec F, Briand V, Huynh BT, Koura GK, Accrombessi MMK, Fievet N, Massougbodji A, Deloron P, Cot M. Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy. Malaria J, 2012, 11:348.
  45. Ecker A, Lehane AM, Clain J, Fidock DA. PfCRT and its role in antimalarial drug resistance. Trends Parasitol. 2012, 28:504-14.
  46. Pirkle CM, Dumont A, Traore M, Zunzunegui MV. Validity and reliability of criterion based clinical audit to assess obstetrical quality of care in West Africa. BMC Pregnancy Childbirth, 2012, 12:118.
  47. Briand V, Dumont A, Abrahamowicz M, Traore M, Watier L, Fournier P. Individual and institutional determinants of caesarean section in Senegal and Mali referral hospitals: a cross-sectional epidemiological survey. BMC Pregnancy Childb, 2012, 12:114.
  48. Faucher JF, Chirouze C, Coutris C, Fery-Blanco C, Maurin M, Hoen B. Typhoidal tularemia: 2 familial cases. Case Rep Infect Dis, 2012, 2012:214215.
  49. Boström S, Ibitokou S, Oesterholt M, Schmiegelow C, Persson JO, Minja D, Lusingu J, Lemnge M, Fievet N, Deloron P, Luty AJF, Troye-Blomberg M. 2012. Biomarkers of Plasmodium falciparum infection during pregnancy in women living in northeastern Tanzania. PLoS One, 2012,7:e48763.
  50. Pirkle C, Dumont A, Zunzunegui MV. Medical recordkeeping, essential but overlooked aspect of quality of care in resource-limited countries. Int J Quality in Health Care, 2012, 24:564-7.
  51. Imrie HJ, Fowkes FJI, Migot-Nabias F, Luty AJF, Deloron P, Hajduk SL, Day KP. Individual variation in levels of haptoglobin-related protein in children from Gabon. PLoS One, 2012, 7:e49816.
  52. Groh M, Faussart A, Villena I, Ajzenberg D, Carme B, Demar M, Joly V, Houze S, Simon S, Aubert D, Charlois-Ou C, Yeni P. Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient. PLoS Negl Trop Dis, 2012, 6:e1802.
  53. Doritchamou J, Bertin G, Moussiliou A, Viwami F, Massougbodji A, Deloron P, Tuikue Ndam N. First trimester Plasmodium falciparum infections display a ‘typical placental phenotype’. J Infect Dis, 2012, 12:1911-19.
  54. Ibitokou S, Oesterholt M, Brutus L, Borgella S, Agbowaï C, Ezinmègnon S, Lusingu J, Massougbodji A, Deloron P, Troye-Blomberg M, Varani S, Luty AJF, Fievet N. Peripheral blood cell signatures of Plasmodium falciparum infection during pregnancy. PLoS One, 2012, 7:e49621.
  55. Koura KG, Ouédraogo S, Cottrell G, Le Port A, Massougbodji A, Garcia A. Maternal anaemia at delivery and haemoglobin evolution in children during their first 18 months of life using latent class analysis. PLoS One, 2012;7:e50136.
  56. Fournier P, Dumont A, Traoré M, Philibert A, Tourigny C, Coulibaly A. Évaluation de la gratuité de la césarienne au Mali. Rev Épidém Santé Publ, 2012, 60:S90.
  57. Ravit M, Philibert A, Coulibaly A, Dumont A, Tourigny C, Fournier P. Analyse des dépenses des femmes césarisées dans la région de Kayes au Mali. Rev Épidém Santé Publ, 2012, 60:S136.
  58. Patillon B, Luisi P, Blanché H, Patin E, Cann HM, Génin E, Sabbagh A. Positive selection in the chromosome 16 VKORC1 genomic region has contributed to the variability of anticoagulant response in humans. PLoS One, 2012, 7:e53049.
  59. Dumont A. How to reduce maternal mortality? Bull Acad Natl Med, 2012, 196:1521-32.
  60. Sandeu M, Moussiliou A, Moiroux N, Padonou G, Massougbodji A, Corbel V, Tuikue Ndam N. Optimized pan-species and speciation duplex real-time PCR assays for Plasmodium parasites detection in malaria vectors. PLoS One, 2012, 7:e52719.
  61. Dumont A, Gueye M, Sow A, Diop I, Konate KM, Dambé P, Abrahamowicz A, Fournier P. Utilisation des données recueillies en routine pour évaluer l’activité des maternités au Mali et au Sénégal (essai QUARITE). Rev Epidémiol Santé Publ, 2012, 60:489-96.
  62. Durand R, Cannet A, Berdjane Z, Bruel C, Haouchine D, Delaunay P, Izri A. Infestation by pyrethroids resistant bed bugs in the suburb of Paris, France. Parasite, 2012, 19:381-7
  63. Ndounga M, Tahar R, Casimiro PN, Loumouamou D, Basco LK. Clinical efficacy of artemether-lumefantrine in Congolese children with acute uncomplicated falciparum malaria in Brazzaville, 2012, Malar Res Treat, 2012, 2012:749479.
  64. Estavoyer JM, Chirouze C, Faucher JF, Floret N, Couetdic G, Leroy J, Hoen B. Leptospirosis in Franche-Comté (France): clinical, biological, and therapeutic data. Med Mal Infect, 2012, 43:379-85.
  65. Bouquier J, Fauconnier A, Fraser W, Dumont A, Huchon C. Diagnosis of pelvic inflammatory disease. Which clinical and paraclinical criteria? Role of imaging and laparoscopy? J Gynecol Obstet Biol Reprod, 2012, 41:835-49.
  66. Ménard D, Andriantsoanirina V, Khim N, Ratsimbasoa A, Witkowski B, Benedet C, Canier L, Mercereau-Puijalon O, Durand R. Global analysis of Plasmodium falciparum Na+/H+ exchanger (pfnhe-1) allele polymorphism and its usefulness as a marker of in vitro resistance to quinine. Int J Parasitol Drugs Drug Resist, 2012, 3:8-19.

ACL divers chercheurs avant leur intégration à l’UMR 216

  1. Barbier M, Sabbagh A, Kasper E, Asheuer M, Ahouansou O, Pribill I, Forss-Petter S, Vidaud M, Berger J, Aubourg P. CD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy. PLoS One, 2012, 7:e29872.

ACLN

  1. Baxerres C. Les usages du médicament au Bénin : Quand le contexte local et global s’associent pour favoriser une importante consommation pharmaceutique. Revue Internationale sur le médicament, 2012, sous presse.

ASCL

  1. Chippaux JP. Deux helminthiases historiques : dracunculose et bilharziose. Bull Assoc Anciens El Inst Pasteur, 2012, 54:11-3.

C-INV

  1. Baxerres C, Simon E. La circulation des médicaments au Sud : une « chaîne dérégulée » ? Séminaire « médicaments, drogues, agents thérapeutiques ». 2012, IReSaP, Nancy.
  2. Baxerres C. Pourquoi trouve-t-on des médicaments « du Nigeria et du Ghana » au Bénin ? Une comparaison des systèmes pharmaceutiques des pays anglophones et francophones d’Afrique. Séminaire de recherche en anthropologie de la santé, 2012, UAC – LASDEL – IRD, Cotonou.
  3. Chippaux JP. Meta-análisis de las mordeduras de serpientes en Europa y el uso de antivenenos. Panel de Expertos “Intoxicacion por mordeduras de ofidios venenosos en España”, 2012, Logroño, La Rioja, Espagne.
  4. Chippaux JP. Morsures de serpent en Afrique : un problème de santé publique négligé. Colloque international sur les envenimations par morsure de serpents et piqûres de scorpions, 2012, Cotonou, Bénin.
  5. Chippaux JP. Estimating the global burden of snakebite can help to improve management. 17th World Congress of the International Society of Toxinology, 2012, Honolulu, Hawaï, USA.
  6. Baxerres C. Faux médicaments, de quoi parle-t-on ? Contrefaçons, marché informel, qualité des médicaments… Réflexions à partir d’une étude anthropologique conduite au Bénin. Journée scientifique de la Société de pathologie exotique, 2012, Paris.
  7. Dumont A. Prise en charge obstétricale dans les pays en développement : Comment réduire la mortalité maternelle ? Académie Nationale de Médecine, 2012, Paris.
  8. Deloron P. PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum Indo-french seminar « New vaccines development and immunology of infectious diseases » (CEFIPRA), 2012, Hyderabad, India.
  9. Deloron P. Les défis du paludisme associé à la grossesse. Université Libre de Bruxelles, 2012.
  10. Deloron P. Modifications membranaires du globule rouge infecté par Plasmodium falciparum. 1er congrès scientifique du Gr-Ex, 2012, Paris.

C-ACTI 

  1. Baldé MC, Chippaux JP, Boiro MY, Trape JF, Stock RP, Massougbodji A. Epidemiology and severity of snakebite in Guinea. 17th World Congress of the International Society of Toxinology, 2012, Honolulu, Hawaï, USA.
  2. Gras S, Plantefève G, Chippaux JP. Incidence and management of snakebite in Northern Central African Republic. 17th World Congress of the International Society of Toxinology, 2012, Honolulu, Hawaï, USA. In: Toxicon, 2012, 60:217-218.
  3. Baldé MC, Chippaux JP, Boiro MY, Stock RP, Massougbodji A. Use of antivenoms for the treatment of envenomation by Elapidae in Guinea. 17th World Congress of the International Society of Toxinology, 2012, Honolulu, Hawaï, USA.
  4. Baxerres C. How is it going to end? Pregnancy in a context of high maternal mortality. EASA conference, 2012 Paris,. In: http://www.easaonline.org/conferences/easa2012/downloads/conference_programme.pdf, p182.
  5. Dumont A, Fournier P. QUARITE (quality of care, risk management and technology in obstetrics): a cluster-randomised trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali. 20th FIGOn World Congress of Gynaecology and Obstetrics, 2012, Rome, Italie.
  6. Pirkle C, Dumont A. Reliability and validity of criterion based clinical audit to assess obstetric quality of care in Mali and Senegal. 20th FIGOn World Congress of Gynaecology and Obstetrics, 2012, Rome, Italie
  7. Fournier P, Dumont A. Mother and newborn survival after free caesarian section in Mali (Africa). 20th FIGOn World Congress of Gynaecology and Obstetrics, 2012, Rome, Italie.
  8. Bordbar B, Gnidehou S, Tuikue Ndam N, Doritchamou J, Moussiliou A, Quiviger M, Deloron P, Scherman D, Bigey P. Electroporation-mediated genetic vaccination for antigen mapping : application to Plasmodium falciparum VAR2CSA protein. 15th Annual Meeting of the American Society of Gene and Cell Therapy, 2012, Philadelphia, USA. In: Molecular Therapy, 2012, 20:
  9. Gbédandé K, Ezinmegnon S, Ibitokou S, Borgella S, Nouatin S, Hougbegnon P, Massougbodji A, Adeotou-laï A, Moutairou K, Varani S, Troye-Blomberg M, Deloron P, Fievet N, Luty AJF. Consequences of malaria during pregnancy on neonatal antigen presenting cell activation and on responses to toll-like receptors and falciparum antigens in Benin. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:S210.
  10. Nouatin O, Agbowai C, Ibitokou S, Ezinmègnon S, Borgella S, Gbedande B, Houngbégnon P, Massougbodji A, Moutairou K, Varani S, Troye-Blomberg M, Deloron P, Fievet N, Luty AJF. Consequence of malaria during pregnancy on immunological responses of the newborn: a study of regulatory T cells. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:
  11. Ibitokou S, Oesterholt M, Brutus L, Agbowaï C, Ezinmègnon S, Borgella S, Lusingu J, Massougbodji A, Deloron P, Troye-Blomberg M, Varani S, Fievet N, Luty AJF. African women’s peripheral blood mononuclear cell composition is altered by Plasmodium falciparum infection independently of gestational age or delivery. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:
  12. Briand V, Ghafari C, Huynh BT, Massougbodji A, Deloron P, Fievet N, Cot M. Effect of early malaria in pregnancy on fetal growth retardation in Africa. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA.
  13. Fievet N, Borgella S, Huynh BT, Ibitokou S, Hougbegnon P, Hounguevou G, Massougbodji A, Cot M, Deloron P. Impact of pregnancy-associated malaria on infant malaria infection and anemia in southern Benin. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA.
  14. Ouedraogo S, Koura GK, Bodeau-Livinec F, Accrombessi MM, Massougbodji A, Cot M. Maternal anemia in pregnancy: assessing the impact of preventive measures in a malaria endemic area. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:S111-2.
  15. Ouédraogo S, Bodeau-Livinec F, Briand V, Huynh BT, Koura GK, Massougbodji A, Cot M. Malaria and gravidity interact to modify maternal haemoglobin concentrations during pregnancy. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:S110-1.
  16. Gharbi M, Pillai DR, Lau R, Hubert V, Khairnar K, Kendjo E, Existe A, Dahlstrom S, Guérin PJ, Le Bras J. Chloroquine-resistant Plasmodium falciparum malaria in travelers from Haiti after the 2010 earthquake. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:
  17. Gharbi M, Flegg J, Hubert V, Kendjo E, Metcalf J, Guérin PJ, Le Bras J. Return of chloroquine susceptibility of Plasmodium falciparum strains in travelers returning from West Africa. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:
  18. Gharbi M, Flegg J, Ndiaye M, Pradines B, Roper C, Hubert V, Kendjo E, Brasseur P, Gaye O, Djimdé A, Berenger A, Offianan AT, Penali L, Le Bras J, Guérin PJ. Traveler’s surveillance: a tool for detecting emergence of antimalarial drug resistance in endemic countries. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:S261-2.
  19. Flegg JA, Metcalf J, Gharbi MJ, Guerin PJ. Monitoring antimalarial drug use in relation to national drug policy. 61th Ann Meet Am Soc Trop Med Hyg, 2012, Atlanta, USA. In: Am J Trop Med Hyg, 2012, 67:
  20. Chene A, Briand V, Dechavanne S, Massougbodji A, Deloron P, Luty A, Gamain B, Fievet N. Study of placental cytokines/chemokines associated with mother and child clinical outcomes during Pregnancy Associated Malaria. 62th Ann Meet Am Soc Trop Med Hyg, 2012, Washington, USA.
  21. Argy N, Bertin G, Briand V, Hubert V, Deloron P, Houze S. Study of var genes expression in severe malaria in imported malaria cases. 62th Ann Meet Am Soc Trop Med Hyg, 2012, Washington, USA.

C-COM

  1. Fourcade C, Denoeud-Ndam L, Hounto A, Agossou KV, d’Almeida TM, Azondékon A, Alao J, Dossou-Gbété L, Afangnihoun A, Girard PM, Cot M, Zannou DM. Facteurs prédictifs d’une charge virale du VIH indétectable en fin de grossesse dans le cadre de la PTME au Bénin. Cohorte PACOME, 2009-2011. Afravih, 2012, Genève.
  2. Rouleau D, Medah R, Fournier P, Dumont A. Les effets des décalages entre perceptions et expériences des sages-femmes sur le changement des pratiques de soins maternelles dans les hôpitaux du Mali et du Sénégal. 80e Congrès de l’Association Canadienne pour le Savoir (ACFAS). 2012, Montréal, Canada
  3. Ndour C, Dossou-Gbété S, Dumont A. Association rules mining approach for binary classication when response’s distribution is imbalanced. 57ª Reunião Anual da Região Brasileira da Sociedade Internacional de Biometria (RBras). 2012, Piracicaba, Brésil.
  4. Baxerres C. Impact de la privatisation de l’offre de soins biomédicale sur les pratiques des femmes enceintes en milieu urbain béninois. Colloque AMADES, 2012, Brest.
  5. Lam-Faye A, Chippaux JP, Massougbodji A, Diouf A. La venimologie et la lutte contre les envenimations en Afrique. Colloque International sur les Envenimations par Morsures de Serpents et Piqûres de Scorpions, 2012, Cotonou, Bénin.
  6. Baldé MC, Chippaux JP, Boiro MY, Stock RP, Massougbodji Utilisation d’un antivenin polyvalent pour le traitement des envenimations par Elapidae en Guinée. Colloque International sur les Envenimations par Morsures de Serpents et Piqûres de Scorpions, Cotonou, Bénin, 20 juin 2012.
  7. Gras S, Plantefève G, Chippaux JP. Incidence et prise en charge des morsures de serpent dans le nord de la République Centrafricaine. Colloque International sur les Envenimations par Morsures de Serpents et Piqûres de Scorpions, 2012, Cotonou, Bénin.
  8. Tchaou B, Zouménou E, Konaté M, Chobli M, Massougbodji A, Chippaux JP. Evaluation de la prise en charge des envenimations graves par morsure de serpent dans l’hôpital universitaire de Parakou après le congrès de Dakar. Colloque International sur les Envenimations par Morsures de Serpents et Piqûres de Scorpions, 2012, Cotonou, Bénin.
  9. Aloukoutou Layo E, Chippaux JP, Massougbodji A. Epidémiologie et prise en charge des envenimations dans la commune de Tchaourou, nord Bénin. Colloque International sur les Envenimations par Morsures de Serpents et Piqûres de Scorpions, 2012, Cotonou, Bénin.
  10. Zongo A, Traoré M, Faye A, Gueye M, Fournier P, Dumont A. Effet de l’organisation des services de gynéco-obstétrique sur la mortalité maternelle hospitalière au Mali. 16èmes Journées des Sciences de la Santé de Bobo-Dioulasso, 2012, Bobo-Dioulasso, Burkina Faso.
  11. Zongo A, Dumont A. Effet de l’organisation des services de gynéco-obstétrique sur la mortalité maternelle hospitalière au Mali. 16èmes Journées des Sciences de la Santé de Bobo-Dioulasso, 2012, Bobo-Dioulasso, Burkina Faso.
  12. Courtin D, Milet J, Sabbagh A, Massaro J, Castelli E, Jamonneau V, Bucheton B, Favier B, Rouass-Freiss N, Moreau P, Donadi E, Garcia A. HLA-G 3′ UTR 2 haplotype is associated with Human African Trypanosomiasis susceptibility. 6th International Conference on HLA-G, 2012, Paris, France.
  13. Dumont A, Fournier P, Traoré M. QUARITE (quality of care, risk management and technology in obstetrics): a cluster-randomised trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali. 20th FIGO World Congress of Gynaecology and Obstetrics, 2012, Rome, Italie.
  14. Fournier P, Dumont A, Traoré M. Mother and newborn survival after free caesarian section in Mali (Africa). 20th FIGO World Congress of Gynaecology and Obstetrics, 2012, Rome, Italie.
  15. Boström S, Ibitokou S, Oesterholt M, Schmiegelow C, Persson JO, Minja D, Lusingu J, Lemnge M, Fievet N, Deloron P, Luty AJF, Troye-Blomberg M. Inflammatory responses during pregnancy associated malaria. Evimalar Conference, 2012, Heidelberg, Germany.
  16. Aubatin A, Hubert V, Le Bras J, Houzé S. Place de la PCR dans le suivi thérapeutique de l’accès palustre à falciparum. Société Française de Parasitologie, 2012, Rennes.
  17. Courtin D, Milet J, Sabbagh A, Massaro J, Castelli E, Jamonneau V, Bucheton B, Favier B, Rouass-Freiss N, Moreau P, Donadi E, Garcia A. HLA-G 3′ UTR 2 haplotype is associated with Human African Trypanosomiasis susceptibility 6th Int Conf on HLA-G, 2012, Paris.
  18. Chippaux JP. Meta-análisis de las mordeduras de serpientes en Europa y el uso de antivenenos. Panel de Expertos “Intoxicacion por mordeduras de ofidios venenosos en España”, Logroño, La Rioja, Espagne, 23-24 mai 2012.

C-AFF

  1. Pirkle C, Dumont A, Nguyen VK, Zunzunegui MV. Paradoxical results when conducting evidence-based population health research, how trials of complex interventions may lead to wrong conclusions. International Conference to Advance a Population Health Intervention Research Agenda. 2012, Montreal, Québec, Canada.
  2. Pirkle C, Dumont A, Zunzunegui MV Using audit to evaluate mechanisms behind improvements in obstetrical quality of care. Forum on quality and safety in healthcare, 2012, Paris.
  3. Baldé MC, Chippaux JP, Boiro MY, Trape JF, Stock RP, Massougbodji Epidémiologie et gravité des morsures de serpent en Guinée. Colloque international sur les envenimations par morsures de serpents et piqûres de scorpions, 2012, Cotonou, Bénin.
  4. Chippaux JP. L’enquête épidémiologique concernant les envenimations : de la théorie à la pratique. Colloque International sur les Envenimations par Morsures de serpents et piqûres de scorpions, 2012, Cotonou, Bénin.
  5. Milet J, Sabbagh A, Courtin D, Massaro J, Castelli E, Favier B, Rouass-Freiss N, Moreau P, Donadi E, Garcia A. Association of HLA-G 3′ UTR polymorphisms with immune response to malaria infection. 6th Int Conf on HLA-G, 2012, Paris, France.
  6. Dechavanne S, Srivastava A, Gangnard S, Aubouy A, Fievet N, Deloron P, Gamain B. Antibody recognition of VAR2CSA single and multiple domains in a cohort of pregnant Senegalese women. Evimalar Conference, 2012, Heidelberg, Germany.
  7. Bertin G, Lavstsen T, Guillonneau F , Doritchamou J, Ezinmegnon S, Fievet N, Tuikue Ndam N, Theander T, Deloron P. Expression des gènes var et des protéines PfEMP1 associées et identifiées par MS/MS dans le cadre du paludisme. Journées Jeunes chercheurs & avenir, Université René Descartes, 2012, Paris.
  8. Ibitokou S, Boström S, Brutus L, Ndam NT, Varani S, Massougbodji A, Deloron P, Troye-Blomberg M, Fievet N, Luty AJF. Cell-Mediated and inflammatory responses during pregnancy-associated malaria. Challenges in Malaria Research: Progress Towards Elimination, 2012, Basel, Suisse.
  9. Denoeud-Ndam L, Amassé Baï J, Afangnihoun A, Pourteau-Adjahi LH, Amoussou A, Agonou F, Akakpo J, Girard PM, Cot M, Zannou DM. Impact du dépistage et de la prise en charge précoces du VIH sur l’assiduité du suivi en PTME de la gestante séropositive et de son enfant à l’hôpital de zone de Suru Léré, Cotonou, Bénin. 6ème conférence francophone VIH-sida AFRAVIH, 2012, Genève, Suisse.
  10. Fourcade C, Denoeud-Ndam L, Hounto A, Agossou KV, d’Almeida M, Azondékon A, Alao J, Dossou-Gbété L, Afangnihoun A, Girard PM, Cot M, Zannou DM. Prévention de la transmission mère-enfant du VIH au Bénin : facteurs prédictifs d’une charge virale indétectable en fin de grossesse. 6ème conférence francophone VIH-sida AFRAVIH, 2012, Genève, Suisse.

OS UMR216 

  1. Bouchaud O, Consigny Ph, Cot M, Odermatt-Biays S. Médecine des voyages – Médecine tropicale. Collection Abrégés de médecine (303 p.). Masson Ed., Paris, 2007-2009-2012 (3ème édition).
  2. Baxerres C, Simon E. (eds.). Les médicaments au Sud : nouveaux produits, nouveaux enjeux. Autrepart, (à paraître en novembre 2012).
  3. Baxerres C. Contrefaçon pharmaceutique: la construction sociale d’un problème de santé publique. In: A Desclaux, M Egrot eds: Anthropologie du médicament au Sud: Sens et usages « à la marge », Paris, Editions de l’IRD, sous presse.
  4. Baxerres C. Du médicament informel au médicament libéralisé : Une anthropologie du médicament pharmaceutique au Bénin, Paris, Les Editions des Archives Contemporaines, sous presse.
  5. Le Loup G. La santé internationale. In Bouchaud O, Consigny PH, Cot M, Le Loup G, Odermatt-Biays S. Médecine des Voyages, Médecine tropicale. Paris : Masson, 2012. 3° édition. A paraître.
  6. Ouwe-Missi-Oukem-Boyer O, Migot-Nabias F, Born C, Aubouy A, Nkenfou C. Application of PCR technologies to humans, animals, plants and pathogens from Central Africa. In: Polymerase Chain Reaction, Intech Open Access Book, ISBN 979-953-307-473-2, Hernandez-Rodriguez P Ed, Bogota, Colombia, 2012.

ACL

  1. Le Port A, Cottrell G, Dechavanne C, Briand V, Bouraima A, Guerra J, Choudat I, Massougbodji A, Fayomi B, Migot-Nabias F, Garcia A, Cot M. Prevention of malaria during pregnancy: assessing the effect of the distribution of IPTp through the national policy in Benin. Am J Trop Med Hyg, 2011, 84:270-5.
  2. Le Port A, Watier L, Cottrell G, Ouedraogo S, Dechavanne C, Pierrat C, Rachas A, Bouscaillou J, Bouraïma A, Massougbodji A, Fayomi B, Thiébaud A, Chandre F, Migot-Nabias F, Martin-Prével Y, Garcia A, Cot M. Infections in infants during the first 12 months of life: role of placental malaria and environmental factors. PLoS One, 2011, 6:e27516.
  3. Koura KG, Briand V, Massougbodji A, Chippaux JP, Cot M, Garcia A. Prévalence et étiologies de l’anémie chez la femme enceinte au sud Bénin au moment du changement de politique nationale de prise en charge. Med Trop, 2011, 71:63-7.
  4. d’Almeida TC, Agboton-Zoumenou MA, Garcia A, Massougbodji A, Briand V, Imorou Y, Cottrell G. Field evaluation of the intermittent preventive treatment of malaria during pregnancy (IPTp) in Benin: evolution of the coverage rate since its implementation. Parasit Vectors, 2011, 4:108
  5. Jambou R, Le Bras J, Randrianarivelojosia M. Pitfalls in new artemisinin-containing antimalarial drug development. Trends Parasitol, 2011, 27:82-90.
  6. Le Nagard H, Vincent C, Mentré F, Le Bras J. Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Comput Methods Programs Biomed, 2011, 104:10-8.
  7. Traore M, Dumont A, Kaya AB, Traore SO, Traore OM, Dolo A. L’approvisionnement et l’utilisation du sang au centre de sante de référence de la Commune V à Bamako au Mali. Santé, 2011, 21:33-40.
  8. Baxerres C, Pourquoi un marché informel du médicament dans les pays francophones d’Afrique ? Politique Africaine, 2011, 123:117-36.
  9. Baxerres C, Compte rendu de l’ouvrage de D. Bonnet, Repenser l’hérédité, Paris, Éd. des Archives contemporaines, L’Homme, 2011, 198-199:420-2.
  10. Bellanger AP, Faucher JF, Robedat P, Schmitt A, Millon L, Hoen B. Malaria outbreak in French troops returning from Côte d’Ivoire. Scand J Infect Dis, 2011, 43:230-3.
  11. Crouzet J, Faucher JF, Toubin M, Hoen B, Estavoyer JM. Serum C-reactive protein (CRP) and procalcitonin (PCT) levels and kinetics in patients with leptospirosis. Eur J Clin Microbiol Infect Dis, 2011, 30:299-302.
  12. Baxerres C, Le Hesran JY. Where do pharmaceuticals on the market originate? An analysis of the informal drug supply in Cotonou (Benin), Soc Sci Med, 2011, 73:1249-56.
  13. Bodeau-Livinec F, Briand V, Berger J, Xiong X, Massougbodji A, Day K, Cot M. Maternal anemia in Benin: Prevalence, risk factors and association with low birth weight. Am J Trop Med Hyg, 2011, 85:414-20.
  14. Bottero J, Briand V, Agbowai C, Doritchamou J, Massougbodji A, Cot M. Spontaneous postpartum clearance of Plasmodium falciparum parasitemia in pregnant women, Benin.   Am J Trop Med Hyg, 2011, 84:267-9.
  15. Brutus L, Ernould JC, Postigo J, Romero M, Schneider D, Santalla JA. Influence of pregnancy on Trypanosoma cruzi parasitemia in chronically infected women in a rural Bolivian community. Am J Trop Med Hyg. 2011, 84:808-12.
  16. Buekens P, Bréart G, Cot M, Leveque A, Massougbodji A, Rodriguez López MH. Global health: a globalized public health. Rev Epidemiol Sante Publique, 2011, 59:73-5.
  17. Chippaux JP. Estimate of the burden of snakebites in sub-Saharan Africa: a meta-analytic approach. Toxicon, 2011, 57:586-99.
  18. Chippaux JP, Diouf A, Stock RP, Parra HJ, Massougbodji A. Report of the 4th international conference on envenomations by snakebites and scorpion stings in Africa, Dakar, April 25-29, 2011. Toxicon, 2011, 58:426-9.
  19. Archundia IG, de Roodt AR, Ramos-Cerrillo B, Chippaux JP, Olguín-Pérez L, Alagón A, Stock RP. Neutralization of Vipera and Macrovipera venoms by two experimental polyvalent antisera: a study of paraspecificity. Toxicon, 2011, 57:1049-56.
  20. Flateau C, Le Loup G, Pialoux G. Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Lancet Infect Dis, 2011,11:541-56.
  21. Khattabi A, Soulaymani-Bencheikh R, Achour S, Salmi LR, Scorpion consensus expert group (dont Chippaux JP). Classification of clinical consequences of scorpion stings: consensus development. Trans R Soc Trop Med Hyg, 2011, 105:364-9.
  22. Basile L, Jansà JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, Seixas J, Van Gool T, Cañavate C, Flores-Chávez M, Jackson Y, Chiodini PL, Albajar-Viñas P, Working Group on Chagas Disease (dont Le Loup G). Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill, 2011, 16:37
  23. Le Loup G, Pialoux G, Lescure FX. Update in treatment of Chagas disease. Curr Opin Infect Dis, 2011, 24:428-34.
  24. Stankovic Stojanovic K, Lionnet F, Girot R, Lescure FX, Pialoux G, Le Loup G. The risk of going abroad in sickle cell disease: a study of 148 adults. Trans R Soc Trop Med Hyg, 2011, 105:310-4.
  25. MBaye E, Dumont A, Ridde V, Briand V, Ridde V. « En faire plus pour gagner plus » : la pratique de la césarienne dans trois contextes d’exemption des paiements au Sénégal. Santé Publique 2011, 23:207-19.
  26. Romero M, Postigo J, Schneider D, Chippaux JP, Santalla JA, Brutus L. Door-to-door screening as a strategy for the detection of congenital Chagas disease in rural Bolivia. Trop Med Int Health. 2011, 16:562-9.
  27. Sarrassat S, Lalou R, Cissé M, Le Hesran JY. Management of uncomplicated malaria in children under 13 years of age at a district hospital in Senegal: from official guidelines to usual practices. Malar J, 2011, 10:285
  28. Pirkle C, Dumont A, Zunzunegui MV. Criterion-based clinical audit to assess quality of obstetrical care in low- and middle-income countries: a systematic review. Intern J Quality in Health Care, 2011, 23:456-63.
  29. Dogba M, Fournier P, Dumont A, Zunzunegui MV, Tourigny C, Berthe-Cisse S. Mother and newborn survival according to point of entry and type of human resources in a maternal referral system in Kayes (Mali). Reprod Health, 2011, 8:13
  30. Le Hesran JY. L’élaboration des stratégies de lutte : nécessité d’une réflexion transdisciplinaire : commentaire. Sciences Sociales et Santé, 2011, 29:95-103.
  31. Magistrado PA, Minja D, Doritchamou J, Ndam NT, Davis J, Schmiegelow C, Massougbodji A, Dahlbäck M, Ditlev SB, Pinto VV, Resende M, Lusingu J, Theander TG, Salanti A, Nielsen MA. High efficacy of anti-DBL4e-VAR2CSA antibodies in inhibition of CSA-binding Plasmodium falciparum-infected erythrocytes from pregnant women. Vaccine, 2011, 29:437-43.
  32. Bigey P, Gnidehou S, Doritchamou J, Quiviger M, Viwami F, Couturier A, Salanti A, Nielsen MA, Scherman D, Deloron P, Tuikue Ndam N. Identification of functionally antigenic sites in the Plasmodium falciparum erythrocyte membrane protein VAR2CSA. J Infect Dis, 2011, 204:1125-33.
  33. Chen DS, Barry AE, Leliwa-Sytek A, Smith TA, Petersen I, Brown SM, Migot-Nabias F, Deloron P, Kortok MK, Marsh K, Daily JP, Ndiaye D, Sarr O, Mboup S, Day K. A molecular epidemiological study of var gene diversity to characterize the reservoir of Plasmodium falciparum in humans in Africa.  PLoS One, 2011, 6:e16629.
  34. Menemedengue V, Sahnouni K, Basco L, Tahar R. Molecular epidemiology of malaria in Cameroon. XXX. Sequence analysis of Plasmodium falciparum ATPase 6, dihydrofolate reductase, and dihydropteroate synthase resistance markers in clinical isolates from children treated with an artesunate-sulfadoxine-pyrimethamine combination. Am J Trop Med Hyg, 2011, 85:22-5.
  35. Prendki V, Stirnemann J, Pham I, Poignard P, Le Henaff L, Houzé S, Sellier N, Fain O. Amebic liver abscess, extensive thrombosis, and patent cardiac foramen ovale. J Travel Med, 2011, 18:427-9.
  36. Yera H, Dupont D, Houzé S, Ben M’rad M, Pilleux F, Sulahian A, Gatey C, Andrieu FG, Dupouy-Camet J. Confirmation and follow-up of neurocysticercosis by real-time PCR in cerebrospinal fluid samples of patients living in France. J Clin Microbiol, 2011, 49:4338-40.
  37. Migot-Nabias F, Lokossou AG, Vigan-Womas I, Guitard E, Guillotte M, Noukpo JM, Mercereau-Puijalon O, Dugoujon JM, Garcia A. Combined effects of Gm or Km immunoglobulin allotypes and age on antibody responses to Plasmodium falciparum VarO rosetting variant in Benin. Microbes Infect, 2011, 13:771-5.
  38. Soulard V, Amadoudji ZM, Fitting C, Ibitokou S, Oesterholt M, Luty AJF, Perrin RX, Massougbodji A, Deloron P, Bandeira A, Fievet N. Placental malaria-associated suppression of parasite-specific immune response in neonates has no major impact on systemic CD4 T cell homeostasis. Infect Immun, 2011, 79:2801-9.
  39. Tahar R, Vivas L, Basco L, Thompson E, Ibrahim H, Boyer J, Nepveu F. Indolone–N-oxide derivatives: In vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs. J Antimicrob Chemother, 2011, 66:2566-72.
  40. Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M, Deloron P. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Malar J, 2011, 10:196
  41. Courtin D, Djilali-Saïah A, Milet J, Soulard V, Gaye O, Migot-Nabias F, Sauerwein R, Garcia A, Luty AJ. Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria. Parasite Immunol, 2011, 33:124-31.
  42. Courtin D, Milet J, Bertin G, Vafa M, Sarr JB, Watier L, Deloron P, Troye-Blomberg M, Garcia A, Migot-Nabias F. G6PD A-variant influences the antibody responses to Plasmodium falciparum Infect Genet Evol, 2011, 11:1287-92.
  43. Houzé S, Hubert V, Cohen DP, Rivetz B, Le Bras J. Evaluation of the Clearview® malaria pLDH malaria rapid diagnostic test in a non-endemic setting. Malar J, 2011, 10:284
  44. Houzé S, Hubert V, Le Pessec G, Le Bras J, Clain J. Combined deletions of pfhrp2 and pfhrp3 genes result in Plasmodium falciparum malaria false-negative rapid diagnostic test. J Clin Microbiol. 2011, 49:2694-6.
  45. Huynh BT, Fievet N, Gbaguidi G, Dechavanne S, Borgella S, Guezo-Mevo B, Massougbodji A, Tuikue Ndam N, Deloron P, Cot M. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anaemia in Benin. Am J Trop Med Hyg, 2011, 85:221-4.
  46. Huynh BT, Fievet N, Massougbodji A, Deloron P, Cot M. Malaria associated symptoms in pregnant women followed-up in Benin. Malar J, 2011, 10:72
  47. Sabbagh A, Darlu P, Crouau-Roy B, Poloni ES. Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS One, 2011, 6:e18507.
  48. Seringe E, Thellier M, Fontanet A, Legros F, Bouchaud O, Ancelle T, Kendjo E, Houzé S, Le Bras J, Danis M, Durand R, French national reference center for imported malaria study group. Severe imported Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis, 2011, 17:807-13.

ACL divers chercheurs avant leur intégration à l’UMR 216

  1. Pasmant E, Sabbagh A, Vidaud M, Bièche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J, 2011, 25:444-8.
  2. Yazdanbakhsh M, Luty AJF. Wormy mothers, healthy babies:case closed or conundrum? Lancet, 2011, 377:6-8.
  3. van Santen S, de Mast Q, Luty AJF, Wiegerinck ET, van der Ven AJAM, Swinkels DW. Iron homeostasis in mother and child during placental malaria infection. Am J Trop Med Hyg, 2011, 84:148-51.
  4. Depinay N, Franetich JF, Gruner AC, Mauduit M, Chavatte JM, Luty AJF, van Gemert GJ, Sauerwein RW, Siksik JM, Hannoun L, Mazier D, Snounou G, Renia L. Inhibitory effect of TNF-a on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations. PLoS One, 2011, 6:e17464.
  5. Roestenberg M, Teirlinck AC, McCall MBB, Teelen K, Nganou-Makamdop K, Wiersma J, Arens T, Beckers P, van Gemert GJ, van de Vegte-Bolmer M, van der Ven AJAM, Luty AJF, Hermsen CC, Sauerwein RW. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study. Lancet, 2011, 377:1770-6.
  6. Adegnika AA, Luty AJF, Grobusch MP, Ramharter M, Yazdanbakhsh M, Kremsner PG, Schwarz NG. ABO blood group and the risk of placental malaria in sub-Saharan Africa. Malar J, 2011, 10:101
  7. Köhler C, Adegnika AA, van der Linden R, Luty AJF, Kremsner PG. Phenotypic characterization of mononuclear blood cells from pregnant Gabonese and their newborns. Trop Med Int Health, 2011, 16:1061-9.
  8. Douradinha B, van Dijk M, van Gemert GJ, Khan SM, Janse CJ, Waters AP, Sauerwein RW, Luty AJF, Silva-Santos B, Mota MM, Epiphanio S. Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver. J Immune Based Ther Vaccines, 2011, 9:6
  9. Pasmant E, Sabbagh A, Masliah-Planchon J, Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K, Valeyrie-Allanore L, Parfait B, Vidaud D, Bièche I, Lantieri L, Wolkenstein P, Vidaud M, the members of the NF France network. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J Natl Cancer Inst, 2011, 103:1713-22.
  10. Teirlinck AC, McCall MBB, Roestenberg M, Scholzen A, Woestenenk R, de Mast Q, vd Ven AJAM, Hermsen CC, Luty AJF, Sauerwein RW. Longevity and composition of cellular immune responses following experimental Plasmodium falciparum malaria infection in humans. PLoS Pathogens, 2011, 7:e1002389.

ACLN

  1. Baxerres C. Local/global articulations and the high use of pharmaceuticals in Cotonou, Benin. Medische antropologie, 2011, 23:287-98.

ASCL

  1. Chippaux JP, Perdriez B. René Le Berre (1932-2010), l’entomologiste du bout de la piste. Bull Assoc Anciens El Inst Pasteur, 2011, 53:56

BRE

  1. Migot-Nabias F, Dechavanne C, Guillonneau F, Dugoujon J-M, Lefranc M-P. Méthode de diagnostic sérologique néonatal. Brevet d’invention, demande INPI n°1157296, août 2011.

C-INV

  1. Dumont A. Santé des femmes et des nouveaux-nés. Quelles sont les solutions innovatrices pour réduire la morbidité et la mortalité maternelles? Qu’en est-il des risques infectieux? IIIème Conférence Charles Mérieux, 2011, Montréal, Québec, Canada.
  2. Dumont A. Mortalité maternelle dans le monde. Journée de réflexion sur la stratégie de Médecins du Monde pour les années 2013 à 2016. 2011, Lausanne.
  3. Chippaux JP. Immunothérapie en milieu tropical : aspects théoriques et pratiques. Congrès de la Société Française de Pédiatrie, 2011, Marseille, France. Arch Pédiatr, 2011, 18(S1): H160-1.
  4. Chippaux JP. El alacranismo en África. Réunion internationale « Escorpionismo – actualizacão em saúde pública no Brasil », Niteroí, 2011, Rio de Janeiro, Brésil.
  5. Houze S. Actualités sur le paludisme : implications pour la pratique du biologiste. 31ème Journée Normande de Biologie Clinique. 2011, Rouen
  6. Baxerres C. Pratiques des femmes et recommandations biomédicales en matière de grossesse et d’accouchement dans la banlieue de Dakar, Sénégal. Séminaire « Regards croisés sur la petite enfance », 2011, EHESS.

C-ACTI UMR216: Equipe Risques et Interventions

  1. Koura KG, Beheton T, Deloron P, Garcia A, Cot M, Faucher JF. Determinants of antibiotics prescription for schoolchildren at Allada, South 3rd North American Congress of Epidemiology, 2011, Montreal, Canada. In Am J Epidemiol, 2011, 173:S225
  2. Le Port A, Watier L, Cottrell G, Ouedraogo S, Dechavanne C, Pierrat C, Bouraima A, Massougbodji A, Fayomi B, Chandre F, Migot-Nabias F, Martin-Prével Y, Garcia A, Cot M. Malaria infections in infants during the first 12 months of life: role of placental malaria and environmental factors. 7th European Congress on Tropical Medicine and International Health, 2011, Barcelone, Espagne. In: Trop Med Intern Health, 2011, 16 (Suppl. 1):88
  3. Huynh BT, Fievet N, Borgella S, Massougbodji A, Deloron P, Cot M. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anaemia in Benin. 7th European Congress on Tropical Medicine and International Health, 2011, Barcelona, Espagne. In: Trop Med Intern Health, 2011, 16 (S1):34
  4. Faucher JF, Koura G, Béhéton T, Deloron P, Garcia A, Cot M. Determinants of antibiotics prescription in school children at Allada, South Benin. 7th European Congress on Tropical Medicine and International Health, 2011, Barcelona, Espagne In: Trop Med Intern Health, 2011, 16 (S1):261-2.
  5. Koura G, Beheton T, Deloron P, Garcia A, Cot M, Faucher JF. Determinants of antibiotics prescription in schoolchildren at Allada, South Benin. 60th Ann Meet Am Soc Trop Med Hyg, 2011, Philadelphia, Pennsylvania, USA. In: Am J Trop Med Hyg, 2011, 85 S1:46-7.
  6. Huynh BT, Fievet N, Gbaguidi G, Massougbodji A, Deloron P, Cot M. Influence of the timing of malaria infection during pregnancy on birth weight and on maternal anaemia in Benin. 60th Ann Meet Am Soc Trop Med Hyg, 2011, Philadelphia, Pennsylvania, USA. In: Am J Trop Med Hyg, 2011, 85 S1:46-7.
  7. Dechavanne C, Guillonneau F, Sago L, Lévy P, Salnot V, Guitard E, Ehrenmann F, Broussard C, Chafey P, Le Port A, Lefranc MP, Dugoujon JM, Mayeux P, Migot-Nabias F. Mother and neonate distinct immunoglobulin G: a new approach using proteomics for neonatal serological diagnosis. 60th Ann Meet Am Soc Trop Med Hyg, 2011, Philadelphie, USA. In Am J Trop Med Hygiene, 2011, 85:76
  8. Boström S, Ibitokou S, Oesterholt M, Schmiegelow C, Minja D, Lusingu J, Lemnge M, Fievet N, Deloron P, Luty AJF, Troye-Blomberg Inflammatory responses during pregnancy-associated malaria. 31st Ann Meet American Society for Reproductive Immunology, 2011, Salt Lake City, USA. In: Am J Reprod Immun, 2011, 65(S1):15.
  9. Boström S, Oesterholt M, Schmiegelow C, Minja D, Lusingu J, Lemnge M, Deloron P, Luty AJF, Troye-Blomberg M. Inflammatory responses during pregnancy-associated malaria. 40th Scandinavian Society for Immunology meeting and Winter School on Vaccines, 2011, Geilo, Norway. In: Scand J Immunol, 2011, 73:381
  10. Gbédandé K, Ezinmegnon S, Ibitokou S, Borgella S, Nouatin O, Agbowai C, Massougbodji A, Adeoti A, Moutairou K, Varani S, Troye-Blomberg M, Luty AJF, Deloron P, Fievet N. Consequences of malaria during pregnancy on neonatal cytokine responses to TLR ligands and falciparum antigens in Benin. 7th European Congress on Tropical Medicine and International Health, 2011, Barcelona, Espagne. In: Trop Med Intern Health, 2011, 16 (Suppl. 1):304.
  11. Nouatin O, Agbowai C, Ibitokou S, Ezinmegnon S, Borgella S, Massougbodji A, Gbedande B, Moutairou K, Varani S, Troye-Blomberg M, Luty AJF, Deloron P, Fievet N. Consequence of malaria during pregnancy on immunological responses of the newborn: a study of regulatory T cells. 7th European Congress on Tropical Medicine and International Health, 2011, Barcelona, Espagne In: Trop Med Intern Health, 2011, 16 (Suppl. 1):86-7.
  12. Ibitokou S, Nouatin O, Ezinmegnon S, Massougbodji A, Deloron P, Luty AJF, Varani S, Fievet N. Innate immune responses related to the timing of infection with Plasmodium falciparum during pregnancy. 7th European Congress on Tropical Medicine and International Health, 2011, Barcelona, Espagne. In: Trop Med Intern Health, 2011, 16 (Suppl. 1):120
  13. Gnidehou S, Bigey P, Doritchamou J, Bordbar B, Quiviger M, Viwami F, Couturier A, Scherman D, Deloron P, Tuikue Ndam N. The N-terminal region of VAR2CSA induces cross-reactive antibodies that inhibit adhesion of several Plasmodium falciparum isolates to chondroitin-sulfate. 7th European Congress on Tropical Medicine and International Health, 2011, Barcelona, Espagne In: Trop Med Intern Health, 2011, 16 (Suppl. 1):119
  14. Briand V, Dumont A, Abrahamowicz M, Traore M, Watier L, Fournier P. Individual and institutional predictors for caesarean delivery and maternal mortality in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey. 7th European Congress of Tropical Medicine and International Health, 2011, Barcelone, Espagne. In: Trop Med Int Health 2011, 16(Suppl. 1):297
  15. Ouedraogo S, Koura GK, Accrombessi M, Massougbodji A, Cot M. Maternal anaemia at first antenatal visit: prevalence and aetiology in a West African malaria endemic area. 7th European Congress on Tropical Medicine & International Health 2011, Barcelone, Espagne. In: Trop Med Intl Hlth, 2011, 16 S1:57
  16. Denoeud-Ndam L, Romby A, Fourcade C, Akakpo J, Afangnihoun A, Atadokpede F, Dossou-Gbete L, Perrin RX, Girard PM, Zannou DM, Cot M. Prevention of malaria in HIV-infected pregnant women: PACOME trial testing cotrimoxazole prophylaxis versus intermittent preventive treatment with mefloquine – Preliminary results. 7th European Congress on Tropical Medicine & International Health 2011, Barcelone, Espagne. In: Trop Med Intl Hlth, 2011, 16 S1:57
  17. Briand V, Watier L, Abrahamowicz M, Traore M, Fournier P, Dumont A. Individual and institutional predictors for caesarean delivery and maternal mortality in referral hospitals in Senegal and Mali: a cross-sectional epidemiological survey. 7th European Congress on Tropical Medicine & International Health, 2011, Barcelone, Espagne. In: Trop Med Intl Hlth, 2011, 16 S1:297
  18. Dos Santos S, Rautu I, Le Hesran JY, Diop M, Mourtala A, Ndonky A, Lalou R. Environmental threats and childhood fever during the rainy season in Dakar Senegal : interest in using hierarchical models. 3rd North American Congress of Epidemiology. 2011, Montreal, Canada. In: Am J Epidemiol, 2011, 173 (Suppl. 11):S73.
  19. Diallo A, Dos Santos S, Diop A, Barbosa L, Le Hesran JY. Urban malaria in Dakar: rapid diagnostic test implementation and presumptive diagnosis. 3rd North American Congress of Epidemiology. 2011, Montreal, Canada. Am J Epidemiol, 2011, 173 (Suppl. 11):S26.
  20. Koura GK, Briand V, Massougbodji A, Cot M, Garcia A. Prevalence and risk factors for soil-transmitted helminth infection in Beninese women during pregnancy. 3rd North American Congress of Epidemiology, 2011, Montreal, Canada. In: Am J Epidemiol, 2011, 173 Suppl.11:S225.
  21. Koura GK, Le Port A, Ouedraogo S, Watier L, Guerra J, Choudat I, Rachas A, Bouscailloux J, Massougbodji A, Cot M, Garcia A. Anemia during pregnancy: impact on birth outcome and on infants’ hemoglobin level during the 18 first months of life. 3rd North American Congress of Epidemiology, 2011, Montreal, Canada. In: Am J Epidemiol, 2011, 173 Suppl.11:S292

C-ACTN

  1. Baxerres C, Diop F, Gbofan F, Le Hesran JY. Pratiques des femmes et recommandations biomédicales en matière de grossesse et d’accouchement au Sénégal et au Bénin. Actualités du Pharo, 2011, Marseille. In: Méd Trop, 2011, 71:388
  2. Garcia A, Cot M, Le Port A, Cottrell G, Migot-Nabias F, Dechavanne C, Courtin D, Milet J, Koura G, Ouédraogo S, Pierrat C, Lokossou A, Nuel G, Watier L, Tabeaud M, Martin-Prével Y, Chandre F, Fayomi B, Massougbodji A. Survenue des premières infections palustres chez le nouveau-né : déterminants génétiques, biologiques et environnementaux. In : Colloque bilan des projets financés dans le cadre du programme SEST 2006. 2011, Paris : ANR, 12 p. Colloque Santé-Environnement Santé-Travail, Paris.
  3. Baxerres C, Houngnihin R.A, Egrot M. Pour éliminer le paludisme, nécessité de prendre en considération les perceptions et usages des populations : réflexions autour des moustiquaires (MILD) et des médicaments (TPI, CTA) au Bénin. Actualités du Pharo, 2012, Marseille.
  4. Koura KG, Beheton T, Deloron P, Garcia A, Cot M, Faucher JF. Déterminants de la prescription d’une antibiothérapie en milieu scolaire au sud du Bénin. Actualités du Pharo au Chevet de la Santé de la Mère et de l’Enfant, 2010, Marseille. In : Méd Trop, 2011, 71:381
  5. Koura KG, Garcia A, Beheton T, Deloron P, Cot M, Faucher JF. Prise en charge des enfants malades et déterminants d’une antibiothérapie en milieu scolaire au sud du Bénin. 17èmes Actualités du Pharo, 2011, Marseille. In: Méd Trop, 2011, 71:381

C-COM

  1. Koura KG, Beheton T, Deloron P, Garcia A, Cot M, Faucher JF. Determinants of antibiotics wprescription for schoolchildren at Allada, South Benin. 23rd Meeting of the European Society of Clinical Microbiology and Infectious Diseases – 27th International Congress of Chemotherapy (ECCMID-ICC 2011), 2011, Milano, Italy.
  2. Dahlström S, Maïga-Ascofaré O, Faucher JF, Aubouy A, Houzé P, Deloron P, Le Bras P, Houzé S. Characterisation of recurrent infections after treatment with ACT in Benin using a comprehensive approach including falciparum genetic polymorphisms, drug concentrations and pharmacogenetics. Gotdon conference, 2011, Lucca, Italie.
  3. Fouilloux M, Hubert V, Le Bras J, Godineau N, Siriez JY, Bemba D, Houzé S. Cas groupés de paludisme : infection simultanée ou risqué partage? 12ème Journées Nationales d’Infectiologie, 2011, Toulouse.
  4. Gnidehou S, Bigey P, Doritchamou J, Quiviger M, Viwami F, Couturier A, Salanti A, Scherman D, Deloron P, Tuikue Ndam N. Genetic electrotransfer immunization for the identification of functionally important epitopes: the example of Plasmodium falciparum. 21st 
International Symposium on Bioelectrochemistry and Bioenergetics, 2011, Cracow, Pologne.
  5. Chippaux JP. Evaluation expérimentale du titre et de la purification d’un sérum antivenimeux. Assemblée Générale de la Banque des Sérums Antivenimeux, 2011, Nantes, France.
  6. Chippaux JP. Méthodologie générale des essais cliniques concernant les antivenins ; application à l’Afrique. Atelier sur la prise en charge des envenimations au Sénégal, 2011, Dakar, Sénégal.
  7. Chippaux JP. Prise en charge des envenimations dans les dispensaires périphériques non médicalisés. Atelier sur la prise en charge des envenimations au Sénégal, 2011, Dakar, Sénégal.
  8. Fournier P, Dumont A, Tourigny C, Coulibaly A, Sissoko K, Philibert A, Traore M. Qui bénéficie de la gratuité de la césarienne dans les pays à faibles ressources? Une étude en milieu rural à Kayes (Mali). 2ème conférence de l’association africaine d’économie et de politique de la santé. 2011, Dakar, Sénégal.
  9. Mak G, Djenepo F, Kone G, Dumont A, Fournier P, Haddad S. Réduire la mortalité maternelle en milieu hospitalier : coûts du passage à l’échelle d’un programme national d’audit de décès maternels au Sénégal et au Mali. Présentation au 3ème colloque international « Financement de la santé dans les pays en développement et émergents », 2011, CERDI, Clermont-Ferrand, France.
  10. Mbaye E, Dumont A. Votre Karité n’est pas assez huilé : la place de l’argent dans la recherche en santé mondiale au Sénégal. Contributions des approches anthropo-sociales au champ transdisciplinaire et intersectoriel de la recherche en santé mondiale. Colloque transdisciplinaire au 79e congrès de l’Association francophone pour le savoir, 2011, Université de Sherbrooke, Québec, Canada.
  11. Chippaux JP. Recommandations de l’OMS concernant la fabrication et le contrôle de qualité des antivenins. Atelier sur la prise en charge des envenimations au Sénégal, 2011, Dakar, Sénégal.
  12. Denoeud-Ndam L, Clement MC, Akakpo J, Afangnihoun A, Atadokpede F, Dossou-Gbete L, Perrin RX, Girard PM, Zannou DM, Cot M. Tolerance of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women receiving HAART in Benin. 6th IAS conference on HIV pathogenesis, treatment and prevention. 2011, Rome, Italy.
  13. Baxerres C. Savoirs savants – Savoirs populaires au Bénin : Le médicament au centre de problématiques sanitaires, commerciales et… anthropologiques. 1er Congrès de l’Association Française d’Ethnologie et d’Anthropologie, 2011, EHESS Paris.
  14. Chippaux JP. Méthodologie des enquêtes épidémiologiques concernant les envenimations et valorisation des résultats. Atelier sur la prise en charge des envenimations au Sénégal, 2011, Dakar, Sénégal.
  15. Briand V, Dumont A. Politique de gratuité de la césarienne au Sénégal et au Mali : conséquences sur les pratiques médicales. Séminaire de l’Ecole des Hautes Etudes en Sciences Sociales, 2011, Paris, France.
  16. Abrahamowicz M, Beauchamp ME, Fournier P, Dumont A. Evidence of a subgroup-specific exposure effect in the absence of an overall effect: is there really a contradiction? 3rd North American Congress of Epidemiology, 2011, Montreal, Quebec, Canada.
  17. Baxerres C. The uses of pharmaceuticals in Benin: when local and global contexts promote an important drugs consumption. 4ème congrès international sur la chaîne des medicaments, 2011, Paris.
  18. Briand V, Dumont A, Abrahamowicz M, Traore M, Watier L, Fournier P. Les mortalités maternelle et périnatale associées à la césarienne au Sénégal et au Mali. 41èmes journées de la Société Française de Médecine Périnatale, 2011, Grenoble, France.

C-AFF

  1. Mák G, Fournier P, Djenepo F, Kone G, Dumont A, Haddad S. Effets d’un programme d’audit de décès maternels sur les changements de pratique dans 23 maternités au Sénégal et au Mali. 3ème Colloque international sur le financement de la santé dans les pays en développement et émergents, CERDI, 2011, Clermont Ferrand, France.
  2. Pirkle C, Dumont A, Zunzunegui MV. Evaluation of obstetric quality of care across 32 hospitals in Mali and Senegal. Canadian Global Health Conference, Montréal, Québec, Canada, November 2011.
  3. Baxerres C, Diop F, Gbofan F, Le Hesran JY. Pratiques des femmes et recommandations biomédicales pendant la grossesse et l’accouchement au Sénégal et au Bénin, Congrès ADELF – EPITER, 2011, Marseille.
  4. Yaba W, Chippaux JP, Msellati P. Médecine parallèles et prise en charge des personnes vivant avec le VIH au Gabon Journées de l’Ecole doctorale de Santé Publique de Paris 6, 2011, Saint-Malo, France.
  5. Denoeud-Ndam L, Clément MC, Akakpo J, Afangnihoun A, Atadokpede F, Dossou-Gbete L, Perrin RX, Girard PM, Zannou DM, Cot M. Tolerance of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin. 6th International Aids Society Conference, 2011, Rome.
  6. Ilboudo H, Jamonneau V, Holzmuller P, Cuny G, Garcia A, Bucheton B, Courtin D. Characterization of ex-vivo cellular response in individuals infected by b. gambiense. 31ème ISCTRC, 2011, Bamako, Mali.
  7. Bertin G, Guillonot F, Ezinmegnon S, Salnot V, Fievet N, Deloron P. Etude des structures « knobs » selon les formes cliniques palustres. Congrès français de spectrométrie de masse et d’analyse protéomique, 2011, Avignon.
  8. Dechavanne C, Guillonneau F, Sago L, Salnot V, Guitard E, Chafey P, Lefranc MP, Dugoujon JM, Mayeux P, Migot-Nabias F. Apport d’une nouvelle technique de détection et de quantification des anticorps néo-synthétisés par le nouveau-né. Congrès français de spectrométrie de masse et d’analyse protéomique, 2011, Avignon.
  9. Sago L, Dechavanne C, Migot-Nabias F, Salnot V, Leduc M, Mayeux P, Guillonneau F. Mise au point d’une analyse quantitative label-free ciblée d’isoformes de protéines dans un échantillon enrichi. Congrès français de spectrométrie de masse et d’analyse protéomique, 2011, Avignon.
  10. Sabbagh A, Darlu P, Crouau-Roy B, Poloni ES. Co-évolution du polymorphisme d’acétylation et du mode de subsistance des populations humaines. XXXème Colloque du Groupement des Anthropologistes de Langue Française, 2011, Dakar, Sénégal.
  11. Ilboudo H, Jamonneau V, Holzmuller P, Cuny G, Garcia A, Bucheton B, Courtin D. Characterization of ex-vivo cellular response in individuals infected by Trypanosoma brucei gambiense. 31st ISCTRC, 2011, Bamako, Mali.
  12. Patillon B, Luisi P, Génin E, Sabbagh A. Detecting signatures of recent positive selection at the VKORC1 gene locus. 20th annual international genetic epidemiology society conference, 2011, Heidelberg, Allemagne.
  13. Pasmant E, Sabbagh A, Masliah-Planchon J, Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K, Valeyrie-Allanore L, Parfait B, Vidaud D, Bièche I, Lantieri L, Wolkenstein P, Vidaud M. Plexiform neurofibromas genesis in NF1 is modulated by modifier ANRIL. 56ème Journées Internationales de Biologie, 2011, Paris, France.

OS UMR216 

  1. Cot M. Maladies à transmission vectorielle en zone intertropicale: l’exemple du paludisme (pp 272-6). In: Surveillance épidémiologique: principes, méthodes et applications en santé publique, P. Astagneau et T. Ancelle. Lavoisier, Médecine Sciences Publications, Paris 2011 (360 p).
  2. Goyffon M, Chippaux JP. Les venins. In « La science au présent – 2011 », Encyclopædia Universalis, 2011:210-224.

OS divers chercheurs avant leur intégration à l’UMR 216

  1. Villard O, Jung-Etienne J, Cimon B, Franck J, Fricker-Hidalgo H, Villena I, Candolfi E, et le réseau du centre national de référence de la toxoplasmose (dont Houzé S). Sérodiagnostic de la toxoplasmose en 2010 : conduite à tenir et interprétation en fonction des profils sérologiques obtenus par les méthodes de dépistage. Feuillets de Biologie, 2011, LII, 298.

ACL 

  1. Milet J, Nuel G, Watier L, Courtin D, Slaoui Y, Senghor P, Migot-Nabias F, Gaye O, Garcia A. Genome wide linkage and association study of falciparum infection and mild malaria attack in a senegalese population. PLoS One, 2010, 5:e11616.
  2. Milet J, Le Gac G, Scotet V, Gourlaouen I, Thèze C, Mosser J, Bourgain C, Deugnier Y, Férec C. A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: a follow-up study. Blood Cell Mol Dis, 2010, 44:34-7.
  3. Sarr D, Aldebert D, Marrama L, Frealle E, Gaye A, Brahim HO, Niang M, Dangou JM, Mercereau-Puijalon O, Le Hesran JY, Jambou R. Chronic infection during placental malaria is associated with up-regulation of cycloxygenase-2. Malar J. 2010, 9:45
  4. Souares A, Lalou R, Senghor P, Le Hesran JY. Child age or weight: difficulties related to the prescription of the right dosage of antimalarial combinations to treat children in Senegal. Trans R Soc Trop Med Hyg. 2010, 104:104-9.
  5. Le Loup G, Fleury S, Camargo K, Larouzé B. International institutions, global health initiatives and the challenge of sustainability: lessons from the Brazilian AIDS programme. Trop Med Int Health, 2010, 15:5-10.
  6. Lescure FX, Le Loup G, Freilij H, Delevoux M, Paris L, Brutus L, Pialoux G. Chagas disease, changes in knowledge and management. Lancet Infect Dis, 2010, 10:556-70.
  7. Brutus L, Castillo H, Bernal C, Salas NA, Schneider D, Santalla JA, Chippaux JP. Short Report: Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg, 2010, 83:1044-7.
  8. Chippaux JP, Clavijo AN, Santalla JA, Postigo JR, Schneider D, Brutus L. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole. Trop Med Int Health. 2010, 15:87-93.
  9. Chippaux JP, Boyer L. The 3 + 3 dose escalation design is not appropriate for antivenom dose finding. Toxicon. 2010, 55:1408-9.
  10. Chippaux JP, Stock RP, Massougbodji A. Methodology of clinical studies dealing with the treatment of envenomation. Toxicon. 2010, 55:1195-212.
  11. Garba A, Pion S, Cournil A, Milet J, Schneider D, Campagne G, Chippaux JP, Boulanger D. Risk factors for Schistosoma haematobium infection and morbidity in two villages with different transmission patterns in Niger. Acta Trop. 2010, 115:84-9.
  12. Chippaux JP. Immunothérapie d’urgence : antivenins de serpent et scorpion. Biol Aujourd’hui, 2010, 204:61-70.
  13. Chippaux JP. Recommandations pour la production, le contrôle et l’enregistrement des immunoglobulines antivenimeuses. Biol Aujourd’hui, 2010, 204:87-91.
  14. González-Andrade F, Chippaux JP. 1. Snake bite envenomation in Ecuador. Trans R Soc Trop Med Hyg, 2010,104:588-91.
  15. Guyavarch E, Pison G, Duthé G, Marra A, Chippaux JP. La mortalité violente dans 3 régions rurales du Sénégal. Eur J Pop, 2010, 26:483-505.
  16. Lim P, Wongsrichanalai C, Chim P, Khim N, Kim S, Chy S, Sem R, Nhem S, Yi P, Duong S, Bouth DM, Genton B, Beck HP, Gobert JG, Rogers WO, Coppee JY, Fandeur T, Mercereau-Puijalon O, Ringwald P, Le Bras J, Ariey F. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine and quinine in Cambodia from 2001 to 2007. Antimicrob Agents Chemother, 2010, 54:2135-42.
  17. Villena I, Ancelle T, Delmas C, Garcia P, Brezin AP, Thulliez P, Wallon M, King L, Goulet V, Toxosurv network and National Reference Centre for Toxoplasmosis (dont Houzé S). Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill, 2010, 15:19600.
  18. ANOFEL Cryptosporidium National Network (dont Houzé S). Laboratory-based surveillance for Cryptosporidium in France, 2006-2009. Euro Surveill, 2010, 15:19642.
  19. Saliba G, Kamouh W, Fontanet A, Le Bras J. Predictive factors of severe disease secondary to falciparum malaria among travelers. Pathol Biol (Paris). 2010, 59:230-3.
  20. Whegang SY, Tahar R, Foumane VN, Soula G, Gwét H, Thalabard JC, Basco LK. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Malar J. 2010 9:56.
  21. Badaut C, Bertin G, Rustico T, Fievet N, Massougbodji A, Gaye A, Deloron P. Towards a rational way to design vaccine candidate against pregnancy associated malaria: conserved sequences are found in the variable blocks of the DBL6e domain. PLoS One, 2010, 5:e11276.
  22. Barfod L, Dobrilovic T, Magistrado P, Khunrae P, Viwami F, Brun J, Dahlbäck M, Bernasconi NL, Fried M, John D, Duffy PE, Salanti A, Lanzavecchia A, Lim CT, Ndam NT, Higgins MK, Hviid L. CSA-adhering Plasmodium falciparum-infected erythrocytes express functionally important antibody epitopes shared by multiple variants. J Immunol, 2010, 185:7553-61.
  23. Boulkroun S, Guenin-Macé L, Thoulouze MI, Monot M, Merckx A, Langsley G, Bismuth G, Di Bartolo V, Demangel C. Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J Immunol, 2010, 184:1436-44.
  24. Brucato N, Cassar O, Tonasso L, Tortevoye P, Migot-Nabias F, Plancoulaine S, Guitard E, Larrouy G, Gessain A, Dugoujon JM. The imprint of the Slave Trade in an African American population: mitochondrial DNA, Y chromosome and HTLV-1 analysis in the Noir Marron of French Guiana. BMC Evol Biol, 2010, 10:314.
  25. Gangnard S, Tuikue Ndam NG, Gnidehou S, Quiviger M, Juillerat A, Faure G, Baron B, Viwami F, Deloron P, Bentley GA. Functional and immunological characterization of the var2CSA DBL5e domain of a placental Plasmodium falciparum Mol Biochem Parasitol, 2010, 173:115-22.
  26. Gnidehou S, Jessen L, Gangnard S, Ermont C, Triqui C, Quiviger M, Guitard J, Lund O, Deloron P, Tuikue Ndam N. Insight into antigenic diversity of VAR2CSA-DBL5e domain from multiple Plasmodium falciparum placental isolates. PLoS One, 2010, 5:e13105.
  27. Guitard J, Andersen P, Ermont C, Gnidehou S, Lund O, Fievet N, Sow S, Deloron P, Tuikue Ndam N. Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal. Malar J, 2010, 9:165.
  28. Kheliouen N, Viwami F, Lalya F, Tuikue-Ndam N, Eboumbou Moukoko EC, Rogier C, Deloron P, Aubouy A. Plasmodium falciparum parasites causing cerebral malaria share variant surface antigens, and their prevalence is low in southern Benin. Malar J, 2010, 9:220.
  29. Smati M, Taillé C, Menotti J, Le Bras J, Houzé S. [Contribution of Toxoplasma gondii-specific PCR for the diagnosis of disseminated toxoplasmosis in a non-HIV and non-grafted adult patient]. Med Mal Infect, 2010, 40:596-9.
  30. Bon B, Houzé S, Talabani H, Magne D, Belkadi G, Develoux M, Senghor Y, Chandenier J, Ancelle T, Hennequin C. Evaluation of a rapid enzyme-linked immunosorbent assay for diagnosis of strongyloidiasis. J Clin Microbiol, 2010, 48:1716-9.
  31. Menotti J, Garin YJ, Thulliez P, Sérugue MC, Stanislawiak J, Ribaud P, de Castro N, Houzé S, Derouin F. Evaluation of a new 5′-nuclease real-time PCR assay targeting the Toxoplasma gondii AF146527 genomic repeat. Clin Microbiol Infect, 2010, 16:363-8.
  32. Nepveu F, Kim S, Boyer J, Chatriant O, Ibrahim H, Reybier K, Monje MC, Chevalley S, Perio P, Lajoie BH, Bouajila J, Deharo E, Sauvain M, Tahar R, Basco L, Pantaleo A, Turini F, Arese P, Valentin A, Thompson E, Vivas L, Petit S, Nallet JP. Synthesis and antiplasmodial activity of new indolone N-oxide derivatives. J Med Chem, 2010, 53:699-714.
  33. Pidot SJ, Porter JL, Marsollier L, Chauty A, Migot-Nabias F, Badaut C, Bénard A, Ruf MT, Seemann T, Johnson PDR, Davies JK, Jenkin GA, Pluschke G, Stinear TP. Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics. PLoS Negl Trop Dis, 2010, 4:e872.
  34. Deloron P, Bertin G, Briand V, Massougbodji A, Cot M. Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy.   Emerg Infect Dis, 2010, 16:1666-70.
  35. Faucher JF, Aubouy A, Makoutode P, Abiou G, Béhéton T, Doritchamou J, Kossou H, Houzé P, Ouendo E, Deloron P, Cot M.  What would PCR assessment change in the management of fevers in a malaria endemic area? A school-based study in Benin in children with and without fever.  Malar J, 2010, 9:224.
  36. Faucher JF, Makoutode P, Abiou G, Béhéton T, Kossou H, Houzé P, Ouendo E, Houzé S, Deloron P, Cot M. Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based study in Benin in children with and without fever. Malar J, 2010, 9:104.
  37. Bellanger AP, Bruneel F, Barbot O, Mira JP, Millon L, Houzé P, Faucher JF, Houzé S. Severe Plasmodium malariae malaria in a patient with multiple susceptibility genes. J Travel Med, 2010, 17:201-2.
  38. Andriantsoanirina V, Ménard D, Rabearimanana S, Hubert V, Bouchier C, Tichit M, Le Bras J, Durand R. Association of microsatellite variations of falciparum Na+/H+ exchanger (Pfnhe-1) gene with reduced in vitro susceptibility to quinine: lack of confirmation in clinical isolates from Africa. Am J Trop Med Hyg, 2010, 82:782-7.
  39. MaïgaAscofaré O, Le Bras J, Mazmouz R, Renard E, Falcão S, Broussier E, Bustos D, Randrianarivelojosia M, Omar SA, Aubouy A, Lepère JF, Vély JF, Djimdé AA, Clain J. Adaptive differentiation of Plasmodium falciparum populations inferred from Single‐Nucleotide Polymorphisms (SNPs) conferring drug resistance and from neutral SNPs. J Infect Dis, 2010, 202:1095-103
  40. Vigan-Womas I, Lokossou A, Guillotte M, Juillerat A, Bentley G, Garcia A, Mercereau-Puijalon O, Migot-Nabias F. The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children. Malar J, 2010, 9:267.
  41. Bruneel F, Tubach F, Corne P, Megarbane B, Mira JP, Peytel E, Camus C, Schortgen F, Azoulay E, Cohen Y, Georges H, Meybeck A, Hyvernat H, Trouillet JL, Frenoy E, Nicolet L, Roy C, Durand R, Le Bras J, Wolff M, Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. PLoS One, 2010, 5:e13236.
  42. Garat A, Lino Cardenas CL, Lionet A, Devos A, Glowacki F, Kenani A, Migot-Nabias F, Allorge D, Lo-Guidice JM, Broly F, Cauffiez C. Inter-ethnic variability of three functional polymorphisms affecting the IMPDH2 gene. Mol Biol Rep, 2010, 38:5185-8.

ACL divers chercheurs avant leur intégration à l’UMR 216

  1. Castéra L, Sabbagh A, Dehainault C, Michaux D, Mansuet-Lupo A, Patillon B, Lamar E, Aerts I, Lumbroso-Le-Rouic L, Couturier J, Stoppa-Lyonnet D, Gauthier-Villars M, Houdayer C. MDM2 as a modifier gene in retinoblastoma. J Natl Cancer Inst, 2010, 102:1805-8.
  2. Pasmant E, Laurendeau I, Sabbagh A, Parfait B, Vidaud M, Vidaud D, Bièche I. ANRIL ou l’étonnante histoire d’un grand ARN non codant. Med Sci, 2010, 26:564-6.
  3. Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dollfus H, Dieux-Coeslier A, Bièche I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D, réseau NF France. NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat, 2010, 31:E1506-8.
  4. Shekalaghe SA, ter Braak R, Daou M, Kavishe R, van den Bijllaardt W, van den Bosch S, Koenderink JB, Luty AJ, Whitty CJ, Drakeley C, Sauerwein RW, Bousema T. In Tanzania, hemolysis after a single dose of primaquine co-administered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase (G6PD) deficient individuals in Africa. Antimicrob Agents Chemother, 2010, 54:1762-8.
  5. Supali T, Verweij JJ, Wiria AE, Djuardi Y, Hamid F, Kaisar M, Wammes L, van Lieshout L, Luty AJF, Sartono E, Yazdanbakhsh M. Polyparasitism and its impact on the immune system. Int J Parasitol, 2010, 40:1171-6.
  6. Kone A, van de Vegte-Bolmer M, Siebelink-Stoter R, van Gemert GJ, Dara A, Niangaly H, Luty A, Doumbo OK, Sauerwein R, Djimde AA. Sulfadoxine–pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int J Parasitol, 2010, 40:1221-8.
  7. Ouedraogo AL, Bousema T, de Vlas S, Cuzin-Ouattara N, Verhave JP, Drakeley C, Luty AJF, Sauerwein R. The plasticity of Plasmodium falciparum gametocytaemia in relation to age in Burkina Faso. Malar J, 2010, 9:281.

ACLN

  1. Baxerres C, Le Hesran JY. Quelles ressources familiales financent la santé des enfants ? Les difficultés du recours aux soins pour traiter le paludisme en milieu rural sénégalais, Revue Tiers Monde, 2010, 202:149-65.
  2. Chippaux JP. Surgery should not be used as a first line treatment. J Venom Anim Toxins incl Trop Dis, 2010, 16:3-4.
  3. Chippaux JP. Control of ophidism in Brasil: a model for Africa. J Venom Anim Toxins incl Trop Dis, 2010, 16:188-90.
  4. Chippaux JP. Morsures de serpent en Afrique : un problème de santé publique négligé. Mondes et Cultures, 2010, 69:37-55.

BRE

  1. Tuikue Ndam N, Deloron P, Gnidéhou S, Quiviger M, Bigey P, Scherman D. Induction of potent anti-CSA adhesion antibodies to Plasmodium falciparum infected erythrocytes using the N-terminal parts of VAR2CSA. Dépôt de brevet FR1056294 du 30 Juillet 2010.

C-INV

  1. Chippaux JP. Prise en charge des envenimations en Afrique. 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, 2010, Dakar, Sénégal.
  2. Chippaux JP. Stratégies de mise à disposition des immunoglobulines antivenimeuses dans les structures de prise en Charge des envenimations. 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, 2010, Dakar, Sénégal.
  3. Goyffon M, Chippaux JP. Complexicité du scorpionisme en Afrique : l’exemple du Maroc. 1er Symposium International sur les envenimations scorpioniques et vipérines, 2010, Marrakech, Maroc.
  4. Massougbodji A, Chippaux JP. Etudes cliniques des antivenins en Afrique subsaharienne. 1er Symposium International sur les envenimations scorpioniques et vipérines, Marrakech, Maroc.
  5. Chippaux JP. Les morsures de serpent en Afrique subsaharienne. 1er Symposium International sur les envenimations scorpioniques et vipérines, Marrakech, Maroc.
  6. Chippaux JP. Meta-análisis de todos los estudios clínicos con antivenenos. 9th International Meeting of Experts in Venomous Animal Poisonings, 2010, Cuernavaca, Mexique.
  7. Chippaux JP. Factores de riesgos y tratamiento de la enfermedad de Chagas congénita. Coloquio franco-mexicano sobre enfermedades infecciosas, 2010, Veracruz, Mexique.
  8. Dumont A. Action continues discontinuées du MAEE au Sénégal : de la maternité de l’hôpital régional de Saint-Louis à la maternité Roi Baudoin (Pikine, Senegal). Mise en place d’une plateforme d’experts français/francophones sur la santé maternelle et reproductive et infantile pour la réflexion et le suivi des actions de la France. Ministère des Affaires Étrangère et Européennes, 2010, Paris.
  9. Dumont A. Recherche en santé maternelle par l’IRD-Dakar. Mise en place d’une plateforme d’experts français/francophones sur la santé maternelle et reproductive et infantile pour la réflexion et le suivi des actions de la France. Ministère des Affaires Étrangère et Européennes, 2010, Paris
  10. Dumont A. Les effets de la satisfaction au travail des sages-femmes sur l’épuisement professionnel, l’intention de quitter son poste et la mobilité professionnelle : une étude longitudinale au Sénégal. Colloque International Interdisciplinaire sur la réduction de la mortalité maternelle : Mieux comprendre pour mieux agir? 2010, Université Cheikh Anta Diop, Dakar, Sénégal.
  11. Houze S. Plasmodium vivax : actualités épidémiologiques et thérapeutiques ; Plasmodium knowlesi : mise au point. Du vaccin aux conseils aux voyageurs. 18ème rencontre Actualités sur Plasmodium vivax. 2010, Hôpital Delafontaine, Saint Denis.
  12. Tuikue Ndam N. Current knowledge pertaining to malaria in pregnancy: Is there a hope for a VAR2CSA-based vaccine? ICOPA XII, 2010, Melbourne, Australia.

C-INV divers chercheurs avant leur intégration à l’UMR 216

  1. Sabbagh A. Contrasting histories of the acetylation polymorphism in human and non human primates. 5th international workshop on Arylamine N-acetyltransferases, 2010, Paris, France.
  2. Sabbagh A. Pharmacogénétique des antagonistes de la vitamine K. Congrès de la Société Française d’Hématologie, 2010, Paris, France.

C-ACTI UMR216: Equipe Risques et Interventions

  1. Baldé C, Massougbodji A, Boiro M. Y, Millimono E, Diallo M. C, Stock R. P, Chippaux JP. Clinical study of safety and apparent efficacy of Antivipmyn® Africa for the treatment of snakebite in Kindia, a forest region of Guinea. 59th Annual Meeting of American Society of Tropical Medicine & Hygiene, 2010, Atlanta, USA. Am J Trop Med Hyg, 2010, 83 (Suppl. 5):270.
  2. Deloron P. The STOPPAM project: Pathophysiological, immunological and parasitological characteristics of PAM. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:114.
  3. Fievet N. Cell mediated immune response in relation with the timing of pathology of PAM during a follow-up in Africa. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:114.
  4. Minja DT, Magistrado PA, Lusingu JP, Tuikue Ndam N, Schmiegelow C, Oesterholt M, Bostrom S, John D, Resende M, Dobrilovic T, Barfod L, Pinto V, Dahlback V, Lavsten T, Troye-Blomberg M, Deloron P, Luty AJF, Lemnge MM, Hviid L, Salanti A, Nielsen M, Theander T. VAR2CSA elicits broad reactive anti-adhesive antibodies. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:436.
  5. Ibitokou S, Fievet N, Vianou B, Agbowai C, Ezinmegnon S, Oesterholt M, Massougbodji A, Theander T, Varani S, Troye-Blomberg M, Luty AJF, Deloron P. Phenotype and activation levels of dendritic cells (DC) and monocytes in Pregnancy-Associated Malaria during a follow-up in Benin. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:276.
  6. Gnidehou S, Jessen L, Gangnard S, Ermont C, Triqui C, Quiviger M, Guitard J, Lund O, Deloron P, Tuikue Ndam N. Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:157.
  7. Huynh BT, Fievet N, Massougbodji A, Deloron P, Cot M. Malaria associated symptoms in pregnant women: results of a cohort follow-up in Benin. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:154.
  8. Koura KG, Beheton T, Deloron P, Garcia A, Cot M, Faucher JF. Determinants of antibiotics prescription in schoolchildren at Allada, South Benin. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, USA. In: Am J Trop Med Hyg, 2010, 83 S1:150.
  9. Doritchamou J, Viwami F, Deneud L, Gnidehou S, Moussiliou A, Massougbodji A, Salanti A, Deloron P, Tuikue Ndam N. Antibodies that inhibit binding of Plasmodium falciparum infected erythrocytes to CSA are acquired during pregnancy and correlate with anti-VSA and anti-var2csa. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:274.
  10. Faucher JF, Aubouy A, Makoutode P, Abiou G, Béhéton T, Doritchamou J, Houzé P, Ouendo E, Deloron P, Cot M. What would PCR assessment change in the management of fevers in a malaria endemic area? A school-based study in Benin in children with and without fever. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:83.
  11. Davies Reid A, Hubert V, Le Bras J, Houzé S. Moleculars markers and mefloquine susceptibility in African falciparum isolates. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA.
  12. Houzé S, Hubert V, Pessler Cohen D, Rivetz B, Le Bras J. Evaluation of the Clearview® malaria pLDH as malaria rapid diagnostic test in travellers. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA.
  13. Lokossou AG, Dechavanne C, Bouraïma A, Courtin D, Le Port A, Ladékpo R, Noukpo J, Bonou D, Ahouangninou C, Loumedjinon F, Daoudou M, Garcia A, Migot-Nabias F. Impact of maternal cytokine gene polymorphisms on mother and fetus biological and immunological parameters in the context of placental malaria. 59th Ann Meet Am Soc Trop Med Hyg, 2010, Atlanta, GA, USA. In Am J Trop Med Hygiene, 2010, 83:83.
  14. Lokossou AG, Dechavanne C, Bouraima A, Courtin D, Le Port A, Ladekpo R, Noukpo J, Bonou D, Ahouangninou C, Loumedjinon F, Daoudou M, Garcia A, Migot-Nabias F. Impact of maternal cytokine gene polymorphisms on mother and fetus biological and immunological parameters in the context of placental malaria. 12th International Congress of Parasitology (ICOPA), 2010, Melbourne, Australie.
  15. Dechavanne C, Renard E, Le Port A, Cottrell G, Garcia A, Massougbodji A, Migot-Nabias F. Genetic characterization of Plasmodium falciparum clones infecting mothers at delivery and their children during their first plasmodial infections. 10th International Conference on Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases (MEEGID), 2010, Amsterdam, Pays-Bas.

C-ACTI divers chercheurs avant leur intégration à l’UMR 216

  1. Bodeau-Livinec F, Marchand-Martin L, Zeitlin J, Kaminski M. Comparison of neurodevelopmental outcomes at 5 years in very preterm singletons and twins-the epipage cohort study. 43rd Annual Meeting of the Society for Epidemiologic Research. 2010, Anaheim, Solomon Islands. In: Am J Epidemiol, 2010, 171 S11:S52.

C-ACTN

  1. Chippaux JP. Immunothérapie d’urgence : serpents et scorpions. Réunion thématique « L’immunothérapie passive aujourd’hui », Société de Biologie, 2009, Institut Curie, Paris. In: Biologie Aujourd’hui, 2010, 204:61-70.
  2. Le Hesran JY, Jossa Tchamago C, Baxerres C. Le marché informel du médicament à Cotonou, Bénin. Une place importante dans l’accès aux médicaments. 4ème congrès international d’épidémiologie ‘du Nord au Sud » et 16èmes Actualités du Pharo, 2010, Marseille, France. In : Rev Epidemiol Santé Publique, 2010, 58 S2:S62.
  3. Cottrell G, Daurès M, Bouraima A, Pierrat C, Massougbodgi A, Cot M, Garcia A. Étude des facteurs environnementaux liés à la transmission palustre à Tori Bossito, Sud Bénin. 4ème congrès international d’épidémiologie ‘du Nord au Sud » et 16èmes Actualités du Pharo, 2010, Marseille, France. In : Rev Epidemiol Santé Publique, 2010, 58 S2:S89.
  4. Koura GK, Le Port A, Ouedraogo S, Watier L, Cot M, Garcia A. Conséquences de l’anémie maternelle sur le nouveau-né et le nourrisson à Tori Bossito. 4ème congrès international d’épidémiologie ‘du Nord au Sud » et 16èmes Actualités du Pharo, 2010, Marseille, France. In : Rev Epidemiol Santé Publique, 2010, 58 S2:S115.
  5. Huynh BT, Fievet N, Massougbodji A, Deloron P, Cot M. Conséquences du paludisme pendant la grossesse : apport de l’échographie au sein d’une cohorte au Bénin. 4ème congrès international d’épidémiologie « du Nord au Sud » et 16èmes Actualités du Pharo, 2010, Marseille, France. In : Rev Epidemiol Santé Publique, 2010, 58 S2:S112.
  6. Diallo A, Le Hesran JY, Dos Santos S, Ndonky A, Koné G, Lalou R. Hétérogénéité de la distribution du Plasmodium dans la région de Dakar, Sénégal, 2008. 4ème congrès international d’épidémiologie ‘du Nord au Sud » et 16èmes Actualités du Pharo, 2010, Marseille, France. In : Rev Epidemiol Santé Publique, 2010, 58 S2:S90.
  7. Briand V, Watier L, Abrahamowicz M, Traore M, Fournier P, Dumont A. Déterminants individuels et institutionnels du recours à la césarienne au Sénégal et au Mali. Congrès de l’ADELF (Association Des Epidémiologistes de Langue Française), 2010, Marseille, France. In : Rev Epidemiol Santé Publique, 2010, 58 S2:S74.
  8. Huynh BT, Fievet N, Massougbodji A, Deloron P, Cot M. L’infection palustre pendant la grossesse est-elle réellement peu symptomatique ? Résultats d’une cohorte au Bénin. 4ème congrès international d’épidémiologie « du Nord au Sud » et 16èmes Actualités du Pharo, 2010, Marseille, France. In : Rev Epidemiol Santé Publique, 2010, 58 S2:S74.

C-COM

  1. Briand V, Watier L, Fournier P, Abrahamowicz M, Dumont A. Les déterminants individuels et institutionnels du recours à la césarienne au Sénégal et au Mali. Congrès Congrès de l’ADELF (Association Des Epidémiologistes de Langue Française), 2010, Marseille, France.
  2. Traore M, Dortonne JR, Dumont A, Fournier P. Audits de décès maternels dans les pays à faibles ressources : analyse d’implantation dans 23 établissements de santé au Sénégal et au Mali (essai QUARITE). 11ème Congrès de la Société Africaine de Gynécologie-Obstétrique, 2010, Libreville, Gabon.
  3. Djénépo F, Dumont A, Haddad S. Les changements générés par les Audits de décès maternels dans 12 établissements de santé au Sénégal (essai QUARITE) : étude préliminaire après un an de mise en oeuvre des Audits. 15ème Journées des Sciences de la Santé de Bobo-Dioulasso, 2010, Bobo-Dioulasso, Burkina Faso.
  4. Dumont A, Traore M, Dortonne JR, Fournier P. Audits de décès maternels dans les pays à faibles ressources : analyse d’implantation dans 23 établissements de santé au Sénégal et au Mali (essai QUARITE). 15ème Journées des Sciences de la Santé de Bobo-Dioulasso, 2010, Bobo-Dioulasso, Burkina Faso.
  5. Dumont A, Gueye M, Sow A, Fournier P. Utilisation des données recueillies en routine pour évaluer l’activité des maternités : étude de faisabilité dans 46 hôpitaux de référence au Mali et au Sénégal. 15ème Journées des Sciences de la Santé de Bobo-Dioulasso, 2010, Bobo-Dioulasso, Burkina Faso.
  6. Fournier P, Dumont A, Tourigny C, Coulibaly A, Sissoko K, Philibert A. A qui bénéficie la gratuité de la césarienne dans les pays à faibles ressources? Une étude en milieu rural à Kayes (Mali). Amélioration de l’accès financier aux soins de santé: Atelier technique de partage d’expériences en matière de formulation et de mise en œuvre des politiques. 2010, Dakar, Sénégal.
  7. Baxerres C, Simon E. Le médicament en Afrique : tendances globales, spécificités locales. Congrès du RTP études africaines, Institut des Sciences Politiques, 2010, Bordeaux.
  8. Denoeud-Ndam L, Fourcade C, Akakpo J, Atadokpede F, Afangnihoun A, Dossou-Gbete L, Perrin RX, Hounto A, Girard PM, Cot M, Zannou DM. Prévention du paludisme chez la femme enceinte infectée par le VIH au Bénin: essai randomisé comparant la prophylaxie par cotrimoxazole au traitement préventif intermittent par méfloquine. Symposium International Paludisme / Trypanosomiase Humaine Africaine, 2010, Cotonou, Bénin.
  9. Huynh BT, Fievet N, Gbaguidi G, Borgella S, Massougbodji A, Deloron P, Cot M. Conséquences du paludisme pendant la grossesse : apport de l’échographie au sein d’une cohorte au Bénin. Symposium international Paludisme et Trypanosomose Humaine Africaine en Afrique de l’Ouest : nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  10. Dechavanne C, Renard E, Le Port A, Cottrell G, Garcia A, Massougbodji A, Migot-Nabias F. Cohorte de Tori-Bossito : caractérisation moléculaire des clones plasmodiaux infectant la mère et l’enfant. Symposium international, Paludisme et Trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, Cotonou, 2010, Bénin.
  11. Le Port A, Ouedraogo S, Cottrell G, Dechavanne C, Bouraima A, Massougbodji A, Fayomi B, Migot-Nabias F, Garcia A, Cot M. Survenue des premières infections palustres au Bénin : rôle de l’infection placentaire et de facteurs environnementaux. Symposium international, Paludisme et Trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, Cotonou, 2010, Bénin.
  12. Saïah AD, Milet J, Soulard V, Gaye O, Migot-Nabias F, Sauerwein R, Garcia A, Luty AJF, Courtin D. L’infection par Schistosoma haematobium affecte les réponses IgG anti-Plasmodium falciparum associées à la protection palustre. Symposium international, Paludisme et Trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  13. Briand V, Kossou H, Fayomi B, Ayemonna P, Fievet N, Massougbodji A, Cot M. Traitement préventif intermittent (TPI) pendant la grossesse : intérêt de la méfloquine et alternative. Symposium international, Paludisme et Trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  14. Chippaux JP. Snakebites in subsaharan Africa. XI Congresso da Sociedade Brasileira de Toxinologia, Araxá, MG, 2010, Brésil.
  15. Baxerres C, Tchamago CJ, Le Hesran JY. Le marché informel du médicament à Cotonou : Un acteur clef du système pharmaceutique béninois. Congrès ADELF – EPITER, 2010, Marseille.
  16. Faussart A, Godineau N, Siriez JY, Thellier M, Develoux M, Deloron P. Paludisme d’importation de la femme enceinte en France métropolitaine : Etude rétrospective 1998-2008. Journées conjointes Soc Médecine des Voyages, Soc Fr Parasitol & Soc Fr Mycologie Med, 2010, Angers.
  17. Boström S, Oesterholt M, Schmiegelow C, Minja D, Lusingu J, Lemnge M, Deloron P, Luty AJF, Troye-Blomberg M. Inflammatory responses during pregnancy-associated malaria. 1st Nordic malaria Conference, 2010, Lund, Sweden.
  18. Nouatin O, Agbowai C, Ibitokou S, Ezinmegnon S, Fievet N, Massougbodji A, Varani S, Troye-Blomberg M, Luty A, Deloron P. Conséquences du paludisme gestationnel sur les réponses immunologiques de nouveau-né : étude des lymphocytes T régulateurs. Symposium international Paludisme et Trypanosomose Humaine Africaine en Afrique de l’Ouest: nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  19. Gbédandé K, Ezinmegnon S, Ibitokou S, Nouatin O, Agbowai C, Satchi A, Vianou B, Massougbodji A, Varani S, Troye-Blomberg M, Luty A, Deloron P, Fievet N. Conséquences du paludisme gestationnel sur les réponses cytokiniques à des ligands des TLRs chez les nouveau-nés. Symposium international Paludisme et Trypanosomose Humaine Africaine en Afrique de l’Ouest: nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  20. Aubouy A, Kheliouen N, Tuikue-Ndam N, Viwami F, Lalya F, Eboumbou Moukoko EC, Rogier C, Deloron P. Low prevalence of Plasmodium falciparum parasites causing cerebral malaria in Benin. ‘Parasite to prevention: Advances in the understanding of malaria’ meeting, 2010, Heriot-Watt University, Edinburgh, UK.
  21. Clain J, Petersen I, Gawinowicz MA, Fidock DA. Looking for Plasmodium falciparum Chloroquine Resistance Transporter protein (PfCRT)-associated proteins: a tandem affinity purification strategy using recombinant falciparum parasites. 21st Molecular Parasitology Meeting. 2010, Woods Hole, USA.
  22. Houzé S, Boutron I, Dalichampt M, Marmorat A, Senghor Y, Choquet C, Godineau N, Poilane I, Broutier H, Thellier M, Leguern As, Millet P, Fenneteau O, Hubert V, Houze P, Le Bras J, Matheron S. Evaluation multicentrique de la sensibilité et de la spécificité de quatre tests de diagnostic rapide pour le paludisme d’importation. Société Française de Parasitologie, 2010, Angers.

C-AFF

  1. Koura KG, Beheton T, Deloron P, Cot M, Faucher JF. Déterminants de la prescription d’une antibiothérapie en milieu scolaire à Allada. 4ème congrès international d’épidémiologie « du Nord au Sud » et 16èmes Actualités du Pharo, 2010, Marseille, France.
  2. Dejour-Salamanca D, Le Loup G, Paris L, El Ghouzzi MH, Assal A, Brutus L, Lescure FX. Maladie de Chagas en France: entre estimations et observations, place à la surveillance. 11ièmes Journées Nationales d’Infectiologie, 2010, Montpellier, France.
  3. Ramos-Cerrillo B, Neri CK, Baldé MC, Chippaux JP, Massougbodji A, Stock R. P. Development of a diagnostic ELISA assay for 4 African elapids. 9th International Meeting of Experts in Venomous Animal Poisonings, 2010, Cuernavaca, Mexique.
  4. Ramos-Cerrillo B, Neri Castro K, Baldé M. C, Chippaux JP, Massougbodji A, Stock RP. Development of a diagnostic elisa assay for 4 african elapids. 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, 2010, Dakar, Sénégal.
  5. Chippaux JP. Estimation de l’incidence et de la mortalite par envenimation ophidienne en afrique sub-saharienne. 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, 2010, Dakar, Sénégal.
  6. Chippaux JP, Guyavarch E, Diallo A. Evaluation de l’incidence et de la mortalité par morsures de serpent au Sénégal. 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, 2010, Dakar, Sénégal.
  7. Chippaux JP, Dechamp N. Essai de suivi de Bitis arietans par télémetrie dans la peripherie de Mbour (Sénégal). 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, 2010, Dakar, Sénégal.
  8. Chippaux JP, Massougbodji A. Algorithme de prise en charge des morsures de serpent en afrique sub-saharienne. 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, Dakar, Sénégal, 27-29 avril 2010.
  9. Piquet A, Toudonou C, Konetché L, Sinsin B, Chippaux JP. Etude préliminaire de la faune ophidienne de la forêt classée de la Lama, sud Benin. 4ème Conférence Internationale sur les envenimations par morsures de serpent et piqûres de scorpion en Afrique, 2010, Dakar, Sénégal.
  10. Briand V, Watier L, Abrahamowicz M, Traore M, Fournier P, Dumont A. Individual and institutional determinants of caesarean delivery in Senegal and Mali. XXVe congrès des étudiants gradués et post-gradués du Centre de Recherche du CHU Sainte-Justine, 2010, Montréal, Canada.
  11. Vincent L, Chippaux JP. L’impact du changement climatique sur la Dengue en Amérique Latine. Journées de l’Ecole doctorale de Santé Publique de Paris 6, 2010, Saint-Malo, France,.
  12. Dortonne JR, Couturier F, Dumont A, Fournier P, Traore M. Implementation of maternal death audits in 23 health institutions in Senegal and Mali (QUARITE trial). Canadian Global Health Conference, 2010, Ottawa, Canada.
  13. Ilboudo H, Jamonneau V, Holzmuller P, Cuny G, Garcia A, Bucheton B, Courtin D. Caractérisation de la réponse cellulaire ex-vivo chez des individus infectés par Trypanosoma brucei gambiense. Symposium international sur le paludisme et trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  14. Mak G, Fournier P, Djenepo F, Kone G, Dumont A, Haddad S. Effets d’un programme d’audit de décès maternels sur les changements de pratique dans 23 maternités au Sénégal et au Mali. Congrès des étudiants du Centre de recherche du CHUM, 2010, Montréal, Québec, Canada.
  15. Houzé S, Hubert V, Pessler Cohen D, Rivetz B, Le Bras J. Evaluation of the Clearview® malaria pLDH as Malaria Rapid Diagnostic Test in travellers. Parasite to prevention : advances in the understanding of malaria. 2010, Edinburgh, UK.
  16. Houzé S, Diamantis S, Haouchine D, Pelletier A, Abiteboul D, Le Bras J, Matheron S. Anguillulose et ankylostomiase nosocomiales autochtones : a propos de 2 cas. Société Française de Parasitologie, 2010, Angers.
  17. Cojean S, Matheron S, Haouchine D, Lariven S, Queyrel L, Daunis V, Huteau F, Hubert V, Loiseau PM, Le Bras J, Houzé S. Polymorphismes génétiques et diminution de sensibilité à la Miltéfosine chez un isolat de Leishmania infantum. Société Française de Parasitologie, 2010, Angers.
  18. Garcia A, Milet J, Watier L, Migot-Nabias F, Courtin D, Nuel G, Gaye O. Genome wide linkage and association study of Plasmodium falciparum infection and mild malaria attack. 24th European Immunogenetics and Histocompatibility Conference – 17th Annual meeting of the italian society for immunogenetics and transplantation biology, 2010, Florence, Italie).
  19. Courtin D, Saïah AD, Milet J, Soulard V, Gaye O, Migot-Nabias F, Sauerwein R, Garcia A, Luty AJF. Protective anti-malarial IgG responses are affected by Schistosoma haematobium 7th European Congress on Tropical Medicine and International Health, 2011, Barcelone, Espagne).
  20. Lokossou A, Dechavanne C, Bouraima A, Courtin D, Le Port A, Ladekpo R, Noukpo J, Bonou D, Ahouangninou C, Loumedjinon F, Daoudou M, Garcia A, Migot-Nabias F. Impact des polymorphismes maternels de gènes de cytokines sur les paramètres biologiques et immunologiques de la mère et du fœtus dans le cas du paludisme placentaire. Symposium international, Paludisme et Trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  21. Le Port A, Cottrell G, Dechavanne C, Briand V, Bouraima A, Massougbodji A, Fayomi B, Migot-Nabias F, Garcia A, Cot M. Prévention du paludisme pendant la grossesse : évaluation de l’effet du Traitement préventif intermittent distribué au Bénin. Symposium international, Paludisme et Trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  22. Saïah AD, Dechavanne C, Bouraima A, Viwami F, Cottrell G, Le Port A, Migot-Nabias F, Garcia A, Courtin D. Etude de la réponse IgG anti-Plasmodium falciparum au niveau qualitatif et quantitatif chez des jeunes enfants Béninois. Symposium international, Paludisme et Trypanosomose humaine africaine : nouvelles stratégies de prévention et de contrôle, 2010, Cotonou, Bénin.
  23. Maïga O, Djimdé A, Falcao S, Broussier E, Renard E, Houzé S, Le Bras J, Clain J. Genetic diversity of Plasmodium falciparum populations from sites across Africa inferred from SNPs under selection vs. neutral SNPs. Genomics of Malaria Epidemiology. 2010, Oxford, UK.

C-AFF divers chercheurs avant leur intégration à l’UMR 216

  1. Pasmant E, Sabbagh A, Parfait B, Hamel MJ, Wolkenstein P, Vidaud M, Upadhyaya M, Vidaud D : Réseau NF France. Corrélation génotype-phénotype chez les patients NF1 microdélétés. 5èmes assises de Génétique Humaine et Médicale, 2010, Strasbourg, France.

OS UMR216 :

  1. Choumet V, Chippaux JP, Goyffon M. Les envenimations ophidiennes dans le monde. 2010 In Aspects cliniques et thérapeutiques des envenimations graves, Mion G, Larréché S, Goyffon M, Eds, Urgence Pratique Publications, Paris, 2010:60-69.
  2. Larréché S, Mion G, Puidupin M, Clapson P, Chippaux JP. Envenimation par les élapidés – Syndrome cobraïque. 2010 In Aspects cliniques et thérapeutiques des envenimations graves, Mion G, Larréché S, Goyffon M, Eds, Urgence Pratique Publications, Paris, 2010:90-101.
  3. Choumet V, Chippaux JP, Goyffon M. Scorpionisme : épidémiologie et immunothérapie. In « Aspects cliniques et thérapeutiques des envenimations graves », Mion G, Larréché S, Goyffon M, Eds., Urgence Pratique Publications, Paris, 2010:178-191.
  4. Le Loup G, Malvy D. Paludisme d’importation. Encyclopédie médico-chirurgicale Maladies Infectieuses. Edition Elsevier. 2010.
  5. Mion G, Larréché S, Rudnicki S. de, Chippaux JP. Applications diagnostiques et thérapeutiques des venins. 2010 In: Aspects cliniques et thérapeutiques des envenimations graves, Mion G, Larréché S, Goyffon M, Eds, Urgence Pratique Publications, Paris, 2010:42-53.
  6. Vinetz J, Clain J, Bounkeua V, Eastman RT, Fidock D. Chapter 49: Chemotherapy of malaria. in Goodman & Gilman’s the pharmacological basis of therapeutics. McGraw-Hill Professional; 12th edition, 2010.

PV

  1. Courtin F, Chippaux JP. Eugène Jamot, le rempart de la maladie du sommeil. Biofutur, 2010, 309:60-61.
  2. Deloron P. Bientôt un vaccin antipaludique pour les femmes enceintes. Biofutur, 2010, 306.
  3. Deloron P. Espoir dans la recherche d’un vaccin contre le paludisme de la femme enceinte. Biofutur, 2010, 310:15.
  4. Choumet V, Chippaux JP, Goyffon M. Scorpionisme : épidémiologie et immunothérapie. In: Aspects cliniques et thérapeutiques des envenimations graves, Mion G, Larréché S, Goyffon M, Eds, Urgence Pratique Publications, Paris, 2010:178-191.
  5. Chippaux JP. Proband Afrika. Afrikapost, 2010, 2/10:16-17.
  6. Chippaux JP. Morsures de serpent en Afrique : un problème de santé publique négligé. Mondes et Cultures, 2010, 69:37-55.

ACL

  1. Duval L, Nerrienet E, Rousset D, Sadeuh Mba SA, Houzé S, Fourment M, Le Bras J, Robert V, Ariey F. Chimpanzee malaria parasites related to Plasmodium ovale in Africa. PLoS One, 2009, 4:
  2. Descheemaeker PN, Mira JP, Bruneel F, Houzé S, Tanguy M, Gangneux JP, Flecher E, Rousseau C, Le Bras J, Mallédant Y. Near-fatal multiple organ dysfunction syndrome induced by Plasmodium malariae. Emerg Infect Dis, 2009, 15:832-4.
  3. Mouala C, Guiguet M, Houzé S, Damond F, Pialoux G, Viget N, Costagliola D, Le Bras J, Matheron S, FHDH-ANRS CO4 Clinical Epidemiology Group. Impact of HIV infection on severity of imported malaria is restricted to patients with CD4 cell counts < 350 cells/microl. AIDS. 2009, 23:1997-2004.
  4. Houzé S, Ancelle T, Matra R, Boceno C, Carlier Y, Gajadhar AA, Dupouy-Camet J. Trichinellosis acquired in Nunavut, Canada in September 2009: meat from grizzly bear suspected. Euro Surveill, 2009, 14:
  5. Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia. Malar J. 2009, 8:
  6. Houze S, Dicko Boly M, Le Bras J, Deloron P, Faucher JF. PfHRP2 and PfLDH antigen detection for monitoring the efficacy of artemisinin-based combination therapy (ACT) in the treatment of uncomplicated falciparum malaria. Malar J, 2009, 8:
  7. Briand V, Bottero J, Noël H, Masse V, Cordel H, Guerra J, Kossou H, Fayomi B, Ayemonna P, Fievet N, Massougbodji A, Cot M. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. J Infect Dis, 2009, 200:991-1001
  8. Faucher JF, Aubouy A, Adeothy A, Doritchamou J, Cottrell G, Gourme lB, Houze P, Kossou H, Amedome H, Massougbodji A, Cot M, Deloron P. Sulfadoxine-pyrimethamine versus unsupervised artemether-lumefantrine versus unsupervised amodiaquine-artesunate fixed-dose formulation for uncomplicated falciparum malaria in Benin: a randomised effectiveness non-inferiority trial. J Infect Dis, 2009, 200:57-65.
  9. Ndao CT, Dumont A, Fievet N, Hesran JY. Placental malarial infection as a risk factor for hypertensive disorders during pregnancy in Africa: control study in an urban area of Senegal, West Africa. Am J Epidemiol, 2009, 170:847-53
  10. Courtin D, Oesterholt M, Huismans H, Kusi K, Milet J, Badaut C, Gaye O, Roeffen W, Remarque EJ, Sauerwein R, Garcia A, Luty AJ. The quantity and quality of African children’s IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum PLoS One, 2009, 4:e7590.
  11. Fievet N, Varani S, Ibitokou S, Briand V, Louis S, Perrin RX, Massougbodji A, Hosmalin A, Troye-Blomberg M, Deloron P. Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells. Malar J, 2009, 8:
  12. Fournier P, Dumont A, Tourigny C, Dunkley G, Dramé S. Improved access to comprehensive emergency obstetric care and its effect on institutional maternal mortality in rural Mali. Bull World Health Organ. 2009, 87:30-8.
  13. Munier A, Diallo A, Cot M, Ndiaye O, Arduin P, Chippaux JP. Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004). Malar J, 2009, 8:83.
  14. Munier A, Diallo A, Marra A, Cot M, Arduin P, Ndiaye O, Mboup BM, Gning B, Chippaux JP. Evolution of malaria mortality and morbidity after the emergence of chloroquine resistance in Niakhar, Senegal. Malar J, 2009, 8:
  15. Sander AF, Salanti A, Lavstsen T, Nielsen MA, Magistrado P, Lusingu J, Ndam NT, Arnot DE. Multiple var2csa-type PfEMP1 genes located at different chromosomal loci occur in many Plasmodium falciparum isolates. PLoS ONE, 2009, 4:
  16. Sarrassat S, Sakho M, Le Hesran JY. Biological measure of compliance to artesunate plus amodiaquine association: Interest in a mono-desethyl-amodiaquine blood assay? Acta Trop, 2009, 110:1-6.
  17. Souares A, Lalou R, Sene I, Sow D, Le Hesran JY. Factors related to compliance to anti-malarial drug combination: example of amodiaquine/ sulphadoxine-pyrimethamine among children in rural Senegal. Malar J, 2009, 8:
  18. Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, Le Hesran JY. Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal. Malar J, 2009, 8:
  19. Dumont A, Tourigny C, Fournier P. Improving obstetric care in low-resource settings: implementation of facility-based maternal death reviews in five pilot hospitals in Senegal. Hum Resour Health, 2009, 7:61-72.
  20. Casasola A, Ramos-Cerrillo B, de Roodt AR, Saucedo AC, Chippaux JP, Alagón A, Stock RP. Paraspecific neutralization of the venom of African species of cobra by an equine antiserum against Naja melanoleuca: a comparative study. Toxicon, 2009, 53:602-8.
  21. Chippaux JP, Santalla JA, Postigo JR, Romero M, Salas Clavijo NA, Schneider D, Brutus L. Sensitivity and specificity of Chagas Stat-Pak® test in Bolivia. Trop Med Int Health. 2009, 14:732-5.
  22. Dumont A, Fournier P, Fraser W, Haddad S, Traore Ma, Diop I, Gueye M, Gaye A, Couturier F, Pasquier JC, Beaudoin F, Lalonde A, Hatem M, Abrahamowicz M. QUARITE (quality of care, risk management and technology in obstetrics): a cluster-randomized trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali. Trials, 2009, 10:
  23. Munier A, Diallo A, Chippaux JP. Absence of impact of resistance to chloroquine on consultations for malaria in Niakhar, Senegal (1992-2004). Trans R Soc Trop Med Hyg, 2009, 103:1288-90.
  24. Briand V, Badaut C, Cot M. Placental malaria, maternal HIV infection and infant morbidity. Ann Trop Paediatr, 2009, 29:71-83.
  25. Cottrell G, Cot M, Mary JY. L’imputation multiple des données manquantes aléatoirement: concepts généraux et présentation d’une méthode Monte Carlo. Rev Epidemiol Sante Publique, 2009, 57:361-72.
  26. Dumont A, Fournier P. Protocol 08PRT/6935: QUARITE (quality of care, risk management, and technology in obstetrics): a cluster-randomised trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali (ISRCTN46950658). com. juillet 2009. http://www.thelancet.com/protocol-reviews/08PRT-6935
  27. Dortonne JR, Dumont A, Traore M, Perreault G, Couturier F, Kanouté K. [Maternal mortality audits in low-resource countries: analysis of 23 hospitals in Senegal and Mali (the QUARITE study)]. J Obstet Gynaecol Can. 2009, 31:936-44.
  28. Chippaux JP. Conception, utilisation et exploitation des autopsies verbales. Med Trop, 2009, 69:143-50.
  29. Munier A, Diallo A, Sokhna C, Chippaux JP. Evaluation d’un test de diagnostic rapide du paludisme dans les postes de santé ruraux au Sénégal. Med Trop, 2009, 69:496-500.
  30. Chippaux JP. Rôle de l’environnement sur l’incidence et la sévérité des envenimations. Med Sci, 2009, 25:858-62.
  31. Munier A, Diallo A, Sokhna C, Senghor P, Ba F, Chippaux JP. Assessing the reliability of clinical malaria diagnosis in children consulting in three peripheral health care facilities, in Niakhar rural area, Senegal. Bull Soc Pathol Exot, 2009, 102:113-8.
  32. Brutus L, Santalla JA, Salas NA, Schneider D, Chippaux JP. Screening for congenital infection by Trypanosoma cruzi in France. Bull Soc Pathol Exot, 2009, 102:300-9.
  33. Chippaux JP. Incidence mondiale et prise en charge des envenimations ophidiennes et scorpioniques. Médecine Sciences, 2009, 25:197-200.

ACL divers chercheurs avant leur intégration à l’UMR 216

  1. Sabbagh A, Darlu P, Vidaud M. Evaluating the performance of NAT2PRED for inferring the individual acetylation status from unphased genotype data. BMC Med Genet, 2009, 10:
  2. Al-Obaidly A, Sabbagh A, Pravin S, Krishnamoorthy R. Present day inbreeding does not forbid the forensic utility of commonly explored STR loci : a case study of native Qataris. Forensic Sci Int Genet, 2009, 4:e11-3.
  3. Pasmant E, Sabbagh A, Masliah J, Haddad V, Laurendeau I, Martin L, Lacombe D, Leheup B, Pasquier L, Isidor B, Soulier J, Parfait B, Wolkenstein P, Bièche I, Vidaud M, Vidaud D. Detection and characterization of NF1 microdeletions by custom high resolution array CGH. J Mol Diagn, 2009, 11:524-9.
  4. Benyamina A, Bonhomme-Faivre L, Picard V, Sabbagh A, Richard D, Blecha L, Rahioui H, Karila L, Farinotti R, Picard V, Lukasiewicz, Falissard B, Reynaud M. Association between ABCB1 C3435T polymorphism and increased risk of cannabis dependence. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33:1270-4.
  5. Sabbagh A, Pasmant E, Laurendeau I, Parfait B, Barbarot S, Guillot B, Combemale P, Ferkal S, Vidaud M, Aubourg P, Vidaud D, Wolkenstein P: Réseau NF France. Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet, 2009, 18:2768-78.
  6. Pasmant E, Sabbagh A, Hanna N, Masliah J, Jolly E, Parfait B, Ballerini P, Cartault F, Barbarot S, Landman-Parker J, Soufir N, Vidaud M, Wolkenstein P, Vidaud D, réseau NF France. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype. J Med Genet, 2009, 46:425-30.
  7. Asselah T, Bieche I, Sabbagh A, Bedossa P, Moreau R, Valla D, Vidaud M, Marcellin P. Gene expression and hepatitis C virus infection. Gut, 2009, 58:846-58.
  8. Merckx A, Bouyer G, Thomas SL, Langsley G, Egée S. Anion channels in Plasmodium falciparum-infected erythrocytes and protein kinase A. Trends Parasitol, 2009, 25:139-44.
  9. Hänscheid T, Codices V, Luty AJF, Adegnika AA, Kremsner PG, Grobusch MP. Detection and quantification of Plasmodium DNA in dried blood spots using a commercial real-time PCR assay and filter card system. Human Parasitic Diseases, 2009, 1:1-4.
  10. Hänscheid T, Längin M, Codices V, Luty AJ, Adegnika AA, Kremsner PG, Grobusch MP. Automated detection of haemozoin-containing monocytes for the diagnosis of malaria in microscopically negative cases during pregnancy. Acta Trop, 2009, 149:245-6.
  11. Hartgers FC, Obeng BB, Kruize YCM, Dijkhuis A, McCall M, Sauerwein RW, Luty AJF, Boakye DA, Yazdanbakhsh M. Responses to malarial antigens are altered in helminth-infected children. J Infect Dis, 2009, 199:1528-35.
  12. de Mast Q, van Dongen-Lases EC, Swinkels DS, Nieman AE, Roestenberg M, Druilhe P, Arens TA, Luty AJF, Hermsen CC, Sauerwein RW, van der Ven AJ. Mild increases in serum hepcidin and interleukin-6 concentrations impair iron incorporation in haemoglobin during an experimental human malaria infection. Br J Haematol, 2009, 145:657-64.
  13. Olivieri A, Camarda G, Bertuccini L, van de Vegte-Bolmer M, Luty AJF, Sauerwein R, Alano P. The Plasmodium falciparum protein Pfg27 is dispensable for gametocyte and gamete production, but contributes to cell integrity during gametocytogenesis. Mol Microbiol, 2009, 73:180-93.
  14. Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJF, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T, Spaarman L, de Mast Q, Roeffen W, Brouwe A, Snounou G, Renia L, van der Ven A, Hermsen C, Sauerwein R. Protection against a malaria challenge by sporozoite inoculation. New Engl J Med, 2009, 361:468-77.
  15. Kavishe RA, van den Heuvel JJMW, van de Vegte-Bolmer M, Luty AJF, Russel FGM, Koenderink JB. Localization of the ATP-binding cassette (ABC) transport proteins PfMRP1, PfMRP2, and PfMDR5 at the Plasmodium falciparum plasma membrane. Malar J, 2009, 8:
  16. Sirima SB, Tiono AB, Ouédraogo A, Diarra A, Ouédraogo AL, Yaro JB, Ouédraogo E, Gansané A, Bougouma E, Konaté AT, Kaboré Y, Traoré A, Chilengi R, Soulama I, Luty AJF, Cousens S, Nébié I. Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12-24 months-old Burkinabe children. PLoS One, 2009, 4:
  17. Ploemen IHJ, Prudêncio M, Douradinha B, Ramesar J, Fonager J, van Gemert GJ, Luty AJF, Hermsen CC, Sauerwein RW, Baptista FG, Mota MM, Waters AP, Que I, Lowik C, Khan SM, Janse CJ, Franke-Fayard BMD. Visualisation and quantitative analysis of the malaria liver stage by real time imaging. PLoS One, 2009, 4:
  18. Ouédraogo AL, Bousema T, Schneider P, Roeffen W, De Vlas SJ, Nébié I, Ilboudo-Sanogo E, Cuzin-Ouattara N, Verhave JP, Luty AJF, Sauerwein R. Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal malaria transmission in Burkina Faso. PLoS One, 2009, 4:
  19. Wammes LJ, Hamid F, Wiria AE, de Gier B, Sartono E, Maizels RM, Luty AJF, Fillié YE, Brice GT, Supali T, Smits HH, Yazdanbakhsh M. Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. European J Immunol, 2009, 40:437-42.
  20. Wiria AE, Hamid F, Wammes LJ, Lell B, Ariawan I, Won H, Wibowo H, Djuardi Y, Wahyuni S, Verweij JJ, Sutanto I, Luty AJF, Sartono E, Yazdanbakhsh M, Supali T. Does treatment of intestinal helminth infections influence malaria? Background and methodology of a longitudinal study of clinical, parasitological and immunological parameters in Nangapanda, Flores, Indonesia (ImmunoSPIN Study). BMC Infect Dis, 2009, 10:
  21. Tahar R, Ringwald P, Basco LK. Molecular epidemiology of malaria in Cameroon. XXVIII. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum and sequence analysis of pfatp6 gene. Am J Trop Med Hyg, 2009, 81:13-8.
  22. Sayang C, Basco LK, Tahar R, Soula G, Gazin P, Delmont J, Moyou JR. Use of HRP2-based rapid diagnostic test for malaria by health personnel during routine consultation of febrile outpatients in a peripheral health facility in Yaoundé, Cameroon. Am J Trop Med Hyg, 2009, 81:343-7.
  23. Le Loup G, Ibrahim K, Malvy D. [Chagas disease and immunodeficiency: HIV infection and transplantation]. Bull Soc Pathol Exot, 2009, 102:310-8.
  24. Lescure FX, Paris L, Elghouzzi MH, Le Loup G, Develoux M, Touafek F, Mazier D, Pialoux G. [Experience of targeted screening of Chagas disease in Ile-de-France]. Bull Soc Pathol Exot, 2009, 102:295-9.
  25. World Health Organization maximizing positive synergies collaborative group (dont Le Loup G), Samb B, Evans T, Dybul M, Atun R, Moatti JP, Nishtar S, Wright A, Celletti F, Hsu J, Kim JY, Brugha R, Russell A, Etienne C. An assessment of interactions between global health initiatives and country health systems. Lancet, 2009, 373:2137-69.
  26. Le Loup G, de Assis A, Costa-Couto MH, Thoenig JC, Fleury S, de Camargo K Jr, Larouzé B. A public policy approach to local models of HIV/AIDS control in Brazil. Am J Public Health, 2009, 99:1108-15.
  27. Le Loup G, Lescure FX, Develoux M, Pialoux G. [Chagas disease: clinical aspects and treatment in non-endemic countries]. Presse Med, 2009, 38:1654-66.
  28. Develoux M, Lescure FX, Le Loup G, Pialoux G. [Chagas disease]. Rev Med Interne, 2009, 30:686-95.

ACLN

  1. Goyffon M, Chippaux JP. Les envenimations scorpioniques en Afrique. Rev Médico-pharmaceutique, 2009, 53:17-21.

ASCL

  1. Chippaux JP, Massougbodji A. Epidémiologie des envenimations en Afrique – Une condition essentielle à l’amélioration de leur prise en charge. Bull Assoc Anciens El Inst Pasteur, 2009, 51:53-7.

C-INV

  1. Chippaux JP. Viper bite in Africa: Epidemiology and management. Venom Week, 2009, Albuquerque, USA.
  2. Cot M. Traitement préventif intermittent par la sulfadoxine-pyriméthamine au Bénin : comparaison de l’efficacité de la distribution nationale et de l’administration lors d’un essai randomisé. Congrès de pharmaco-épidémiologie de l’ADELF, 2009, Paris.
  3. Baxerres C. La distribution pharmaceutique : du médicament informel au médicament libéralisé. Réflexions à partir de la question du marché informel du médicament en Afrique de l’Ouest francophone. Séminaire du LASDEL, 2009, Parakou, Bénin.
  4. Houze S. Paludisme d’importation. Microbiologie clinique 2009 : les évènements de l’année en microbiologie clinique. Vème Journée. 2009. Paris.

C-INV divers chercheurs avant leur intégration à l’UMR 216

  1. Sabbagh A. Evolutionary pharmacogenetics of the NAT gene family. SFG/SFGH Joint Meeting “Darwin’s legacy: new insights into human evolution”, 2009, Paris, France.

C-ACTI IRD UR10, 2007-2009

  1. Le Port A, Cottrell G, Dechavanne C, Briand V, Bouraima A, Rachas A, Massougbodji A, Migot-Nabias F, Garcia A, Cot M. Intermittent preventive treatment during pregnancy (IPTp) by sulfadoxine pyrimetamine (SP) in a rural region of Benin : effect on placental parasitemia and low birth weight one year after national implementation of IPTp. 6th European Congress on Tropical Medecine and International Health, 2009, Vérone, Italie. In: Trop Med Intl Hlth, 2009, 14 (Suppl. 2):
  2. Munier A, Diallo A, Marra A, Cot M, Arduin P, Ndiaye O, Mboup BM, Gning B, Chippaux JP. Trends in mortality and morbidity attributable to malaria do not follow resistance to chloroquine in Niakhar rural area, Senegal, 1992-2004. 6ème Congrès de Médecine Tropicale et Santé Internationale, 2009, Vérone, Italie. Trop Med Intern Health, 2009, 14 (Suppl. 2):
  3. Ibitokou S, Varani S, Vianou B, Briand V, Louis S, Perrin RX, Massougbogji A, Hosmalin A, Troye-Blomberg M, Deloron P, Fievet N. Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of fetal antigen presenting 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 28 [MIM16559804]
  4. Gbaguidi G, Huynh BT, Fievet N, Cot M, Guezo-Mévo B, Massougbodji A, Lusingu J, Tuikue Ndam N, Theander T, Troye-Blomberg M, Luty AJF, Deloron P. Pregnancy Associated Malaria (PAM) follow-up in Benin: an epidemiological survey. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 30 [MIM16689806]
  5. Ouédraogo S, Le Port A, Cottrell G, Garcia A, Massougbodgi A, Cot M. Study of the determinants of occurrence of first malarial parasitemia in newborn in Tori-Bossito (southern Bénin). 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. [MIM16669122]
  6. Soulard V, Amadoudji M, Fitting C, Ibitokou S, Luty AJF, Oesterholt M, Massougbodji A, Perrin RX, Deloron P, Bandeira A, Fievet N. Impact of placental malaria on neonatal Treg cells and Plasmodium falciparum-specific immune responses. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 28 [MIM16645854]
  7. Oesterholt M, Lusingu J, Lemnge M, Fievet N, Varani S, Troye-Blomberg M, Salanti A, Minja D, Schmiegelow C, Theander T, Massougbodji A, Tuikue Ndam N, Deloron P, Luty AJF. Cellular immunological responses in pregnancy associated malaria. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 27 [MIM16670864]
  8. Vianou B, Agbowaï C, Fievet N, Oesterholt M, Varani S, Troye-Blomberg M, Luty AJF, Theander T, Salanti A, Tuikue Ndam N, Massougbodji A, Deloron P. T cells IFN-gamma responses in Pregnancy Associated Malaria during a follow-up in Benin. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 28 [MIM16690219]
  9. Minja D, Lusingu J, Magistrado P, Schmiegelow C, Oesterholt M, Tunuka C, Ndam N, Troye-Blomberg M, Massougbodji A, Fievet N, Deloron P, Luty AJF, Theander T, Lemnge M. Changing malaria epidemiology and susceptibility to pregnancy associated malaria among a cohort of pregnant women in Korogwe, northeastern Tanzania. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 31 [MIM16691590]
  10. Ibitokou S, Doritchamou J, Fievet N, Oesterholt M, Massougbodji A, Theander T, Varani S, Troye-Blomberg M, Luty A, Deloron P. Phenotyping and levels of activation of dendrictic cells (DCs) and monocytes in Pregnancy-Associated Malaria during a follow-up in Benin. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 27 [MIM16693964]
  11. Guitard J, Gnidehou S, Sow S, Le Hesran JY, Deloron P, Tuikue Ndam N. Dynamics and placental tropism of Plasmodium falciparum genotypes during pregnancy. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 192 [MIM16672676]
  12. Kheliouen N, Tuikue Ndam N, Deloron P, Aubouy A. Acquisition of antibodies to Plasmodium falciparum Variant Surface Antigens in distinct malaria pathology. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 149 [MIM16672720]
  13. Gnidehou S, Guitard J, Andersen P, Ermont C, Salanti A, Lund O, Deloron P, Tuikue Ndam N. Molecular characterization of distinct VAR2CSA DBL5e variants from placental isolates. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 193 [MIM16673954]
  14. Tuikue Ndam N, Quiviger M, Bigey P, Scherman D, Deloron P. Induction of functional anti-VAR2CSA antibodies in mouse using in vivo DNA electroporation. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 195 [MIM16674984]
  15. Schmiegelow C, Lusingu J, Lemnge M, Bruun Nielsen B, Rasch V, Oesterholt M, Minja D, Tunuka C, Fievet N, Massougbodji A, Deloron P, Theander T. Consequences of pregnancy-associated malaria on fetal growth and development of preeclampsia and gestational hypertension. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 115 [MIM16690749]
  16. Wakpo A, Ezinmegnon S, Houze S, Massougbodji A, Deloron P, Le Bras J, Aubouy A. In vitro susceptibility levels of falciparum isolates to antimalarial drugs in southern Benin. 5th MIM Pan-African Malaria Conference, 2009, Nairobi, Kenya. In: Abstract book, p. 98 [MIM16698919]
  17. Faucher JF, Makoutode P, Abiou G, Béhéton, Aubouy A, Doritchamou J, Houzé P, Houzé S, Ouendo E, Cot M, Deloron P. Can treatment of malaria be restricted to parasitologically confirmed malaria? A school-based prospective, exposed/non exposed to fever, study in Benin. 6th European Congress on Tropical Medicine and International Health and 1st Mediterranean Conference on Migration and Travel Health, 2009, Vérone, Italie. In Trop Med Intl Hlth, 2009, 14 (Suppl. 2):
  18. Pion SDS, Kamgno J, Gardon J, Gardon-Wendel N, Ernould JC, Chippaux JP, Boussinesq M. Ivermectin and Loa loa: can initial microfilaraemias be estimated from post-treatment data? 6ème Congrès de Médecine Tropicale et Santé Internationale, Vérone, Italie. Trop Med Intern Health, 2009, 14 (Suppl. 2):171-172
  19. Chippaux JP, Salas A, Santalla J, Postigo J, Romero M, Espinoza E, Oporto P, Rios T, Schneider D, Brutus L. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole. 58th Ann Meet Am Soc Trop Med Hyg, 2009, Washington, USA. Am J Trop Med Hyg, 2009, 81 (Suppl. 1):
  20. Bodeau-Livinec F, Briand V, Berger J, Xiong X, Day K, Massougbodji A, Cot M. Anemia during pregnancy and low birth weight in an endemic malaria area in Benin. 58th Ann Meet Am Soc Trop Med Hyg, 2009, Washington, USA. Am J Trop Med Hyg, 2009, 81 (Suppl. 1).
  21. Terlouw DJ, Alves FP, Sosa-Estani S, Freilij H, Altcheh J, Brutus L, Kiechel JR, Ribeiro I. A new pediatric tablet strength of benznidazole for the treatment of chagas disease. 58th Ann Meet Am Soc Trop Med Hyg, 2009, Washington, USA. Am J Trop Med Hyg, 2009, 81 (Suppl. 1):

C-ACTN

  1. Faucher JF, Makoutode P, Abiou G, Béhéton T, Aubouy A, Doritchamou J, Houzé P, Ouendo EM, Deloron P, Cot M. Traitement exclusif des cas de paludisme confirmés par un test de diagnostic rapide: une étude prospective de type exposé/non exposé à la fièvre en milieu scolaire au Bénin. Actualités du Pharo, 2009, Marseille Méd Trop, 2009, 69:
  2. Brutus L, Santalla JA, Salas NA, Schneider D, Chippaux JP. Le dépistage de l’infection congénitale par Trypanosoma cruzi en France métropolitaine. Atelier de consensus sur la maladie de Chagas en zone non endémique, 2009, Val-de-Grâce, Paris. Bull Soc Pathol Exot, 2009, 102:300-309.

C-COM

  1. Brutus L. La detección de parásitos circulantes de Trypanosoma cruzi en la sangre maternal y el riesgo e transmission congenital en la enfermedad de Chagas. La enfermedad de Chagas: aspectos pediátricos a 100 años de su descubrimiento. 2009, Hospital de Niños Ricardo Gutierréz, Buenos Aires, Argentina.
  2. Abrahamowicz M, Beauchamp ME, Dumont A, Fournier P. Necessary and sufficient conditions for statistically significant subgroup-treatment interactions and non-significant main effects in randomized clinical trials: a simulation study. The 6th International conference on multiple comparison procedures, 2009, Tokyo, Japan.
  3. Abrahamowicz M, Dumont A, Fournier P. Subgroup-specific treatment effects in the absence of the overall effect: is there really a contradiction? 4th Asian conference on pharmacoepidemiology (ACPE), 2009, Tainan, Taiwan. Abstract Number: OG-1.
  4. Fievet N, Ibitokou S, Vianou B, Agbowaï C, Massougbodji A, Varani S, Troye-Blomberg M, Theander T, Deloron P, Luty A. Phenotyping and levels of activation of dendrictic cells (DCs) and monocytes in Pregnancy-Associated Malaria during a follow-up in Benin. International federation of placenta associations meeting, 2009, Adelaide, Australie.
  5. Lokossou AG, Vigan-Womas I, Guillotte M, Mercereau-Puijalon O, Migot-Nabias F. Naturally acquired antibodies to the VarO variant from falciparum PfEMP1 protein in Beninese children. Congrès constitutif de la Société béninoise de Parasitologie-Mycologie, 2009, Cotonou, Bénin.
  6. Faucher JF, Makoutode P, Abiou G, Béhéton T, Aubouy A, Doritchamou J, Houzé P, Ouendo E, Deloron P, Cot M. Traitement exclusif des cas de paludisme confirmés par un test de diagnostic rapide: une étude prospective de type exposé/non exposé à la fièvre en milieu scolaire au Bénin. Actualités du Pharo, 2009, Marseille.
  7. Chippaux JP. Morsures de serpent en Afrique : situation épidémiologique actuelle et ressources thérapeutiques. Atelier de préparation du séminaire régional pour une meilleure connaissance de l’épidémiologie et la prise en charge des envenimations ophidiennes, 2009, Dakar, Sénégal.
  8. Dumont A, Gueye M, Diop I, Fournier P. Qualité des soins, gestion du risque et technologie obstétricale dans les pays en développement (Essai QUARITE) : Analyse situationnelle pré-intervention. Première journées de santé publique – Association Sénégalaise des professionnels de la santé publique. 2009, Dakar, Sénégal.
  9. Jamonneau V, Kaboré J, Ilboudo H, Courtin D, Garcia A, Coulibaly B, N’Dri L, Solano P, Büscher P, Bucheton B. Long term follow-up of sleeping sickness patients refusing treatment and aparasitemic seropositive individuals in Côte d’Ivoire: implications for long term control strategies. 30ème ISCTRC, 2009, Kampala, Ouganda.
  10. Dortonne JR, Dumont A, Fournier P, et al. Qualité des soins, gestion du risque et technologie obstétricale dans les pays en développement (essai QUARITE). Société des Obstétriciens et Gynécologues du Canada. Annual Clinical Meeting, 2009, Halifax, Canada.
  11. Le Hesran JY, Baxerres C. Distribution des médicaments et prescription médicale en Afrique de l’Ouest : La marchandisation du médicament en question. 3ème congrès international sur la chaîne des médicaments, Université des études de Milano Bicocca, 2009, Milan, Italie.

C-AFF

  1. Brucato N, Cassar O, Tonasso L, Guitard E, Migot-Nabias F, Tortevoye P, Plancoulaine S, Larrouy G, Gessain A, Dugoujon JM. Genetic diversity and dynamics of the noir marron settlement in French Guyana: a study combining mitochondrial DNA, Y chromosome and HTLV-1 genotyping. 14th international conference on human retrovirology HTLV and related retroviruses, 2009, Salvador, Brésil.
  2. Lokossou AG, Le Port A, Ladekpo R, Noukpo J, Bonou D, Ahouangninou C, Loumedjinon F, Daoudou M, Garcia A, Migot-Nabias F. Impact of maternal cytokine gene polymorphisms on mother and child biological parameters in the context of placental malaria. EMBO Conference “Genetics and mechanisms of susceptibility to infectious diseases”, 2009, Paris, France.
  3. Soulard V, Amadoudji Zin M, Fitting C, Ibitokou S, Luty AJF, Oesterholt M, Massougbodji A, Perrin RX, Deloron P, Bandeira A, Fievet N. Impact du paludisme placentaire sur les cellules T régulatrices néonatales et la réponse immune spécifique de Plasmodium falciparum chez le nouveau-né. Keystone Symposium – Regulatory T Cells, 2009, Keystone, USA.
  4. Gangnard S, Tuikue Ndam N, Ramboarina S, Juillerat A, Srivastar A, Faure G, Gnidéhou S, Quiviger M, Gamain B, Deloron P, Bentley G. Functionnal and structural studies of VAR2CSA Plasmodium falciparum erythrocyte protein 1 (PfEMP1) DBL5e Gordon research conference, Malaria: parasite biology and host-parasite interactions, 2009, Oxford, United Kingdom
  5. Salas Clavijo NA, Postigo J, Santalla J, Schneider D, Chippaux JP. La enfermedad de Chagas congénita en Bolivia: optimizacion del tratamiento por el benznidazole. Centenario del descubrimiento de la enfermedad de Chagas, 2009, Mexico DF, Mexique.
  6. Chippaux JP. Viper bites in Africa: epidemiology and management. Venom Week 2009, 2009, Albuquerque, USA.
  7. Chippaux JP. IgG de Camelidae et traitement des envenimations. Séminaire sur l’utilisation thérapeutique des immunoglobulines de Camelidae, Latoxan, 2009, Valence, France.
  8. Chippaux JP. Stabilité et dénaturation des venins. Séminaire sur la stabilité et la conservation des venins, Latoxan, 2009, Valence, France.
  9. Dumont A, Gueye M, Diop I, Sow A, Djénépo F, Tessougué GJ, Konate MK, Fournier P. Implementation of a maternal and perinatal health programme in West Africa (QUARITE test). 26th International Population Conference in Marrakech, 2009, Morocco.
  10. Chippaux JP, Massougbodji A, Stock R. Preliminary dose-finding study with a new F(ab’)2 antivenom. 16th World Congress of the International Society on Toxinology & 10th Congress of the Brazilian Society on Toxinology, 2009, Recife, Brésil.
  11. Gangnard S, Badaut C, Faure G, Tuikue Ndam N, Bertin G, Chaffotte A, Khattab A, Klinkert MQ, Nato F, Deloron P, Bentley G. Functional and structural studies of varPAM732 Plasmodium falciparum Erythrocyte Protein 1 (PfEMP1) DBL3γ domain. BioMalPar Conference, 2009, Heidelberg, Germany.
  12. Rollard C, Chippaux JP, Goyffon M. The Paris National Museum of Natural History course on venomous and poisonous animals. 16th World Congress of the International Society on Toxinology – 10th Congress of the Brazilian Society on Toxinology, 2009, Recife, Brésil.
  13. Chippaux JP. Scorpionism in Amazonia. International consensus process on the terminology of clinical consequences, classification and management of scorpion stings, 2009, Rabat, Maroc.
  14. Chippaux JP, Santalla J. A, Postigo J. R, Romero M, Salas Clavijo AN, Schneider D, Brutus L. Sensibilidad y especificad de la prueba de Chagas Stat-Pak® en Bolivia. XIXº Congreso Latinomericano de Parasitologia, 2009, Asunción, Paraguay.
  15. Salas-Clavijo A, Santalla J, Postigo J, Schneider D, Chippaux JP. Enfermedad de Chagas congenita en Bolivia: optimizacion del tratamiento por benznidazol. XIXº Congreso Latinomericano de Parasitologia, 2009, Asunción, Paraguay.
  16. Salas-Clavijo A, Chippaux JP. La prise en charge de la maladie de Chagas congénitale en Bolivie : optimisation du traitement par le benznidazole. Journées de l’Ecole doctorale de Santé Publique de Paris 6, 2009, Saint-Malo, France.

OS UMR216 :

  1. Chippaux JP. Snakebite in Africa: current situation and urgent needs. In: Reptile venoms and toxins, Mackessy Ed, Taylor, Francis/CRC Press, Boca Raton, 2009:445-465.
  2. Bellefleur JP, Chippaux JP. Envenimations ophidiennes. In: Maladies rares en réanimation, Léone M, Ed, Springer-Verlag, Paris, 2009:121-131.
  3. Phelps B. R, Chippaux JP. Snakebite. In Atlas of pediatrics in the tropics and ressource-limited settings. Spector JM, Gibson TE, Eds, American Academy of Pedriatics, Elk Grove Village, IL, 2009:233-240.

OS divers chercheurs avant leur intégration à l’UMR 216

  1. Sabbagh A, Darlu P. Data-mining methods as tools for predicting individual drug response. In: Pharmaceutical Data Mining: Approaches and Applications for Drug Discovery, Balakin KV, eds, 2009:156-179.

PV

  1. Chippaux JP. Charles Lucien Bonaparte, un zoologiste éclectique. Biofutur, 2009, 303:60-61.

ACL

  1. Mouala C, Houzé S, Guiguet M, Abboud P, Pialoux G, Viget N, Costagliola D, Matheron S. Imported malaria in HIV-infected patients enrolled in the ANRS CO4 FHDH study. J Acquir Immune Defic Syndr, 2008, 49:55-60.
  2. Armengaud A, Legros F, D’Ortenzio E, Quatresous I, Barre H, Houzé S, Valayer P, Fanton Y, Schaffner F. A case of autochthonous Plasmodium vivax malaria, Corsica, August 2006. Travel Med Infect Dis, 2008, 6:36-40.
  3. Durand R, Prendki V, Cailhol J, Hubert V, Ralaimazava P, Massias L, Bouchaud O, Le Bras J. Plasmodium falciparum malaria and atovaquone-proguanil treatment failure. Emerg Infect Dis. 2008, 14:320-2.
  4. Nsimba B, Guiyedi V, Mabika-Mamfoumbi M, Mourou-Mbina JR, Ngoungou E, Bouyou-Akotet M, Loembet R, Durand R, Le Bras J, Kombila M.   Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy. Malar J. 2008, 7:31.
  5. Durand R, Ariey F, Cojean S, Fontanet A, Ranaivo L, Ranarivelo LA, Vonimpaisomihanta JA, Menard D, Pietra V, Le Bras J, Modiano D, Randrianarivelojosia M. Analysis of circulating populations of Plasmodium falciparum in mild and severe malaria in two different epidemiological patterns in Madagascar. Trop Med Int Health, 2008, 13:1392-9.
  6. Kaddouri H, Djimdé A, Dama S, Kodio A, Tekete M, Hubert V, Koné A, Maiga H, Yattara O, Fofana B, Sidibe B, Sangaré CP, Doumbo O, Le Bras J. Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali. Int J Parasitol. 2008, 38:791-8.
  7. Blondé R, Naudin J, Bigirimana Z, Holvoet L, Fenneteau O, Vitoux C, Bourdon O, Angoulvant F, Lorrot M, D’Ortenzio E, Bourrillon A, Le Bras J, Matheron S, Faye A. Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris. Arch Pediatr, 2008, 15:245-52.
  8. Chippaux JP, Massougbodji A, Stock R, Akiana J, Mokondjimobe E, Parra HJ. Compte rendu de la 3ème conférence internationale sur les envenimations en Afrique. Bull Soc Pathol Exot, 2008, 101:437-8.
  9. Buffet P, Briand V, Rénia L, Thellier M, Danis M, Mazier D. Intermittent preventive anti-malarial treatment to children (IPTc): firebreak or fire trap? Trends in Parasitol, 2008, 24:482-5
  10. Chippaux JP, Alagón A. Envenimations et empoisonnements par les animaux venimeux ou vénéneux. VII:l’arachnidisme du Nouveau Monde. Med Trop, 2008, 68:215-21.
  11. Chippaux JP. Incidence et mortalité par animaux venimeux dans les pays tropicaux. Med Trop, 2008, 68:334-9.
  12. Chippaux JP. Control of meningococcal meningitis outbreaks in sub-Saharan Africa. J Infect Dev Countries, 2008, 2:335-45.
  13. Chippaux JP. First GICT 2008, Melbourne, Australie. Med Trop, 2008, 68:581-2.
  14. Chippaux JP. Estimating the global burden of snakebite can help to improve management. PLoS Med, 2008, 5:e221.
  15. Males S, Gaye O, Garcia A. Long term asymptomatic carriage of Plasmodium falciparum protects from malaria attack a prospective study among Senegalese children. Clin Infect Dis, 2008, 46:516-22.
  16. Tuikue Ndam N, Bischoff E, Proux C, Lavstsen T, Salanti A, Guitard J, Nielsen MA, Bertin G, Coppée JY, Gaye A, Theander T, David PH, Deloron P. Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression. PLoS One, 2008, 3:e1855.
  17. Ayouba A, Badaut C, Kfutwah A, Cannou C, Juillerat A, Gangnard S, Behr C, Mercereau-Puijalon O, Bentley GA, Barré-Sinoussi F, Menu E. Specific stimulation of HIV-1 replication in human placental trophoblasts by an antigen of Plasmodium falciparum. AIDS, 2008, 22:785-7.
  18. Briand V, Denoeud L, Massougbodji A, Cot M. Efficacy of intermittent preventive treatment versus chloroquine prophylaxis to prevent malaria during pregnancy in Benin. J Infect Dis, 2008, 198:594-601.
  19. Magistrado P, Salanti A, Tuikue Ndam N, Mwakalinga S, Resende M, Dahlback M, Hviid L, Lusingu J, Theander TG, Nielsen MA. VAR2CSA expression on the surface of placenta-derived falciparum infected erythrocytes. J Infect Dis, 2008 198:1071-4
  20. Migot-Nabias F, Noukpo JM, Guitard E, Doritchamou J, Garcia A, Dugoujon JM. Imbalanced distribution of GM immunoglobulin allotypes according to the clinical presentation of falciparum malaria in Beninese children. J Infect Dis, 2008 198:1892-5.
  21. Vafa M, Troye-Blomberg M, Anchang J, Garcia A, Migot-Nabias F. Multiplicity of Plasmodium falciparum infection in asymptomatic children in Senegal: relation to transmission, age and erythrocyte variants. Malar J, 2008, 7:17.
  22. Ramos-Cerrillo B, de Roodt AR, Chippaux JP, Olguín L, Casasola A, Guzmán G, Paniagua-Solís J, Alagón A, Stock RP. Characterization of a new polyvalent antivenom (Antivipmyn® Africa) against African vipers and elapids. Toxicon, 2008, 52:881-8.
  23. Souares A, Lalou R, Sene I, Sow D, Senghor P, Le Hesran JY. Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal. Trans R Soc Trop Med Hyg, 2008, 102:751-8.
  24. Guitard J, Cottrell G, Moulopo Magnouha NM, Salanti A, Li F, Sow S, Deloron P, Tuikue Ndam N. Differential evolution of anti-VAR2CSA-IgG3 in primigravidae and multigravidae pregnant women infected by Plasmodium falciparum. Malar J, 2008, 7:10.
  25. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A. Relation between falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. Malar J, 2008, 7:193.
  26. Resende M, Nielsen MA, Dahlback M, Ditlev SB, Andersen P, Sander AF, Tuikue Ndam N, Theander TG, Salanti A. Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA. Malar J, 2008, 7:104.
  27. Sarrassat S, Senghor P, Le Hesran JY. Trends in malaria morbidity following the introduction of artesunate plus amodiaquine combination in M’lomp village dispensary, south-western Senegal. Malar J, 2008, 7:215.
  28. Sosa-Estani S, Gamboa-Leon MR, Del Cid-Lemus J, Althabe F, Alger J, Almendares O, Cafferata ML, Chippaux JP, Dumonteil E, Gibbons L, Padilla-Raygoza N, Schneider D, Belizán JM, Buekens P, and Working Group. Use of umbilical cord blood to assess the risk of congenital transmission of Trypanosoma cruzi in pregnant women from Argentina, Bolivia, Honduras, and Mexico. Am J Trop Med Hyg 2008, 79:755-9.
  29. Poinsignon A, Remoue F, Rossignol M, Cornelie S, Courtin D, Grebaut P, Garcia A, Simondon F. Human IgG antibody response to glossina saliva: an epidemiological marker of exposure to glossina bites. Am J Trop Med Hyg, 2008, 78:750-3.
  30. Chippaux JP, Goyffon M. Epidemiology of scorpionism: a global appraisal. Acta Trop, 2008, 107:71-9.
  31. Chippaux JP, Postigo J. R, Santalla J. A, Schneider D, Brutus L. Epidemiological evaluation of Chagas disease in a rural area of southern Bolivia. Trans R Soc Trop Med Hyg, 2008, 102:578-84.
  32. Courtin D, Berthier D, Thevenon S, Guiguigbaza-Kossigan Dayo, Garcia A, Bucheton B. Host genetics in African trypanosomiasis. Infect Genet Evol, 2008, 8:229-38.
  33. Courtin D, Jamonneau V, Duvallet G, Garcia A, Coulibaly B, Doumenge JP, Cuny G, Solano P. Sleeping sickness in West Africa (1906-2006): Changes in spatial repartition and lessons from the past. Trop Med Int Health, 2008, 13:334-44.
  34. Brutus L, Schneider D, Postigo J, Romero M, Santalla J, Chippaux JP. Congenital Chagas disease: Diagnostic and clinical aspects in an area without vectorial transmission, Bermejo, Bolivia. Acta Trop, 2008, 106:195-9.
  35. Chippaux JP. Quelle éthique pour les essais de prévention ? Bull Soc Pathol Exot 2008, 101:85-9.
  36. Estevez J,  Magaña P, Chippaux JP, Vidal N,  Mancilla R, Paniagua JF, Roodt AR. Etude des venins des principaux serpents venimeux de Guyane française et de leur neutralisation. Bull
  37. Soc Pathol Exot, 2008, 101:353-9.
  38. Gollub EL, Leroy V, Gilbert R, Chêne G, Wallon M. European toxoprevention study group (EUROTOXO) (dont M Cot). Effectiveness of health education on Toxoplasma-related knowledge, behaviour, and risk of seroconversion in pregnancy. Eur J Obstet Gynecol Reprod Biol, 2008, 136:137-45.
  39. Tuikue Ndam N, Deloron P. Towards a vaccine against pregnancy-associated malaria. Parasite, 2008, 15:515-21.
  40. Bénard A, Petersen E, Salamon R, Chêne G, Gilbert R, Salmi LR. European Toxo Prevention Study Group (EUROTOXO) dont Cot M. Survey of European programmes for the epidemiological surveillance of congenital toxoplasmosis. Euro Surveill. 2008, 10:13.
  41. Labbo R, Ernould JC, Djibrilla A, Garba A, Chippaux JP. [Focusing of Schistosoma haematobium transmission in irrigated perimeters of the Niger valley (Niger): importance of malacological factors.] Rev Epidemiol Sante Publique, 2008, 56:3-9.
  42. Cojean S, Jafari-Guemouri S, Le Bras J, Durand R. Cytoadherence characteristics to endothelial receptors ICAM-1 and CD36 of Plasmodium falciparum populations from severe and uncomplicated malaria cases. Parasite, 2008, 15:163-9.

ACL divers chercheurs avant leur intégration à l’UMR 216

  1. Asselah T, Bieche I, Narguet S, Sabbagh A, Laurendeau I, Ripault MP, Boyer N, Martinot M, Valla D, Vidaud M, Marcellin P. Liver gene expression signature to predict response outcome to pegylated interferon plus ribavirin in patients with chronic hepatitis C. Gut, 2008, 57:516-24.
  2. Sabbagh A, Langaney A, Darlu P, Gérard N, Krishnamoorthy R, Poloni ES. Worldwide distribution of NAT2 diversity: implications for NAT2 evolutionary history. BMC Genet, 2008, 9:21.
  3. Sabbagh A, Génin E, Darlu P. Selecting predictive markers for pharmacogenetic traits: tagging vs. data-mining approaches. Hum Hered, 2008, 66:10-8.
  4. McCollum AM, Basco LK, Tahar R, Udhayakumar V, Escalante AA. Hitchhiking and selective sweeps of Plasmodium falciparum sulfadoxine and pyrimethamine resistance alleles in a population from Central Africa. Antimicrob Agents Chemother, 2008, 52:4089-97.
  5. Merckx A, Echalier A, Langford K, Sicard A, Langsley G, Joore J, Doerig C, Noble M, Endicott J. Structures of falciparum protein kinase 7 identify an activation motif and leads for inhibitor design. Structure, 2008, 16:228-38.
  6. Merckx A, Nivez MP, Bouyer G, Alano P, Langsley G, Deitsch K, Thomas S, Doerig C, Egée S. Plasmodium falciparum regulatory subunit of cAMP-dependent PKA and anion channel conductance. PLoS Pathog, 2008, 4:228-38.
  7. Douradinha B, Mota MM, Luty AJF, Sauerwein RW. Cross-species immunity in malaria vaccine development: two, three or even four for the price of one? Infect Immun, 2008, 76:873-8.
  8. Fowkes FJI, Michon P, Pilling L, Ripley RM, Tavul L, Imrie HH, Woods CM, Mgone CS, Luty AJF, Day KP. Host erythrocyte polymorphisms and exposure to Plasmodium falciparum in Papua New Guinea. Malar J, 2008, 7:1.
  9. Outchkourov NS, Roeffen W, Kaan A, Jansen J, Luty AJF, Schuiffel D, van Gemert GJ, van de Vegte-Bolmer M, Sauerwein RW, Stunnenberg HG. Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice. Proc Natl Acad Sci USA, 2008, 105:4301-5.
  10. Siau A, Silvie O, Franetich JF, Marinach C, Hannoun L, van Gemert GJ, Luty AJF, Bishoff E, David P, Vaquero C, Snounou G, Froissard P, Mazier D. Temperature shift and host cell contact up-regulate the expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog, 2008, 4:e1000121.
  11. Cavanagh DR, Remarque EJ, Sauerwein RW, Hermsen CC, Luty AJF. Influenza virosomes: a flu jab for malaria? Trends Parasitol, 2008, 24:382-5.
  12. Adegnika AA, Koehler C, Agnandji ST, Chai S, Breitling LP, Labuda L, Schonkeren D, Weerdenburg E, Issifou S, Luty AJF, Kremsner PG, Yazdanbakhsh M. Pregnancy-associated malaria affects TLR ligand-induced cytokine responses. J Infect Dis, 2008, 198:928-36.
  13. Rodrigues CD, Hannus M, Prudêncio M, Martin C, Gonçalves LA, Portugal S, Akin A, Hadwiger P, Jahn-Hofmann K, Röhl I, van Gemert GJ, Franetich JF, Luty AJF, Sauerwein R, Mazier D, Koteliansky V, Vornlocher HP, Echeverri CJ, Mota MM. Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe, 2008, 4:271-82.
  14. Yalaoui S, Huby T, Franetich JF, Gego A, Rametti A, Moreau M, Collet X, Siau A, van Gemert GJ, Sauerwein RS, Luty AJF, Vaillant JC, Hannoun L, Chapman J, Mazier D, Froissard P. Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium Cell Host Microbe, 2008, 4:283-92.
  15. Poncon N, Tran A, Toty C, Luty AJF, Fontenille D. A quantitative risk assessment approach for mosquito-borne diseases: malaria re-emergence in Southern France. Malar J, 2008, 7:147.
  16. Schwarz NG, Adegnika AA, Breitling LP, Gabor J,Agnandji ST, Newman RD, Lell B, Issifou S, Yazdanbakhsh M, Luty AJF, Kremsner PG, Grobusch MP. Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis, 2008, 47:1017-25.
  17. Köhler C, Adegnika AA, van den Linden R, Chai SK, Luty AJF, Szepfalusi Z, Kremsner PG, Yazdanbakhsh M. Comparison of immunological status of African and European cord blood. Pediatr Res, 2008, 64:631-6.
  18. Hartgers FC, Obeng B, Voskamp A, Larbi IA, Amoah AS, Luty AJF, Boakye D, Yazdanbakhsh M. 2008. Enhanced TLR responsiveness associated with MAPK activation in Plasmodium falciparum-infected children. Infect Immun, 2008, 76:5149-57.
  19. Lasonder E, Janse CJ, van Gemert GJ, Mair GR, Vermunt AMW, Douradinha B, van Noort V, Huynen MA, Luty AJF, Kroeze H, Khan S, Sauerwein RW, Waters AP, Mann M, Stunnenberg HG. Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivity. PLoS Pathog, 2008, 4:e1000195.
  20. Prudêncio M, Rodrigues CD, Hannus M, Martin C, Real E, Deus L, Carret C, Dorkin R, Röhl I, Jahn-Hoffmann K, Luty AJF, Sauerwein R, Echeverri CJ, Mota MM. Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection. PLoS Pathog, 2008, 4:e1000201.
  21. Mayengue PM, Luty AJF, Rogier C, Baragatti M, Kremsner PG, Ntoumi F. The multiplicity of Plasmodium falciparum infections is associated with acquired immunity to asexual blood stage antigens. Microbes Infect, 2008, 11:108-14.
  22. Bodeau-Livinec F, Marlow N, Ancel PY, Kurinczuk JJ, Costeloe K, Kaminski M. The impact of intensive care practices on short and long-term outcomes for extremely preterm babies: a comparison between the British Isles and France. Pediatrics, 2008, 122:e1014-21.
  23. Develoux M, Le Loup G, Pialoux G. A case of ciguatera fish poisoning in a French traveler. Euro Surveill, 2008, 13:19027.

ACLN

  1. Dumont A, Chergui M, Gaye A, Landry A, Tourigny C, Fournier P. Identifying barriers and facilitators towards implementing facility-based maternal death reviews in Senegal. SOGC International Women’s Health Special report. Sept 2008.

C-INV

  1. Deloron P. Endpoints for placental malaria interventional trials: newborn outcomes. Expert meeting on biomarkers for pregnancy malaria (BMG Foundation), 2008, Annecy, France.
  2. Tuikue Ndam T, Deloron P. Towards a vaccine against Pregnancy-associated malaria. 10th European Multicolloquium of Parasitology (EMOP X), 2008, Paris.
  3. Baxerres C. Savoirs et usages populaires actuels concernant le médicament pharmaceutique à Cotonou : Réflexion anthropologique menée à partir des pratiques de médication populaire contre le « palu ». Séminaire du LASDEL, 2008, Parakou, Bénin.
  4. Cot M. Intermittent treatment for the prevention of malaria during pregnancy in Benin : a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine. 57th Ann Meet Am Soc Trop Med Hyg, 2008, Nouvelle Orléans, USA.

C-ACTI IRD UR10, 2007-2009

  1. Briand V, Bottero J, Massougbodji A, Cot M. Spontaneous postpartum clearance of Plasmodium falciparum in Beninese women. 57th Ann Meet Am Soc Trop Med Hyg, 2008, Nouvelle Orléans. Am J Trop Med Hyg, 2008, 79:S62
  2. Lokossou AG, Vigan-Womas I, Guillotte M, Mercereau-Puijalon O, Migot-Nabias F. Naturally acquired antibodies to the VarO variant from falciparum PfEMP1 protein in Beninese children. Xth European Multicolloquium of Parasitology (EMOP), 2008, Paris, France.
  3. Guitard J, Tuikue Ndam T, Deloron P. Follow up of Plasmodium falciparum genotype and anti-VAR2CSA immune response during pregnancy in Senegal. Xth European Multicolloquium of Parasitology, 2008, Paris
  4. Cot M, Briand V. A trial on mefloquine for the intermittent preventive treatment of malaria in pregnancy in Benin. 57th Ann Meet Am Soc Trop Med Hyg, 2008, New Orleans, LA, USA. In: Am J Trop Med Hyg, 2008, 79
  5. Faucher JF, Aubouy A, Adeothy A, Doritchamou J, Kossou H, Lameyre V, Amedome H, Massougbodji A, Cot M, Deloron P. Sulfadoxine-pyrimethamine versus unsupervised artemether-lumefantrine versus unsupervised amodiaquine-artesunate coformulation for uncomplicated falciparum malaria in Beninese children: a randomized effectiveness non-inferiority trial. 57th Ann Meet Am Soc Trop Med Hyg, 2008, New Orleans, LA, USA. In: Am J Trop Med Hyg, 2008, 79:350.
  6. Faucher JF, Houzé P, Gourmel B, Wong J, Lameyre V, Deloron P. Compliance to unsupervised ACTs in yound Beninese children: data from a randomised trial comparing artemether-lumefantrine to amodiaquine-artesunate fixed-dose formulations. 57th Ann Meet Am Soc Trop Med Hyg, 2008, New Orleans, LA, USA. In: Am J Trop Med Hyg, 2008, 79:23.
  7. Magistrado P, Salanti A, John D, Tuikue Ndam NG, Mwakalinga SB, Resende M, Dahlbäck M, Lusingu J, Theander TG, Nielsen MA. Assessment of the ability of antibody reagents with specificity against VAR2CSA to recognize the surface of infected erythrocytes from pregnant women. 57th Ann Meet Am Soc Trop Med Hyg, 2008, New Orleans, LA, USA
  8. Chippaux JP. Ethical issues regarding prevention trials. Internationl Workshop on Ethics of health research in resource-poor countries, 2007, Paris. In: Bull Soc Pathol Exot, 2008, 101:85-89
  9. Barry AE,Smith TA, Chen D, Sytek AL, Imrie H, Tavul L, Migot-Nabias F, Brown SM, Deloron P, Daily J, Marsh K, McVean G, Day KP. Geographic population structure of the immune evasion (var) genes of Plasmodium falciparum. Molecular Approaches to Malaria Meeting, 2008, Lorne, Australia. In: Intl J Parasitol, 2008, 38:S38-S39.

C-ACTN

  1. Chippaux JP. Incidence et mortalité par animaux venimeux dans les pays tropicaux. 15ème Actualités du Pharo, 2008, Marseille, France. Méd Trop, 2008, 68:334-339.
  2. Chippaux JP. Les sérums aujourd’hui et demain. 15ème Actualités du Pharo, 2008, Marseille, France. Méd Trop, 2008, 68:395.
  3. Guyavarch E, Pison G, Duthé G, Marra A, Chippaux JP. La mortalité violente en Afrique : niveaux et causes dans trois régions rurales du Sénégal. Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S295.
  4. Briand V, Bottero J, Noel H, Masse V, Cordel H, Guerra J, Fayomi B, Kossou H, Ayemonna P, Fievet N, Massougbodji A, Cot M. Traitement préventif intermittent pour la lutte contre le paludisme au cours de la grossesse : essai d’équivalence, randomisé, ouvert, comparant sulfadoxine-pyriméthamine et méfloquine. Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S268.
  5. Koura G, Briand V, Massougbodji A, Cot M, Garcia A. Intestinal helminthiasis in pregnant women: prevalence and impact on maternal anaemia. Congrès de l’association des epidémiologistes de langue française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S308.
  6. Le Port A, Garcia A, Watier L, Migot-Nabias F, Dechavanne C, Cot M. Survenue des premières infections palustres chez le nouveau né : présentation générale de l’étude. Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S308.
  7. Munier A, Diallo A, Chippaux JP. Evolution de la morbidité palustre et des traitements antipaludiques prescrits dans les postes de santé, zone d’étude de Niakhar, Sénégal (1992-2004). Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S268.

C-ACTN

  1. Chippaux JP. Incidence et mortalité par animaux venimeux dans les pays tropicaux. 15ème Actualités du Pharo, 2008, Marseille, France. Méd Trop, 2008, 68:334-339.
  2. Chippaux JP. Les sérums aujourd’hui et demain. 15ème Actualités du Pharo, 2008, Marseille, France. Méd Trop, 2008, 68:395.
  3. Guyavarch E, Pison G, Duthé G, Marra A, Chippaux JP. La mortalité violente en Afrique : niveaux et causes dans trois régions rurales du Sénégal. Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S295.
  4. Briand V, Bottero J, Noel H, Masse V, Cordel H, Guerra J, Fayomi B, Kossou H, Ayemonna P, Fievet N, Massougbodji A, Cot M. Traitement préventif intermittent pour la lutte contre le paludisme au cours de la grossesse : essai d’équivalence, randomisé, ouvert, comparant sulfadoxine-pyriméthamine et méfloquine. Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S268.
  5. Koura G, Briand V, Massougbodji A, Cot M, Garcia A. Intestinal helminthiasis in pregnant women: prevalence and impact on maternal anaemia. Congrès de l’association des epidémiologistes de langue française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S308.
  6. Le Port A, Garcia A, Watier L, Migot-Nabias F, Dechavanne C, Cot M. Survenue des premières infections palustres chez le nouveau né : présentation générale de l’étude. Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S308.
  7. Munier A, Diallo A, Chippaux JP. Evolution de la morbidité palustre et des traitements antipaludiques prescrits dans les postes de santé, zone d’étude de Niakhar, Sénégal (1992-2004). Congrès de l’Association Des Epidémiologistes de Langue Française, 2008, Paris, France. Rev Epidémiol Santé Pub, 2008, 56:S268.

C-COM divers chercheurs avant leur intégration à l’UMR 216

  1. Sabbagh A. Evaluation de la part des facteurs génétiques dans la variabilité d’expression de la neurofibromatose de type 1. Journées dermatologiques de Paris, 2008, Paris, France.
  2. Sabbagh A. Etude du rôle du gène RNF135 dans l’excès de croissance observé chez des patients atteints de neurofibromatose de type 1. 4èmes assises de génétique humaine et médicale, 2008, Lille, France.
  3. Sabbagh A. Contribution of genetic factors to the variable expressivity of neurofibromatosis type 1. 13th Annual European Neurofibromatosis Meeting, Novembre 2008, Killarney, Irlande.

C-AFF

  1. Vincent L, Chippaux JP. Impact du changement climatique sur l’évolutiuon de la dengue en Amérique latine. Journées de l’Ecole doctorale de Santé Publique de Paris 6, 2008, Saint-Malo, France.
  2. Munier A, Diallo A, Ndiaye O, Arduin P, Cot M, Chippaux JP. Morbidité attribuable au paludisme et évolution des prescriptions d’antipaludiques après l’emmergence de la chloroquinorésistance dans la zone d’étude de Niakhar, au Sénégal (1992-2204). Journées de l’Ecole doctorale de Santé Publique de Paris 6, 2008, Saint-Malo, France.
  3. Chippaux JP. Clinical assessment of antivenoms. WHO Regional Workshop on production, control, and regulation of antivenoms, 2008, Addis Ababa, Ethiopia.
  4. Chippaux JP, Brutus L. La enfermedad de Chagas congénita : diagnóstico y tratamiento en regiones con elevada prevalencia de Cruzi. Coloquio franco-mexicano sobre enfermedades infecciosas, 2008, Veracruz, Mexique.
  5. Brutus L, Chippaux JP. Investigacion centrada en el paciente. Tratamiento de la enfermedad de Chagas en el niño: necessidad de nuevos ensayos clinicos. Coloquio franco-mexicano sobre enfermedades infecciosas, 2008, Veracruz, Mexique.
  6. Chippaux JP. Clinical assessment of antivenoms: history and present situation. Global issue in Clinical Toxinology, 2008, Melbourne, Australie.
  7. Barry AE, Smith TA, Chen D, Sytek AL, Imrie H, Tavul L, Migot-Nabias F, Brown SM, Deloron P, Daily J, Marsh K, McVean G, Day KP. Geographic population structure of the immune evasion (var) genes of Plasmodium falciparum. 3rd Molecular Approaches to Malaria Meeting (MAM 2008), 2008, Lorne, Australie.
  8. Guitard J, Cottrell G, Moulopo Magnouha N, Salanti A, Li T, Sow S, Deloron P, Tuikue Ndam N. Longitudinal study of Plasmodium falciparum infection during pregnancy in Senegal. Keystone Symposium – Malaria immunology, pathogenesis and vaccine perspectives, 2008, Alpbach, Austria.
  9. Houzé S, Loiseau PM, Haouchine D, Lariven S, Cojean S, Michard F, Bories C, Izri A, Pratlong F, Le Bras J, Matheron S. Echec de la miltéfosine dans le traitement préventif des rechutes de leishmaniose viscérale : données cliniques et in vitro chez un patient co-infecté par le VIH. 28ème RICAI, 2008, Paris.
  10. Houzé S, Souletie I, Le Bras J, Houze P. Simultaneous determination of monodesethylchloriquine, chloroquine, cycloguanil and proguanil on dried blood spots by reverse-phase liquid chromatography. Xth European Multicolloquium of Parasitology, 2008, Paris.
  11. Houzé S, Dicko Boly M, Le Bras J, Deloron P, Faucher JF. PfHRP2 and pLDH antigens detection for monitoring artemisinin-based combination therapy (ACT) efficacy in uncomplicated falciparum malaria in Benin. Xth European Multicolloquium of Parasitology, 2008, Paris.
  12. Tuikue Ndam N, Bischoff E, Proux C, Lavstsen T, Salanti A, Guitard J, Nielsen M.A, Coppée JY, Gaye A, Theander T, David P, Deloron P. Plasmodium falciparum transcriptome analysis reveals pregnancy malaria associated gene expression. Keystone Symposium – Malaria immunology, pathogenesis and vaccine perspectives, 2008, Alpbach, Austria.

C-AFF divers chercheurs avant leur intégration à l’UMR 216

  1. Pasmant E, Sabbagh A, Masliah J, Parfait B, Wolkenstein P, Vidaud D, Vidaud M : Réseau NF France. Etude du rôle du gène SPRED1 chez des patients présentant un phénotype apparenté à la neurofibromatose de type 1. 4èmes assises de Génétique Humaine et Médicale, 2008, Lille, France.
  2. Sabbagh A, Vidaud D, Vidaud M, Valeyrie-Allanore L, Ferkal S, Wolkenstein P : Réseau NF France. Evaluation de la part des facteurs génétiques dans la variabilité d’expression de la neurofibromatose de type 1. 4èmes assises de Génétique Humaine et Médicale, 2008, Lille, France.
  3. Sabbagh A, Parfait B, Hamel MJ, Wolkenstein P, Vidaud M, Vidaud D : Réseau NF France. Corrélation génotype-phénotype chez les patients NF1 microdélétés. 4èmes assises de Génétique Humaine et Médicale, 2008, Lille, France.

OS UMR216

  1. WHO Technical Expert Group Meeting on Intermittent Preventive Treatment in Pregnancy (IPTp), dont COT M (14 p.). WHO headquarters, Geneva, 2008
  2. Chippaux JP. Envenimations par serpents et premiers soins. In: Reptiles du Gabon, Pauwels O. S. G, Vande weghe JP.Smithsonian Institution Washington, 2008:241-245.
  3. Chippaux JP. Préface. In: Démarche qualité et norme ISO 9001. Une culture managériale appliquée à la recherche, E. Giesen, IRD Paris, coll. Didactiques, 2008:7-11.

OS divers chercheurs avant leur intégration à l’UMR 216

  1. Le Loup G, de Assis A, Costa-Couto MH et al. The Brazilian experience of scaling up: a public policy approach. in Coriat B et al. The Political economy of HIV/AIDS in developing countries. Northampton: Edward Elgar Publishing, 2008

PV

  1. Chippaux JP. Pénurie de sérum antivenimeux dans les pays en développement. Biofutur, 2008, 290:
  2. Goyffon M, Chippaux JP. La découverte du sérum antivenimeux. Biofutur, 2008, 292:32-35.
  3. Chippaux JP. Les sérums antivenimeux aujourd’hui:préparation, utilisation. Biofutur, 2008, 292:36-39.
  4. Chippaux JP. La crise actuelle de la sérothérapie et ses solutions. Biofutur, 2008, 292:45-48.

PV divers chercheurs avant leur intégration à l’UMR 216

  1. Le Loup G, Malvy D. Hyperéosinophilie. In: Collège des enseignants de maladies infectieuses et tropicales. E Pilly 22ème édition. Paris : Vivactis Plus, 2009.
  2. Malvy D, Le Loup G. Trypanosomoses. In: Collège des enseignants de maladies infectieuses et tropicales. E Pilly 22ème édition. Paris : Vivactis Plus, 2009.

ACL

  1. Stock RP, Massougbodji A, Alagon A, Chippaux JP. Bringing antivenoms to Sub-Saharan Africa. Nat Biotechnol, 2007, 25:173-7.
  2. Cottrell G, Briand V, Cot M. Interest and limits of cohort studies in pregnant women. Lancet Infect Dis, 2007, 7:763-4.
  3. Barry AE, Leliwa-Sytek A, Tavul L, Imrie H, Migot-Nabias F, Brown SM, McVean GAV, Day KP. Population genomics of the immune evasion (var) genes of Plasmodium falciparum. PLoS Pathog, 2007, 3:e34.
  4. Aubouy A, Fievet N, Bertin G, Sagbo JC, Kossou H, Kinde-Gazard D, Kiniffo R, Massougbodji A, Deloron P. Dramatic decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine in southern Benin: mefloquine, an alternative? Trop Med Int Health, 2007, 12:886-94.
  5. Chippaux JP. [Venomous and poisonous animals. III. Elapidae snake envenomation] Med Trop, 2007, 67:9-12.
  6. Courtin D, Garcia A. Trypanosomose humaine africaine: implication de la génétique de l’hôte. Med Trop, 2007, 67:131-3.
  7. Aubouy A, Migot-Nabias F, Deloron P. Correlation between treatment outcome and both anti-MSP119 antibody response and erythrocyte-related genetic factors in Plasmodium falciparum Infect Genet Evol, 2007, 7:147-54.
  8. Chippaux JP, Diallo A, Marra A, Etard JF. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal. Vaccine, 2007, 25:1712-8.
  9. Denoeud L, Fievet N, Aubouy A, Ayemonna P, Kiniffo R, Massougbodji A, Cot M. Is chloroquine chemoprophylaxis still effective to prevent low birth weight? Results of a study in Benin. Malar J, 2007, 6:27.
  10. Badaut C, Faure G, Tuikue Ndam NG, Bertin G, Chaffotte, Klinkert MQ, Deloron P, Bentley G. Receptor-binding studies of the DBLg domain of Plasmodium falciparum Erythrocyte Membrane Protein 1 from a placental isolate. Mol Biochem Parasitol, 2007, 151:89-99.
  11. Briand V, Cottrell G, Massougbodji A, Cot M. Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas. Malar J, 2007, 6:160.
  12. Brutus L, Watier L, Hanitrasoamampionona V, Razanatsoarilala H, Cot M. Confirmation of the protective effect of Ascaris lumbricoides on Plasmodium falciparum infection: results of a randomized trial in Madagascar. Am J Trop Med Hyg, 2007, 77:1091-5.
  13. Brutus L, Schneider D, Postigo J, Delgado W, Molinedo S, Chippaux JP. Evidence of congenital transmission of Trypanosoma cruzi in a vector-free area of Bolivia. Trans R Soc Trop Med Hyg, 2007, 101:1159-60.
  14. Chippaux JP, Massougbodji A, Stock RP, Alagon A, the investigators of African Antivipmyn® in Benin. Clinical trial of an F(ab’)2 polyvalent equine antivenom for African snake bites in Benin. Am J Trop Med Hyg, 2007, 77:538-46.
  15. Chippaux JP, Ramos-Cerrillo B, Stock RP. Study of the efficacy of the black stone on envenomation by snakebite in the murine model. Toxicon, 2007, 49:717-20.
  16. Cottrell G, Mary J.Y, Barro D, Cot M. The importance of the period of malarial infection during pregnancy on birth weight in tropical Africa. Am J Trop Med Hyg, 2007, 76:849-54.
  17. Courtin D, Milet J, Jamonneau V, Sese Yeminanga C, Kande Betu Kumeso V, Miaka Mia Bilengue C, Betard C, Garcia A. Association between human African trypanosomiasis and the IL6 gene in a Congolese population. Infect Genet Evol, 2007, 7:60-8.
  18. Diouf I, Fievet N, Doucouré S, Ngom M, Gaye A, Andrieu M, Mathieu JF, Gaye A, Thiom Thiaw O, Deloron P. IL-12 producing monocytes and IFN-g and TNF-a producing T-lymphocytes are increased in placenta infected by Plasmodium falciparum. J Reprod Immunol, 2007, 74:152-62.
  19. Maïga O, Djimdé AA, Hubert V, Renard E, Aubouy A, Kironde F, Nsimba B, Koram K, Doumbo OK, Le Bras J, Clain J. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis, 2007, 196:165-72.
  20. Briand V, Bouchaud O, Touret J, Behr C, Abgrall S, Ralaimazava P, Le Bras J, Fontanet A. Hospitalisation criteria in imported falciparum malaria. J Travel Med, 2007, 14:306-11.
  21. Khattab A, Chia YS, May J, Le Hesran JY, Deloron P, Klinkert MQ. The impact of IgG antibodies to recombinant Plasmodium falciparum 732var CIDR-1alpha domain in mothers and their newborn babies. Parasitol Res, 2007, 101:767-74.
  22. Labbo R, Djibrilla A, Zamanka H, Garba A, Chippaux JP. Bulinus forskalii: a new potential intermediate host for Schistosoma haematobium in Niger. Trans R Soc Trop Med Hyg, 2007, 101:847-8.
  23. Poinsignon A, Cornelie S, Remoue F, Grebaut P, Courtin D, Garcia A, Simondon F. Human/vector relationships during human african trypanosomiasis: initial screening of immunogenic salivary proteins of glossina species. Am J Trop Med Hyg, 2007, 76:327-33.
  24. Salas NA, Cot M, Schneider D, Mendoza B, Santalla JA, Postigo J, Chippaux JP, Brutus L. Risk factors and consequences of congenital Chagas disease in Yacuiba, South Bolivia. Trop Med Int Health, 2007, 12:1498-505.
  25. Tournel G, Cauffiez C, Leclerc J, Billaut-Laden I, Allorge D, Chevalier D, Migot-Nabias F, Kenani A, Broly F, Lo-Guidice JM. CYP2F1 genetic polymorphism: Identification of interethnic variations. Xenobiotica, 2007, 37:1433-8.
  26. Tuikue Ndam N, Deloron P. Molecular aspects of Plasmodium falciparum infection during pregnancy. J Biomed Biotechnol, 2007, article ID43785.
  27. Virreira M, Truyens C, Alonso-Vega C, Brutus L, Jijena J, Torrico F, Carlier Y, Svoboda M. Comparison of Trypanosoma cruzi lineages and levels of parasitic DNA in infected mothers and their newborns. Am J Trop Med Hyg, 2007, 77:102-6.
  28. Labbo R, Boulanger D, Bremond P, Chippaux JP. [Experimental infection of goats with Schistosoma bovis and curassoni: compared medical impacts]. Parasite. 2007, 14:77-82.
  29. Baxerres C, Le Hesran JY. Le marché parallèle du médicament en milieu rural au Sénégal, les atouts d’une offre de soins populaire. In La Culture Sensible, Anthropologie et Sociétés, 2007, 30:219-30.
  30. Chippaux JP, Diedhiou I, Stock R. Etude de l’action de la Pierre noire sur l’envenimation expérimentale. Cahiers Santé, 2007, 17:127-31.
  31. Briand V, Bonmarin I, Levy-Bruhl D. Study of the risk factors for severe childhood pertussis based on hospital surveillance data. Vaccine, 2007, 25:7224-32
  32. Durand R, Le Bras J, Bouchaud O. [Is chloroquine back?]. Rev Prat, 2007, 57:1513-5.
  33. Legros F, Bouchaud O, Ancelle T, Arnaud A, Cojean S, Le Bras J, Danis M, Fontanet A, Durand R, for the French national reference centers for imported and autochthonous malaria epidemiology and chemosensitivity network. Risk factors for imported fatal Plasmodium falciparum malaria, France, 1996-2003. Emerg Infect Dis, 2007, 13:883-8.
  34. Houzé S, Munier A, Paoletti X, Kaddouri H, Ringwald P, Le Bras J. Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessment. J Clin Microbiol 2007, 45:2734-6.
  35. Noranate N, Durand R, Tall A, Marrama L, Spiegel A, Sokhna C, Pradines B, Cojean S, Guillotte M, Bischoff E, Ekala MT, Bouchier C, Fandeur T, Ariey F, Patarapotikul J, Le Bras J, Trape JF, Rogier C, Mercereau-Puijalon O. Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One, 2007, 2:e139.
  36. Musset L, Le Bras J, Clain J. Parallel evolution of adaptive mutations in Plasmodium falciparum mitochondrial DNA during atovaquone-proguanil treatment. Mol Biol Evol 2007, 24:1582-5.
  37. Hinzpeter A, Fritsch J, Borot F, Trudel S, Vieu DL, Brouillard F, Baudouin-Legros M, Clain J, Edelman A, Ollero M. Membrane cholesterol content modulates ClC-2 gating and sensitivity to oxidative stress. J Biol Chem 2007, 282:2423-32.
  38. Bacon DJ, Jambou R, Fandeur T, Le Bras J, Wongsrichanalai C, Fukuda MM, Ringwald P, Sibley CH, Kyle DE. World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility. Malar J, 2007, 6:120.
  39. Loiseau PM, Le Bras J. [New drugs against parasitic diseases]. Rev Prat, 2007, 57:175-82.

ACL divers chercheurs avant leur intégration à l’UMR 216

  1. Chaillet N, Dumont A. Evidence-based strategies for reducing cesarean section rates: a meta-analysis. Birth, 2007, 34:53-64.
  2. Chaillet N, Dubé E, Dugas M, Francoeur D, Dubé J, Gagnon S, Poitras L, Dumont A. Identifying barriers and facilitators towards implementing guidelines to reduce caesarean section rates in Quebec. Bull World Health Organ, 2007, 85:791-7.
  3. Mahé A, Perret JL, Ly F, Fall F, Rault JB, Dumont A. The cosmetic use of skin-lightening products during pregnancy in Dakar, Senegal: a common and potentially hazardous practice. Trans R Soc Trop Med Hyg, 2007, 101:183-7.
  4. Lavazec C, Boudin C, Lacroix R, Bonnet S, Diop A, Thiberge S, Boisson B, Tahar R, Bourgouin C. Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium transmission blocking vaccine. Infect Immun, 2007, 75:1635-42.
  5. Tahar R, Basco LK. Molecular epidemiology of malaria in Cameroon. XXVI. Twelve-year in vitro and molecular surveillance of pyrimethamine resistance and experimental studies to modulate pyrimethamine. Am J Trop Med Hyg, 2007, 77:221-7.
  6. Tahar R, Ferreira C, Basco LK. Surveillance de la résistance de Plasmodium falciparum à la sulfadoxine-pyriméthamine par le test moléculaire à São Tomé-et-Príncipe. Bull Soc Pathol Exot, 2007, 100:2 pp :
  7. Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under-five year old in Brazzaville, Congo. Trop Med Int Health, 2007, 12:1164-71.
  8. Ndounga M, Mayengue PI, Tahar R, Casimiro PN, Matondo Maya DW, Miakassissa-Mpassi V, Malonga DA, Nsonde-Ntandou F, Mallanda G, Ringwald P, Basco LK, Ntoumi F. Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine-amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo). Acta Trop, 2007, 103:163-71.
  9. Broen K, Brustoski K, Engelmann I, Luty AJF. Placental Plasmodium falciparum infection: causes and consequences of in utero sensitization to parasite antigens. Mol Biochem Parasitol, 2007, 151:1-8.
  10. Heppner DG, Schwenk RJ, Arnot D, Sauerwein RW, Luty AJF. The dog that did not bark: malaria vaccines without antibodies. Trends Parasitol, 2007, 23:293-6.
  11. Bodeau-Livinec F, Surman G, Kaminski M, Wilkinson AR, Ancel PY, Kurinczuk JJ. Recent trends in visual impairment and blindness in the UK. Arch Dis Child, 2007, 92:1099-104.
  12. Douradinha B, van Dijk MR, Ataide R, van Gemert GJ, Thompson J, Mazier D, Luty AJF, Sauerwein R, Janse CJ, Waters AP, Mota MM. Genetically attenuated P36p-deficient Plasmodium berghei sporozoites confer long-lasting protection and partial cross-species immunity. Int J Parasitol, 2007, 37:1511-9.

ACLN

  1. Chippaux JP. Actualités sur les sérums antivenimeux et la sérothérapie. Bull Soc Herpétol Fr, 2007, 123:81-8.
  2. Chippaux JP. Epidémiologie des envenimations. Bull Soc Herpétol Fr 2007, 123:67-79.
  3. Chippaux JP, Pernot C, Jouanneau D, Ciornei G, Moulin-Esnart P, Couret D. Evaluation de la potabilité de l’eau dans une zone peuplée du sahel sénégalais : Niakhar. Environ Risques Santé, 2007, 6:373-81.
  4. Sabbagh A, Langaney A, Darlu P, Poloni ES. Haplotype tagging efficiency and tagSNP sets portability in worldwide populations in NAT2 gene. Bulletins et Mémoires de la Société d’Anthropologie de Paris. 2007, 19:233-40.

C-INV

  1. Briand V. Traitement préventif intermittent chez la femme enceinte infectée par le VIH. 2èmes rencontres Nord-Sud, Palais de l’Unesco, 2007, Paris, France.
  2. Briand V, Cot M. Interactions VIH et paludisme pendant la grossesse. 2èmes rencontres Nord-Sud, Palais de l’Unesco, 2007, Paris, France.
  3. Girard PM, Cot M. Interactions VIH et paludisme, table ronde. 2èmes rencontres Nord-Sud, Palais de l’Unesco, 2007, Paris, France.
  4. Deloron P. Pregnancy-associated malaria: scientific overview. EDCTP Stakeholder meeting « malaria and pregnancy », 2007, Vienne, Autriche.

C-INV divers chercheurs avant leur intégration à l’UMR 216

  1. Sabbagh A. Identifying variants associated with variable drug response in the human genome. Indo-French (CEFIPRA) Symposium on “Pharmacogenomics: concepts, technology, clinical relevance and ethical aspects”, 2007, Kochi, Inde.

C-ACTI IRD UR10, 2007-2009

  1. Sosa-Estani S, Buekens P, Alger J, Alamendares O, Althabe F, Amador D, Belizan J, Bergel E, Cafferata M. L, Del Cid J, Dumonteil E, Gamboa-Leon R, Gibbons L, Giron L, James M, Chippaux JP, Padilla N, Pone C, Ponce E, Zuniga C. Multi-Site epidemiologic study of Chagas’ disease in pregnant women from four Latin American countries. 56th Ann Meet Am Soc Trop Med Hyg, 2007, Philadelphie, USA. Am J Trop Med Hyg, 2007, 77:
  2. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A. Relation between falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. 5th European Congress on Tropical Medicine and International Health, 2007, Amsterdam, Pays-Bas. In: Trop Med Intl Hlth, 2007, 12:231-2.
  3. Tuikue Ndam N, Le Hesran JY, Salanti A, Fievet N, Turner L, Theander T, Deloron P. Analyse de la réponse anti-VAR2CSA dans une cohorte de femmes enceintes du Sénégal. Congrès francophone d’Epidémiologie en milieu tropical, 2007, Ouidah, Bénin. in Bull Soc Path Exot, 2006, 99:

C-ACTI IRD UR10, 2007-2009

  1. Sosa-Estani S, Buekens P, Alger J, Alamendares O, Althabe F, Amador D, Belizan J, Bergel E, Cafferata M. L, Del Cid J, Dumonteil E, Gamboa-Leon R, Gibbons L, Giron L, James M, Chippaux JP, Padilla N, Pone C, Ponce E, Zuniga C. Multi-Site epidemiologic study of Chagas’ disease in pregnant women from four Latin American countries. 56th Ann Meet Am Soc Trop Med Hyg, 2007, Philadelphie, USA. Am J Trop Med Hyg, 2007, 77:
  2. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A. Relation between falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. 5th European Congress on Tropical Medicine and International Health, 2007, Amsterdam, Pays-Bas. In: Trop Med Intl Hlth, 2007, 12:231-2.

C-ACTI IRD UR10, 2007-2009

  1. Sosa-Estani S, Buekens P, Alger J, Alamendares O, Althabe F, Amador D, Belizan J, Bergel E, Cafferata M. L, Del Cid J, Dumonteil E, Gamboa-Leon R, Gibbons L, Giron L, James M, Chippaux JP, Padilla N, Pone C, Ponce E, Zuniga C. Multi-Site epidemiologic study of Chagas’ disease in pregnant women from four Latin American countries. 56th Ann Meet Am Soc Trop Med Hyg, 2007, Philadelphie, USA. Am J Trop Med Hyg, 2007, 77:
  2. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A. Relation between falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. 5th European Congress on Tropical Medicine and International Health, 2007, Amsterdam, Pays-Bas. In: Trop Med Intl Hlth, 2007, 12:231-2.

C-ACTI IRD UR10, 2007-2009

  1. Sosa-Estani S, Buekens P, Alger J, Alamendares O, Althabe F, Amador D, Belizan J, Bergel E, Cafferata M. L, Del Cid J, Dumonteil E, Gamboa-Leon R, Gibbons L, Giron L, James M, Chippaux JP, Padilla N, Pone C, Ponce E, Zuniga C. Multi-Site epidemiologic study of Chagas’ disease in pregnant women from four Latin American countries. 56th Ann Meet Am Soc Trop Med Hyg, 2007, Philadelphie, USA. Am J Trop Med Hyg, 2007, 77:S226.
  2. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A. Relation between falciparum asymptomatic infection and malaria attacks in a cohort of Senegalese children. 5th European Congress on Tropical Medicine and International Health, 2007, Amsterdam, Pays-Bas. In: Trop Med Intl Hlth, 2007, 12:231-2.
  3. Courtin D, Bertin G, Milet J, Sarr JB, Vafa M, Troye-Bloomberg M, Deloron P, Garcia A, Migot-Nabias F. Host genetics-related evolution of the antibody responses to falciparum MSP-2 during the transmission season in Senegal. 5th European Congress on Tropical Medicine and International Health, 2007, Amsterdam, Pays-Bas. In: Trop Med Intl Hlth, 2007, 12:201.

C-COM

  1. Chippaux JP. Actualité et prise en charge des envenimations en Afrique. 3ème Conférence internationale sur les envenimations en Afrique, 2007, Brazzaville, Congo.
  2. Diedhiou I, Chippaux JP. Mesure de la neutralisation des venins de serpent par les sérums antivenimeux. 3ème Conférence internationale sur les envenimations en Afrique, 2007, Brazzaville, Congo.
  3. Houzé S, Dicko Boly M, Le Bras J, Deloron P, Faucher JF. Cinétique de négativité de deux TDR, l’Immunoquick® Malaria et l’Optimal® IT au cours du traitement par les ACT dans le paludisme à Plasmodium falciparum. Congrès de la Société Française de Parasitologie, 2007, Nice.
  4. Aubouy A, Doritchamou J, Ayivi B, Lalya F, Fanou-Alafia V, Goncalvès, Saizonou, Hounmenou, Massougbodji A, Deloron P. Caractérisation phénotypique des isolats de Plasmodium falciparum en fonction du statut clinique de l’infection palustre chez l’enfant au Bénin. Journée annuelle du paludisme, 2007, Cotonou, Bénin.
  5. Youatou G, Briand V, Ibitokou S, Kounou P, Vodounon J, Hounkonnou L, Perrin RX, Gangbo F, Massougbodji A, Deloron P, Fievet N. Prévalence de l’infection à Plasmodium falciparum chez les parturientes à l’Hôpital de la Mère et de l’Enfant Lagune (HOMEL). 9ème congrès de la Société de Gynécologie et d’Obstétrique du Bénin et du Togo, 2007, Lome, Togo.
  6. Briand V, Bottero J, Fievet N, Aubouy A, Migot-Nabias F, Fayomi B, Kossou H, Kiniffo R, Ayemonna P, Massougbodji A, Garcia A, Cot M. Traitement préventif intermittent pour la lutte contre le paludisme au cours de la grossesse : essai d’équivalence, randomisé, ouvert, comparant sulfadoxine-pyriméthamine et méfloquine. Congrès francophone d’épidémiologie en milieu tropical, 2007, Ouidah, Bénin.
  7. Courtin D, Bertin G, Milet J, Sarr JB, Deloron P, Garcia A, Migot-Nabias F. Réponse anticorps spécifique de falciparum au Sénégal : évolution au cours de la saison de transmission en relation avec la protection clinique. Congrès francophone d’épidémiologie en milieu tropical, 2007, Ouidah, Bénin.
  8. Watier L, Cot M, Garcia A. Détermination d’une variable de densité parasitaire individuelle à partir de données répétées de parasitémies palustres. Congrès francophone d’épidémiologie en milieu tropical. 2007, Ouidah, Bénin
  9. Cottrell G, Mary JY, Barro D, Cot M. Importance de l’infection par le paludisme pendant la grossesse sur le poids de naissance en Afrique intertropicale. Congrès francophone d’épidémiologie en milieu tropical. 2007, Ouidah, Bénin
  10. Denoeud L, Fievet N, Aubouy A, Ayemonna P, Kiniffo R, Massougbodji A, Cot M. Conséquences du paludisme gestationnel et efficacité de la prophylaxie hebdomadaire par la chloroquine au Sud Bénin. Congrès francophone d’épidémiologie en milieu tropical. 2007, Ouidah, Bénin
  11. Koffi M, Solano P, Courtin D, Garcia A, Cuny G, Jamonneau V. Diversité génétique de brucei s.l. et épidémiologie de la Trypanosomose Humaine Africaine, nouvelles perspectives. Congrès francophone d’épidémiologie en milieu tropical. 2007, Ouidah, Bénin
  12. Ernould JC, Garcia A. Réseau Epidémiologie et Développement (RED): un réseau pour le Nord et le Sud. Congrès francophone d’épidémiologie en milieu tropical. 2007, Ouidah, Bénin
  13. Baxerres C, Bonnet D, Tingbe Azalou A, Le Hesran JY. Automédication et paludisme à Cotonou : approche d’anthropologie sociale. Congrès francophone d’épidémiologie en milieu tropical, 2007, Ouidah, Bénin.
  14. Baxerres C. Usages et lieux d’achat des médicaments industriels à Cotonou. Automédication dans le secteur informel et prescription dans le secteur formel : logiques croisées et évolution des pratiques. 8ème Forum Pharmaceutique International, 2007, Lomé, Togo.
  15. Baxerres C, Bonnet D, Tingbe-Azalou A, Le Hesran JY. Le marché informel du médicament en Afrique francophone : raisons historiques de son émergence et perspectives contemporaines. Réflexions à partir d’une étude d’anthropologie sociale menée à Cotonou (Bénin). Colloque international économie informelle, travail au noir, enjeux économiques et sociaux, 2007, Université de Marne-la-Vallée, France.

C-COM divers chercheurs avant leur intégration à l’UMR 216

  1. Koucoi M, Dumont A. Analyse des indicateurs associés à la mortalité maternelle dans les maternités chirurgicales au Sénégal. 75ème Congrès de l’ACFAS. 2007, Université du Québec à Trois-Rivières, Québec, Canada.
  2. Sabbagh A. La diversité génétique mondiale de NAT2. XXVIIIème Colloque du Groupement des Anthropologistes de Langue Française (GALF 2007), 2007, Genève, Suisse.
  3. LaBossière F, Fournier P, Tourigny C, Sangaré K, Laplante O, Coulibaly D, Dumont A. Evaluating the impact of a referral system for obstetric emergencies on maternal mortality in rural Africa (Kayes, Mali). 11th World Congress on Public Health and 8th Brazilian Congress in Collective Health. 2007, Rio de Janeiro, Brazil.
  4. Koucoi M, Dumont A. Hatem M. Analyse des indicateurs associés à la mortalité maternelle dans les maternités chirurgicales du Sénégal, 19th IUHPE World Conference. 2007, Vancouver, Canada.
  5. Landry-Samoura A, Dumont A, Fournier P. Les audits de décès maternels en établissements : une analyse d’implantation dans cinq maternités pilote du Sénégal. Congrès francophone d’épidémiologie en milieu tropical. 2007, Ouidah, Bénin.

C-AFF

  1. Noukpo JM, Guitard E, Doritchamou J, Dugoujon JM, Migot-Nabias F. Distribution of Gm and Km immunoglobulin allotypes according to the clinical presentation of falciparum malaria in Beninese children. EMBO Conference “Genetics and mechanisms of susceptibility to infectious diseases”, 2007, Paris, France.
  2. Slaoui Y, Garcia A, Gaye O, Nuel G. A methodological approach to left censored parasite densities in malaria. Congrès European Molecular Biology Organization (EMBO), 2007, Paris.
  3. Nielsen MA, Magistrado P, Dahlback M, Lusingu J, Vestergaard L, Hviid L, Theander TG, Salanti A, Tuikue Ndam N. VAR2CSA expressed on the surface of placenta derived Plasmodium falciparum infected erythrocytes cryo-preserved in glycerolyte. Severe Malaria: Pathogenesis and Intervention Strategies. 2007, Karolinska Institutet, Stockholm, Sweden.
  4. Resende M, Sander A, Nielsen M, Dahlbäck M, Tuikue Ndam N, Theander T, Salanti A. Identification and characterization of A linear CSA binding region of the falciparum encoded placental sequestration ligand, VAR2CSA. Severe Malaria: Pathogenesis and Intervention Strategies. 2007, Karolinska Institutet, Stockholm, Sweden.
  5. Chippaux JP. Clinical manifestations and management of viper bites in Africa. Venom Week 2007, 2007, Tucson, USA.
  6. Chippaux JP. African antivenom shortage. Venom Week 2007, 2007, Tucson, USA.
  7. Chippaux JP. Clinical trial of Antivipmyn Africain®, a new polyspecific antivenom in the North of Benin. 9th Pan-American Conference of the International Society of Toxinology, 2007, Juriquilla, Querétaro, Mexico.
  8. Chippaux JP. Socio-economic cost of the envenomations in sub-Saharan Africa. Consultative Meeting “Rabies and Envenomings: A Neglected Public Health Issue”, 2007, Genève, OMS.
  9. Chippaux JP. Morsures de serpents dans les pays en développement : convergences épidémiologiques et thérapeutiques. 3ème Conférence Internationale sur les envenimations en Afrique, 2007, Brazzaville, Congo.
  10. Chippaux JP. Preliminary study on the incidence of snakebites in Bolivia. 9th Pan-American Conference of the International Society of Toxinology, 2007, Juriquilla, Querétaro, Mexico.
  11. Briand V, Massougbodji A, Kossou H, Fayomi B, Cot M. Prévention du paludisme pendant la grossesse : essai d’équivalence randomisé, comparant sulfadoxine-pyriméthamine versus méfloquine en traitement préventif intermittent. Journées de l’Ecole doctorale de Santé Publique de Paris 6, 2007, Saint-Malo, France.

C-AFF divers chercheurs avant leur intégration à l’UMR 216

  1. Al-Obaidly A, Sabbagh A, Krishnamoorthy R. Genetic polymorphic profile of Qatari population for fifteen autosomal microsatellite loci. Second Pan Arab human genetics conference, 2007, Dubai, Emirats arabes unis.
  2. Sabbagh A, Parfait B, Bellanné-Chantelot C, Pinson S, Wolkenstein P, Vidaud M, Vidaud D, Reseau NF France. Genotype-phenotype correlations in patients with NF1 microdeletions. 12th European Neurofibromatosis Meeting, 2007, Lisbonne, Portugal.
  3. Sabbagh A, Laurendeau I, Pasmant E, Wolkenstein P, Ferkal S, de Toma C, Bièche I, Vidaud D, Vidaud M. Neurofibromatosis type 1: identification of modifier genes and role of mutated and variants of normal NF1 alleles in the onset and evolution of neurofibromas. 12th European Neurofibromatosis Meeting, 2007, Lisbonne, Portugal.

OS UMR216

  1. Baxerres C. Accès aux médicaments en Afrique de l’Ouest: Le marché parallèle du médicament: Présentation et discussion à partir d’une étude réalisée en milieu rural sénégalais: Approche d’anthropologie sociale. In: Moine-Dupuis I ed.: Le médicament et la personne, aspects de droits international, Paris, 2007, LexisNexis Litec : 269-277.
  2. Franckel A, Lalou R, Delaunay V, Adjamagbo A, Faye S, Waïtzenegger F, Le Hesran JY. Paludisme chez l’enfant et recours aux soins en milieu rural sénégalais : approches croisées. In : Adjamagbo A, Msellati P, Vimard P.Santé de la reproduction et fécondité dans les pays du Sud : nouveaux contextes et nouveaux comportements. Louvain-la-Neuve (BEL) ; Marseille : Academia Bruylant ; LPED, 2007, p. 267-
  3. Chippaux JP, Robert V. Préface. In: Résistance des vecteurs du paludisme aux insecticides et utilisation des moustiquaires imprégnées, F. Darriet, IRD Paris, coll. Didactiques, 2007:7-21.

OS divers chercheurs avant leur intégration à l’UMR 216

  1. Ophorst OJE, Radošević K, Luty AJF, Goudsmit J, Havenga MJE. 2007. Recent progress in understanding parasite biology, pathology and disease in malaria: translation of fundamental knowledge into novel malaria vaccines. Research Advances in Virology 2, pp 15-46. R.M. Mohan (editorial executive). Kerala: Global Research Network.

PV

  1. Chippaux JP. La seconde émergence de la maladie de Chagas. Pour La Science, 2007, 356:31.
  2. Chippaux JP. Les venins du diagnostic. La Recherche, 2007, 408:50-52.
  3. Baxerres C. Le marché informel du médicament : une réalité méconnue par les habitants de Cotonou Le journal de Remed, 2007, 34:3-4.